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SUMMARY 
 
Intracellular pathogens rely to varying extents on cellular functions of the host cell for their own 
propagation. A number of bacteria have evolved strategies to invade human cells and to establish 
an intracellular niche, which often consists of a cellular compartment that is modified by the 
pathogen to its own benefit. To understand the infection strategies of such organisms and 
eventually design new medical interventions, knowledge on the host factors exploited by the 
pathogens is critical. To this end, the InfectX consortium attempts to decipher the human 
infectome for a number of bacterial and viral pathogens.  
In this framework, we study the zoonotic pathogen Brucella, which is able to invade phagocytic 
as well as non-phagocytic cells. The molecular mechanisms by which Brucella enters cells, 
evades lysosomal degradation, and finally replicates in an endoplasmic reticulum-like 
compartment, remain largely unknown.  
To identify host factors involved in these processes, genome-wide microscopy-based RNA 
interference (RNAi) screens of Brucella entry and replication in HeLa cells were performed. To 
assign the function of the hits from the genome-wide screen to either early or late stages of 
Brucella infection, a follow-up assay suitable for high-throughput screening of Brucella entry 
was established. Both screening protocols are described in detail in research article I.  
In-depth analysis of the genome-wide siRNA data generated within InfectX found that all screens 
including the one for Brucella infection show signs of miRNA-like off-target effects. Research 
article II focuses on the discovery and validation of this phenomenon in siRNAs screens and 
illustrates the potential of such an analysis to discover natural miRNAs and synthetic miRNA-
like molecules that regulate the process of study. These findings motivated the screening of a 
library of human miRNA mimics for their involvement in Brucella infection. We identified miR-
103 and miR-107 (miR-103/107), which strongly promote Brucella entry in non-phagocytic cells 
as presented in research article III. Interestingly, also the infection of other pathogens tested 
within InfectX was promoted by these miRNAs. Proteome and transcriptome analyses of cells 
with high levels of miR-103/107 indicated that this alters endocytic properties which manifested 
in reduced clathrin dependent uptake of transferrin in these cells. Furthermore, the abundance of 
several surface receptors required by different pathogens is increased. TGF-β receptor 2 showed 
elevated expression upon miR-103/107 transfection and independent experiments could confirm 
  Summary 
 
III 
 
that high levels of this transmembrane kinase promote Brucella infection.  
Having analyzed the full scale of off-target effects, we set out to determine a strategy to validate 
candidate genes of the genome-wide screens. We thus assayed a set of human kinases with a total 
of eleven individual siRNAs and one siRNA pool. Research article IV shows that the true 
discovery rate is directly proportional to the number of siRNAs tested and that siRNA pools tend 
to give more reliable results than individual siRNAs. As a consequence of these findings, we used 
six independent siRNAs and one siRNA pool for the validation of genes discovered in the 
primary screen with one pooled and five single siRNAs. This allowed the identification of several 
host cell pathways relevant for Brucella infection. Besides previously known functions, which 
include actin cytoskeleton remodeling or maturation of endocytic vesicles, also novel ones such 
as FGF and TGF-β signaling were found. While most of these networks were connected to 
Brucella entry into HeLa cells, we were also able to identify retrograde trafficking between 
endosomes and the Golgi apparatus to regulate a post-entry process as presented in research 
article IV.  
Altogether, the results of our studies presented here point out limitations as well as the potential 
of siRNA technology. If off-target effects are accounted for and experimental confirmation is 
applied carefully on identified factors, RNAi allows to successfully reveal genes and pathways 
hitherto unrelated to the mechanism of interest. Additionally, and if analyzed accordingly, off-
target effects also constitute a rich source of information for the discovery of miRNAs and 
miRNA-like molecules that regulate a certain process. Applied to the presented screens for 
human factors taking part in Brucella infection, this led to the description of miRNAs and several 
host pathways, which support pathogenicity. By that our results contribute to the expansion of the 
currently described infectome for this intracellular pathogen. 
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1 INTRODUCTION 
1.1 VESICULAR TRAFFICKING IN MAMMALIAN CELLS 
 
A fundamental difference between eukaryotic and prokaryotic life is the compartmentalization of 
the cytosol. Eukaryotic cells contain several membrane-enclosed compartments such as the 
nucleus, endoplasmic reticulum (ER), or mitochondria. These compartments are characterized by 
specific molecular compositions and chemical properties. In order to exchange material between 
these compartments, cells have evolved different mechanisms. Channels and pores selectively 
transport small molecules, bigger gates, such as the nuclear pore, can accommodate 
macromolecules, and specialized transport vesicles can shuttle large volumes of cargo between 
compartments. 
 
 
 
Figure 1. Vesicular budding and fusion. 1) Initiation of coat assembly. Inner layer of coat proteins (blue) binds to 
cargo and a membrane-associated small GTPase (e.g. Sar1) at a donor membrane. 2) Budding. Outer coat layer 
(green) assembles and forms the complete coat around the concentrated cargo. 3) Scission. Membrane between 
vesicle and donor membrane is severed to release the vesicle from the membrane. 4) Uncoating. Coat proteins are 
released from the vesicle by the action of several processes such as inactivation of the small GTPase. Coat proteins 
are reused on newly forming vesicles. 5) Tethering. Vesicle binds to the target membrane by interaction of a GTP 
bound Rab and a tethering factor. 6) Docking. The v- and t-SNARES assemble to a four-helix bundle pulling the 
vesicle closer to the membrane. 7) Fusion. The action of the SNARE complex promotes fusion of the vesicle and the 
target membrane. Soluble cargo is released into the acceptor compartment. Picture taken from (1). 
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Vesicular transport occurs by budding of vesicles from a donor compartment and subsequent 
fusion to an acceptor membrane (Figure 1). The concentration of selected cargo for transport and 
the bending of the membrane for budding are dependent on coat proteins. The correct targeting of 
the vesicle to the target membrane is determined by tethering and SNARE proteins. The latter 
also provide energy for fusion of the transport vesicle to the acceptor membrane. In order to 
maintain the integrity and identity of all compartments such as the ER, the Golgi apparatus, and 
the endo-lysosomal system, vesicular transport acts bidirectional to return membranes and 
resident proteins to their correct location (1). 
1.1.1 Compartments of vesicular trafficking 
The ER is a continuous membrane system which is connected to the nuclear membrane and forms 
tubular and cisternal structures. The rough ER is coated with ribosomes which translocate 
proteins dedicated to the secretory pathway into the lumen of the ER. These proteins encode a 
translocation signal in their N-terminus, which is recognized by the signal-recognition particle 
SRP as it emerges from the ribosome. The whole complex is then targeted to the translocon 
spanning the ER membrane and the protein is pushed into the lumen of the ER as it emerges from 
the ribosome (2). Membrane proteins are directly integrated into the ER membrane in a process 
which is believed to involve lateral escape of membrane spanning segments through the tranlocon 
(3). For the ER, luminal and membrane proteins are further distributed to lysosomes, Golgi 
apparatus, plasma membrane, or secreted to the extracellular space. The smooth ER is involved in 
the biosynthesis of lipids and steroids. Further functions of the ER include folding and 
modification of proteins, storage of calcium, and it serves as a source of membrane for the 
biogenesis of other organelles (4). 
The Golgi apparatus serves as a central hub where proteins are sorted and get directed to the ER, 
the plasma membrane, and other organelles such as lysosomes. Furthermore, it is the 
compartment where the majority of chemical modifications on proteins and lipids are conducted. 
Long carbohydrate chains are linked to proteins of the extracellular matrix, sugar moieties are 
added to lipids, and sulfotransferases add sulfates to sugar chains or directly to proteins. The 
Golgi forms stacks and can be divided in cis-, medial-, and trans-Golgi depending on specific 
sets of resident proteins. The cis-Golgi faces the ER from where it receives newly synthesized 
proteins while the trans-Golgi sorts incoming and outgoing proteins for their final destination (5, 
6). 
1 Introduction 
 
4 
 
Endosomes and lysosomes together form a highly dynamic network of vesicular structures that is 
scattered throughout the cell. Early endosomes are the first address for incoming vesicles from 
the plasma membrane and are involved in sorting their content; if the cargo is destined for 
degradation, early endosomes will mature to late endosomes and eventually lysosomes. This 
degradative compartment is equipped with hydrolytic enzymes and designed to break down 
virtually any biomolecule (7). 
 
1.1.2 Trafficking routes 
All vesicular compartments of the cell are highly interconnected by trafficking routes as 
illustrated in Figure 2. Among the best studied trafficking routes is the so called secretory 
pathway. It is used to transport proteins which are synthesized in the ER via the ERGIC, Golgi 
apparatus, and secretory granules to the plasma membrane or the extracellular space. The 
transport starts at so called ER exit sites (ERES) where cargo is recognized and locally 
concentrated by COPII coat components (8). The signal for export out of the ER is found on 
cytoplasmic domains of the cargo where they bind to a family of different COPII components 
which ensure the recognition of diverse signal sequences (1). The COPII coat mainly consists of 
the small GTPase Sar1 which together with Sec23 and Sec24 forms the inner layer, while Sec13 
and Sec31 form the outer layer (9). Cargo is then delivered to the ER-Golgi intermediate 
compartment (ERGIC) and from there to the Golgi. GTP hydrolysis of Sar1 initiates the 
destabilization of the COPII complex, which dissociates from the vesicle (10). This allows the 
vesicle to interact with the acceptor membranes where the SNARE of the vesicle (v-SNARE) 
interacts with the target SNARE (t-SNARE) to form a four-helix bundle (11) which assures target 
specificity and provides the energy for vesicle fusion (Figure 1). From the trans-Golgi, the cargo 
continues either to the plasma membrane or other organelles such as the lysosomes. For these 
transport steps other coat proteins, e.g. clathrin, are used instead of COPII (12).  
Retrograde transport from the Golgi apparatus back to the ER and intra-Golgi transport follow 
the same principle steps as COPII-mediated transport. Even though different proteins forming the 
coatomer (COPI complex) are used in the process, they share similar functions. Activation of the 
small GTPase Arf1 recruits the inner core components β-COP, γ-COP, δ-COP, and ζ-COP and 
the outer coat α-COP, β’-COP, and ε-COP (13). Similar to COPII, COPI also recognizes 
cytosolic signal sequences which bring back proteins to the ER (14).  
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Figure 2. Intracellular trafficking routes. Scheme illustrates trafficking between the endoplasmic reticulum (ER), 
ER to Golgi intermediate compartment (ERGIC), Golgi apparatus including the trans-Golgi network (TGN), endo-
lysosomal compartments, and the plasma membrane. The specific location of coat complexes is highlighted in color: 
COPI (red), COPII (blue), and clathrin (yellow). Transport pathways connecting the compartments are indicated by 
arrows. Picture taken from (1).  
 
 
While COPII and COPI coated vesicles regulate anterograde and retrograde transport between 
ER and Golgi, many other pathways regulate trafficking between the Golgi and the plasma 
membrane. Early endosomes are the main sorting station for incoming cargo that is taken up by a 
diverse set of endocytic processes (described in detail in chapter 1.1.3.). From early endosomes, 
cargo can take a number of different routes either leading to degradation in lysosomes or 
targeting to other compartments. Following the degradative pathways, endosomes undergo a 
process of maturation. They are initially characterized by the presence of the small GTPase Rab5 
which is exchanged for Rab7 during maturation to late endosomes (15). At the same time 
conversion of phosphatidylinositol-3-phosphate PtdIns(3)P to phosphatidylinositol-3,5-
bisphosphate (PtdIns(3,5)P2) occurs. Both events are crucial for maturation of the vesicle and 
ensure correct binding of effector proteins (7). The maturation process is also accompanied by 
gradual acidification of the vesicle by the action of the vesicular ATPase that supports ligand-
receptor dissociation or the activity of lysosomal proteases (16).  
In late endosomes, selected cargo is internalized in small vesicles leading to the formation of 
intraluminal vesicle (ILVs) by inward budding of membrane. This process is dependent on the 
function of the ESCRT complex (ESCRT-0, -I, -II, -III) which recognizes ubiquitin-tags on the 
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cytosolic domains of proteins (17). The selective internalization of the complete proteins and of 
lipids into the lumen of the late endosomes stops signaling of transmembrane receptors and 
promotes degradation of the content by hydrolytic enzymes (7).  
Certain endocytosed receptors such as the transferrin receptor (TfR) (18) are generally reused at 
the plasma membrane rather than degraded after internalization. Trafficking back to the plasma 
membrane either occurs via recycling endosomes or directly from early endosomes (19). Another 
important alternative route which deviates from the degradative pathway involves the retromer 
complex which connects endosomes to the trans-Golgi network. In mammalian cells, the 
retromer complex is composed of two functional subcomplexes: a trimer Vps26-Vps29-Vps35 
that is involved in cargo selection and is generally known as the cargo selective trimer (CST), and 
proteins from the sorting nexin (Snx) family (20). Vps35 is the core component of the trimer and 
has a direct role in cargo binding (21, 22) while Vps26 and Vps29 independently associating at 
either end. Different types of Snx are known to interact with the CST and depending on their 
composition are involved in retrograde trafficking from early or late endosomes (23). 
 
1.1.3 Endocytic processes 
A wide variety of mechanisms are known to be involved in the transport of cargo from the 
extracellular space to the inside of a cell by the help of vesicular transport (Figure 3). Some of 
these pathways are constitutive, while others are selectively triggered by binding of certain 
ligands to surface receptors. Endocytic pathways fulfill essential functions in cellular 
homeostasis, however, they are also exploited by toxins, viruses, and bacteria to enter cells. The 
specific nature of these interactions will be discussed in detail in chapter 1.2.2.  
 
Clathrin-mediated endocytosis 
The best studied pathway among all endocytic processes is clathrin-mediated endocytosis (CME). 
It depends on the formation of a clathrin cage around the vesicle and was discovered almost 40 
years ago (24). Owing to the use of different adapter proteins, this process is very versatile in 
terms of cargo which can be internalized. Many surface receptors such as epidermal growth 
factor receptor (EGFR) or transferrin receptor (TfR) are internalized by CME and thus the 
pathway is also referred to as receptor-mediated endocytosis (25). 
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The process is initiated by deformation of the plasma membrane to form a so called pit. It was 
traditionally thought that binding of the adaptor protein complex AP2 to cargo initiates this 
process, however, there is evidence that a class of membrane-bending proteins start the 
nucleation and membrane bending even before the adaptor is recruited (26, 27). These nucleation 
modules are thought to assemble at the plasma membrane solely due to binding to 
phosphatidylinositol-4,5-bisphosphates (PtdIns(4,5)P2) independent of the cargo. Only then, the 
adaptor complex AP2 together with adaptor proteins are recruited to the initial nucleation 
modules. After clathrin, AP2 is the most abundant component of clathrin coated vesicles and 
serves as a central hub during the formation of the vesicle. It interacts directly with PtdIns(4,5)P2 
and cargo (28, 29). AP2 then recruits clathrin triskelia from the cytosol. This helps to stabilize the 
growing pit and promotes membrane bending by organizing curvature effectors (30).  
Once the pit has fully matured, the neck of the vesicle must be pinched off to release it from the 
plasma membrane. This depends on the enzyme dynamin (31) which polymerizes around the 
neck of the vesicle. Dynamin undergoes a GTP hydrolysis driven conformational change which 
leads to membrane fission (32, 33). Once released from the membrane, the clathrin coat is 
released to the cytoplasm and can be recruited to other forming pits. The release of clathrin 
triskelia from the lattice is induced by the ATPase heat shock cognate 70 (HSC70) and its 
cofactor auxilin or GAK (34, 35).  
 
Macropinocytosis 
Macropinocytosis is a clathrin- and dynamin- independent pathway that mediates non-selective 
uptake of liquid phase. This process is generally induced by growth factor stimulation such as 
EGF (36) but some cell types such as antigen presenting cells are capable of constitutive 
macropinocytosis (37, 38). Hallmarks of macropinocytosis are the formation of large membrane 
ruffles on the plasma membrane (see Figure 3) and the folding back of lamellipodia on itself 
followed by fusion with the membrane. This leads to the uptake of large, irregular shaped 
vesicles between 0.2 μm and 5 μm in diameter (39). The process is dependent on actin 
remodeling and the activity of PI3 kinases (40), and small GTPases such as CDC42 (41).  
Interestingly, macropinocytosis was found to be induced in cells when alternative endocytic 
processes were inactivated. In HeLa cells and Drosophila haemocytes, inhibition of dynamin-
dependent processes induces macropinocytosis (42, 43). This indicates that cells compensate for 
the loss of certain endocytic routes by up-regulation of alternative pathways.  
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Figure 3. Endocytic pathways. Illustration of different endocytic pathways of eukaryotic cells. Large particles can 
be taken up by phagocytosis while fluid uptake is mediated by macropinocytosis. Both processes require actin 
remodeling and protrusions of the plasma membrane. The size of the vesicle that can be taken up is much larger 
compared to the other pathways. Clathrin mediated endocytosis requires the formation of a clathrin coat and dynamin 
for the scission. Caveolae are coated in caveolin instead of clathrin and also require dynamin for their release from 
the membrane.  Alternative pathways include clathrin- and dynamin- independent carriers (CLICs) which traffic 
through glycosyl phosphatidylinositol-anchored protein enriched early endosomal compartments (GEEC) before 
reaching early endosomes. Picture taken from (44). 
 
Phagocytosis 
In contrast to macropinocytosis, phagocytosis is a receptor mediated process that allows the 
uptake of large particles. Only some specialized cell types such as neutrophils, macrophages, and 
dendritic cells, are capable of this particular type of endocytosis. Phagocytosis allows the uptake 
of a vast range of foreign bodies including viruses, bacteria, or apoptotic cells and cell debris. It 
involves a variety of different receptors to interact with specific ligands which then trigger very 
distinct downstream signaling events. Some receptors directly recognize pathogen-associated 
molecular patterns (PAMPs) such as peptidoglycan. Others act indirectly by recognizing 
opsonized particles. Opsonins are soluble factors such as complement fragments (iC3b) or 
immunoglobulins (IgG) that recognize foreign bodies and mark them for phagocytosis (45). 
Immunoreceptors such as the Fcγ receptor on the surface of professional phagocytic cells can 
recognize these opsonins and clustering of the receptors induces phagocytosis (46). Even though 
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the receptors and underlying signaling pathways are very distinct, all lead to the formation of 
actin polymerization which induces the growth of pseudopodia around the particle and culminate 
in its engulfment and uptake. Like macropinocytosis, the process of actin polymerization is 
dependent on the activation of small GTPases such as Rac1 and CDC42 (47). (48). 
 
Clathrin-independent endocytosis 
Several less well defined pathways that neither require actin polymerization nor clathrin are 
known. Among those, caveolae with a distinct size between 60-80 nm are the best studied (49). 
Caveolae are characterized by the enrichment of caveolins which are integral membrane proteins. 
These are essential for caveolae formation (50) and responsible for membrane curvature (51). In 
addition, cavins, a class of cytoplasmic proteins, are involved in the process (52). While there are 
many differences between CME and caveolae, also caveolae depend on dynamin for budding of 
the vesicle (53). The biological role of caveolae is diverse and the process includes not only 
endocytosis but also other functions like lipid regulation, integrin signaling, or mechanosensing 
and protection of the plasma membrane (54).  
 
1.2 HOST-PATHOGEN INTERACTIONS 
Host-pathogen interaction is the interplay between one organism, acting as a host, and a second 
organism exploiting the resources of that host. This relationship is associated with a negative 
impact on host fitness and stands in contrast to other interspecies interactions such as 
commensalism or symbiosis. Host-pathogen interactions result in selective pressure on the host to 
minimize the burden inflicted by the pathogen. This has led to the evolution of diverse immune 
strategies to combat pathogens which, in turn, are forced to evolve countermeasures to ensure 
their survival. As an evolutionary concept, this arms race is known as the Red Queen hypothesis 
first used by Leigh van Valen in 1973 as an analogy to the novel “Alice’s Adventures in 
Wonderland” by Charles Lutwidge Dodgeson. It is based on the statement “Now, here, you see, it 
takes all the running you can do, to keep in the same place” “keep in the same place” can be 
interpreted as species survival and “running” as the process of adaptation. This metaphor aims to 
explain the extinction of species if they fail to adapt fast enough to changing conditions (55).  
Host-pathogen interactions are wide-spread throughout all branches of life. In the following I will 
focus on interactions involving mammalian hosts and viral or bacterial pathogens. From a 
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pathogen’s perspective, several constraints have shaped infection strategies. One such constraint 
is that the pathogen must ensure its own survival, which comes at a fitness cost for the host cell, 
while also minimizing those fitness costs in order to maintain its replicative niche. This is crucial 
on an evolutionary time scale in order to avoid the extinction of the host. Some pathogens cause 
acute infections, which have a high impact on the host for a short period of time, but allow for 
rapid pathogen proliferation and spread. Others cause chronic infections which generally have a 
lower impact on the host over a long period of time, but also results in slow pathogen replication.  
Examples of human pathogens that cause acute infections are Shigella, causing a food-borne 
disease associated with acute intestinal infections, or the influenza virus, which causes the flu 
(56, 57). These are generally accompanied by rapid onset of the disease and a high risk of spread 
to other individuals. Since the infection is generally self-limiting, the body is able to clear the 
disease within a few days. Chronic infections however, often will not cure without medical 
interventions and can remain unrecognized for years due to the absence of disease symptoms. 
Examples include Tuberculosis which persists in the lung of patients for decades or Eppstein-
Barr virus which causes mononucleosis (58, 59).  
 
1.2.1 Intracellular pathogens 
In contrast to viruses, which are fully dependent on host cell functions, bacteria show varying 
degrees of host-dependency. Some pathogenic bacteria do not invade host cells but rather adhere 
to cells and survive in body fluids enriched in nutrients. A second class of bacteria are obligate 
intracellular and, like viruses, fully depend on a host cell for replication. Finally, the third class 
includes facultative intracellular bacteria which invade host cells only when it is beneficial. In the 
following, I will give an overview of the different strategies employed by bacterial pathogens 
with a focus on the host-cell interaction.  
One of the advantages of an intracellular niche is the availability of metabolic resources. Obligate 
intracellular bacteria such as Mycobacterium leprae have lost many of their own catabolic 
pathways and take full advantage of metabolites of the host (60). While genome-reduction seems 
to be a general trend for intracellular pathogens, this can lead to a Muller’s ratchet phenomenon, 
where gradual accumulation of deleterious mutations ultimately leads to extinction (61). 
Facultative intracellular bacteria on the other hand generally maintain most of their catabolic 
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processes but take advantage of the rich resources of a cell. They survive outside of host cells and 
can be transmitted to susceptible hosts from environmental niches.  
Aside from favorable nutrient conditions, an intracellular niche also provides protection from 
immune functions such as the complement or antibodies. However, the intracellular niche is not 
devoid of threats to the intruder. Cells are equipped with a number of defense strategies that aim 
at the detection and destruction of foreign particles. These depend on the microenvironment of 
the pathogen with a major difference between a cytosolic and a vacuolar niche. A summary of the 
intracellular lifestyle of different bacterial pathogens is shown in Figure 4.  
 
Bacteria living in the cytosol 
A small number of bacteria are known to replicate within the cytosol, with Listeria 
monocytogenes (Listeria) and Shigella flexneri (Shigella) among the best studied. After invasion 
of the host cell these bacteria are enclosed within a vacuole that gradually acidifies along the 
endocytic pathway. Therefore, the first step for cytosolic bacteria is to escape from the vacuole. 
This process occurs rapidly after cell entry which allows bacteria to avoid contact with the 
microbicidal content of lysosomes (63, 64). Lysis of the vacuole is achieved by secretion of 
bacterial enzymes that attack the membrane. Listeria secretes listeriolysine O (LLO) (65) as well 
as type C phospholipases (66) which are highly regulated to protect the cell from damage that 
could be caused if wrong membranes were attacked (67). Many cytosolic bacteria use actin-based 
motility which allows cell-cell spreading (68). Pushing of the bacterium from one cell to the other 
subsequently requires lysis of a double-membrane to access the cytosol of a neighboring cell. 
Actin polymerization also protects bacteria from detection by the ubiquitin degradation system 
(69). Even though conditions in the cytosol are not as harsh as in lysosomes, the cytosolic 
environment also presents challenges. These include antimicrobial peptides (70) and, perhaps 
more importantly, immune receptors that recognize pathogen-associated molecular patterns 
(PAMPs). Examples are Nod-like receptors (NLRs) and Nod proteins that activate inflammatory 
responses to alarm the immune system (71). The host cell is able to recognize flagellin, 
components of bacterial secretion systems, dsDNA, and several other unique molecular patterns 
that reveal the presence of an intruder (72). 
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Figure 4. Intracellular pathogens. Illustration of entry mechanism and replicative niche of intracellular bacterial 
pathogens. Listeria monocytogenes (light brown) enters epithelial cells by a zipper mechanism induced by two 
internalins. It lyses the vacuolar membrane, replicates in the cytosol and performs actin-based motility. Chlamydia 
trachomatis (dark green) replicates in a compartment that intercepts membranes from the Golgi apparatus. Shigella 
flexneri (black) enters cells by a trigger mechanism induced by a type III secretion system (T3SS), lyses its 
membrane, replicates in the cytoplasm, and performs actin-based motility. Salmonella enterica (red) triggers entry by 
secretion of T3SS (SPI-1) secreted effectors and modulates its vacuole by a second T3SS (SPI-2) which induces the 
formation of membranous extensions. Brucella abortus (blue) replicates in an endoplasmic reticulum-derived 
compartment. Coxiella burnetii (light green) replicates in a lysosome-derived vacuole. Bartonella henselae (dark 
brown) enters endothelial cells as large aggregates in a process dependent on a type IV secretion system. 
Mycobacterium tuberculosis (yellow) block maturation of the phagosome in macrophages. Legionella pneumophila 
(orange) replicates in a vacuolar compartment containing endoplasmic reticulum markers. Picture taken from (62). 
 
Until now, it is not clear why only a few bacterial pathogens chose the host cytoplasm as a niche. 
There are conflicting data regarding the ability of bacteria that generally do not live in the 
cytoplasm to survive and replicate in this compartment if introduced synthetically. It was found 
that non-pathogenic Bacillus subtilis expressing LLO or Escherichia coli that are surface coated 
with LLO and express a Yersinia enterocolitica invasion were both able to replicate in the cytosol 
of cells (73, 74). However, among several species that were microinjected into the cytoplasm of 
host cells only those bacteria that naturally live in this environment were able to replicate (75). It 
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remains to be investigated whether the way of entering the host cell cytoplasm primes the cell or 
the bacteria for cytoplasmic viability. It is also unclear whether only a few bacterial species 
possess the capacity to lyse their vacuole or whether most species are better adapted to 
intravacuolar replication and thus actively prevent vacuolar escape.  
 
Bacteria in membranous compartments 
While bacteria that escape their vacuole do not face potential destruction by the phagolysosome, 
those that remain in a vacuole have evolved various strategies to avoid such a fate. This generally 
involves interference with the normal endocytic pathway in favor of the pathogen by secretion of 
bacterial factors.  
Organisms such as Mycobacterium tuberculosis or Salmonella block the maturation from early to 
late endosomes using phosphoinositide phosphatases (76, 77). These prevent the phosphorylation 
of phosphatidylinositols (PtdIns) which accompanies endosomal maturation. The lack of PtdInsP2 
and PtdInsP3, and a concomitant accumulation of PtdInsP, blocks the vacuoles in an early 
endosomal state. In the case of Salmonella, this is achieved by SopB in a type III secretion 
system (T3SS) dependent manner (78). In a later stage of infection, the Salmonella containing 
vacuole (SCV) is redirected to a perinuclear region in close proximity to the Golgi apparatus and 
induces the formation of membrane tubules. These structures are generated by the secreted 
effector SifA (79) and required for the maintenance of the SCV (80).  
Other bacteria also use the strategy of deviation from the normal endocytic pathway with varying 
degrees of interaction with late endosomes. The Brucella containing vacuole (BCV) interacts 
with late endosomal markers such as Rab7 or Lamp1 (81). Acidification of the vacuole serves as 
a trigger for the expression of a type IV secretion system (T4SS) (82). Secretion of T4SS 
effectors are believe to be involved in redirecting the BCV to an ER-derived compartment, since 
T4SS-deficient mutants are degraded in lysosomes (83). Also Legionella replicates in an ER-
associated compartment and redirects its vacuole with the help of a T4SS which secretes over 200 
proteins with highly redundant functions into host cells (84).  
A radically different strategy is followed by Coxiella. Instead of avoiding trafficking to a 
lysosomal compartment, Coxiella has learned to survive and replicate in this hostile environment 
(85). Even though the pathogen can withstand harsh conditions, it is very active in reshaping its 
own vacuole (Coxiella containing vacuole, CCV) which starts very early after entering the cell. 
While normal endocytic cargo can reach the lysosomes within minutes, fusion of lysosomes with 
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the CCV takes two hours (86) and is accompanied by acquisition of autophagosomal structures 
(87).  
1.2.2 Cell invasion of pathogens 
All intracellular pathogens must reach the inside of a host cell. Even though it seems intuitive to 
directly penetrate the plasma membrane, very few organisms use this route. Examples that follow 
such an entry strategy include enveloped animal viruses such as HIV (88).  In this case the viral 
membrane fuses with the plasma membrane, directly releasing the viral content into the 
cytoplasm. However, this is the exception rather than the rule for intracellular pathogens. In most 
cases, an existing endocytic pathway is used to enter a cell. These include macropinocytosis, 
clathrin-mediated endocytosis (CME), caveolae, and clathrin- and caveolae-independent 
endocytosis. With the following examples I will illustrate how different bacterial and viral 
pathogens hijack these endocytic routes to gain access to the cell.  
 
Clathrin-mediated endocytosis 
The most common mechanism for viral entry is clathrin-mediated endocytosis. Here, the virus 
first binds to surface exposed receptors such as Integrins (Integrin αvβ3 and αvβ5) for 
Adenovirus 2 (89) or LDL-receptor for Rhinovirus (90) with the help of specific ligands exposed 
on the viral surface. Viruses can thus only bind to cells that express the corresponding ligands, 
which determine the tropism of a virus for certain cells. Binding leads to clustering of the 
receptors which induce intracellular signaling. A clathrin coated pit forms around the virus and 
leads to its uptake. Following CME, the coat falls off and the virus is enclosed in an endocytic 
vesicle. Depending on the size of the virus, this process requires actin remodeling to complete the 
internalization process (91).  
 
Zipper mechanism 
Bacteria also make use of clathrin for their uptake even though they are far larger than the normal 
size of a clathrin-coated vesicle of about 100 nm (92). Clathrin was shown to be involved in early 
entry steps of bacteria that enter by a so called zipper mechanism (93). To activate this process, 
bacterial surface structures interact with plasma membrane receptors on the surface of a host cell 
and induce signaling events that result in the endocytosis of the bacterium. The best studied 
organism using this type of invasion is Listeria monocytogenes. This gram-positive bacterium 
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expresses eight internalin proteins, of which Internalin A (InlA) and Internalin B (InlB) are well 
characterized and involved in bacterial entry. InlA binds the cell-cell adhesion molecule E-
cadherin (94) and InlB is a ligand for c-Met, the hepatocyte growth factor receptor (95). Binding 
of either receptor leads to activation of downstream signaling which, in turn, activates Rho 
GTPases and Arp2/3-dependent actin remodeling (96). A similar mechanism is used by Yersinia 
pseudotuberculosis which expresses the outer-membrane protein Invasin to interact with β1-
integrins (97). Integrins usually bind to extracellular matrix components like fibronectin and are 
implicated in cell adherence (98). Invasin induces integrin clustering and downstream signaling 
which activates the Arp2/3 complex leading to actin rearrangement and bacterial uptake (99). 
 
Trigger mechanism 
While, in the zipper mechanism, the plasma membrane wraps around the bacteria until they are 
internalized, the so called trigger mechanism induces large, actin-rich membrane ruffles on the 
cell surface. These resemble macropinosomes and can be induced by different viral and bacterial 
pathogens. One example is Salmonella which is able to utilize this mode of entry via the secretion 
of T3SS effectors. Salmonella first adhere to the cell surface with the fimbrial adhesin FimH and 
with the SPI-1 T3SS (100). SPI-1 is then used to translocate a cocktail of effectors that aim at 
remodeling the actin cytoskeleton. SopE and SopE2 are guanine nucleotide exchange factors that 
activate Cdc42 and Rac1 (101). SipC is part of the T3SS translocon required for effector 
translocation and directly involved in nucleation and bundling of actin (102). Formed actin fibers 
are then prevented from disassembly by the effector SipA that inhibits the depolymerizing factors 
cofilin and the severing factor gelsolin (103). The synergistic action of these effectors efficiently 
induces the uptake of bacteria into host cells.  
 
Invasome 
A very intriguing mode of entry is employed by the zoonotic pathogen Bartonella henselae 
which causes cat scratch disease or angiomatosis-peliosis in humans (104). In addition to 
classical invasion of single bacteria into cells, Bartonella henselae can also enter endothelial cells 
as a large aggregate of bacteria known as the invasome (105). This process requires the action of 
T4SS secreted effectors and is accompanied by massive actin rearrangement surrounding the 
bacterial aggregate (106, 107). Both effector secretion and invasome formation are dependent on 
Integrin β1 signaling (108).  
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1.3 RNA INTERFERENCE 
1.3.1 Mechanisms of RNA interference 
RNA interference (RNAi) is an RNA-mediated gene silencing mechanism. Different types of 
RNAi have been discovered and the exact mode of action depends on the organism and auxiliary 
proteins involved in the process. Despite these differences, each mechanism retains the same 
critical feature in which a long double stranded RNA (dsRNA) , either synthesized by the cell or 
introduced from the outside, is processed into shorter dsRNA by endoribonuclease III enzymes 
(RNase III). Next, the RNA duplexes are unwound and one of the two strands (known as the 
guide strand) is bound to the RNA-induced silencing complex (RISC). This complex scans the 
transcriptome to find potential targets. The guide strand determines the target specificity of the 
RNAi response by complete or partial base paring to the target transcript which is then silenced 
by RISC.  
In the following I will focus on the biogenesis and action of two classes of RNAi in mammalian 
cells (Figure 5), small interfering RNAs (siRNAs) and microRNAs (miRNA). While each has a 
distinct origin, and they vary to some extent in their function, it is increasingly evident that the 
boundaries between these pathways are blurring.  
MicroRNAs are transcribed by RNA polymerase II and thus part of a cell’s repertoire of 
translational regulators. Most miRNAs are encoded by introns of non-coding or coding 
transcripts but miRNAs that originate from exonic regions have also been described (109). Often, 
several miRNAs are encoded in close proximity and processed from a long polycistronic 
transcript (110). The structure of the primary miRNA (pri-miRNA) contains one or several stem-
loops, where the RNA folds back on itself to form specific hairpins. Pri-miRNAs are processed in 
the nucleus by Drosha, an RNase III-type endonuclease similar to Dicer, by cropping the 5’ and 
3’ ends below the stem loop (111). Drosha contains two RNase III domains that cleave one arm 
at the stem leaving a two nucleotide-long 3’ overhang (112, 113). The roughly 70 nucleotide-long 
precursor RNA (pre-miRNA) is then exported from the nucleus to the cytoplasm with the help of 
exportin 5 (114). In the cytoplasm, Dicer removes the loop from the pre-miRNA thus generating 
a mature double-stranded miRNA approximately 20 to 25 nucleotides in length (115, 116).  
miRNAs often contain unpaired regions unlike siRNAs that are fully complementary aside from 
the 5’ overhangs. 
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Figure 5. RNA interference pathways. Endogenous primary microRNAs (pri-miRNAs) are transcribed in the 
nucleus and form stem-loop structures by folding back on themselves. Processing by the endonuclease Drosha 
generates ~70 nt long precursor miRNAs (pre-miRNAs) which are exported to the cytoplasm by Exportin 5 and Ran-
GTP and further trimmed by Dicer to the mature miRNA. These contain 3’ overhangs and often unpaired 
nucleotides. Dicer also produces small interfering RNAs (siRNAs) from long dsRNAs. One strand (guide) of the 
miRNA or siRNA is assembled into the RNA-induced silencing complex (RISC) and directs the complex to target 
mRNAs that show full or partial complementarity to the guide strand. RISC binding causes translational inhibition or 
mRNA destabilization if bound by partial complementarity. Full complementarity leads to cleavage of the target 
mRNA. The major component of RISC is a member of the Argonaut (Ago) family of proteins of which human cells 
encode four. All Ago members can cause translational repression and mRNA destabilization, while only Ago2 has 
endonuclease activity which is required for direct cleavage of the target mRNA. Picture taken from (117). 
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To become active, the guide strand of the mature miRNA must be loaded into an Argonaut 
(AGO) protein part of the RISC complex, while the other strand is degraded. In humans, four 
AGO proteins can incorporate siRNAs or miRNAs with no strict sorting system (118). While 
only AGO2 is able to cleave the target transcript (119), all AGO proteins are able to induce 
translational inhibition and messenger RNA (mRNA) decay (120). The selection of the guide 
strand is primarily based on the differential thermodynamic stability at the ends of the miRNA. 
The strand with the weaker stability at its 5’ end is generally incorporated into RISC (121, 122). 
The other strand, known as passenger strand, is then quickly removed and degraded. AGO2 can 
cleave the passenger strand if the miRNA is matched in the center. However, this is not the 
general case for miRNAs since most contain central mismatches and human AGO1, AGO3, and 
AGO4 do not possess slicer activity (119). Duplexes generally unwind without cleavage and 
mismatches between both strands in positions 2-8 and 12-15 promote this process (123).  
The mature RISC complex, loaded with the guide miRNA, will then scan the cell’s transcriptome 
for targets sharing some degree of complementarity to the guide RNA. The established model for 
target-miRNA interaction states that miRNAs mainly act by partial binding of the miRNA to the 
3’ untranslated region (UTR) of target mRNAs by Watson-Crick base paring. The binding 
specificities of an miRNA is largely determined by complementarity of the so called seed region 
to the target mRNA (124). The seed region comprises a stretch of 6-8 nucleotides located in the 
5’ end of the miRNA. This model is based on the initial discovery that the lin-4 miRNA binds to 
multiple conserved sites in the 3’ UTR of its target lin-14 (125, 126). Later on, crystal structures 
of Argonaut proteins bound to the guide RNA showed that the complex is in a conformation 
which is primed for base pairing in the seed region (127). Furthermore several structures indicate 
that the first nucleotide of the miRNA does not engage in target interaction (128, 129). Even 
though seed paring seems to be a common mechanism of target binding, many exceptions to this 
rule have been found. Some miRNAs compensate partial mismatches in seed pairing by 
compensatory sites in the 3’ end of the miRNA. This has been discovered for miR-196 and its 
target HOXB8 (130). In other cases central sequences, rather than the seed, have been found to 
dictate binding specificity (131). Aside from differences in target interactions, the idea that 
binding sites on the mRNA occur solely in the 3’ UTR is over simplified. Certain miRNAs were 
found to bind to the 5’ UTR or coding regions of mRNAs (132, 133).  
Several other important features that affect target interactions have also been identified. For 
example, binding sites in unstructured regions on the mRNA, located in sequences rich in 
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adenosine und uridine bases (AU-rich) and outside the center of large 3’ UTRs, are more readily 
accessed (134). In addition, the presence of RNA-binding proteins can largely affect the 
efficiency of miRNA interaction. Blocking of miRNA binding sites presents a mechanism for the 
cell to protect mRNAs from miRNA regulation during specific conditions (135). 
The general effect of miRNA-guided RISC binding to a target mRNA is a net reduction of 
protein synthesis. Originally, it was reported that this is exclusively caused by translational 
repression while target mRNA levels were not affected (136). Later on, microarray analysis 
showed that miRNAs have a prominent effect on target mRNA abundance (137). Since both 
translational repression and mRNA degradation affect protein synthesis, the question of the 
relative contributions of these effects remains. While in the majority of studies mRNA 
degradation was found to account for most of the effect (138), there are some indications that 
translational repression without mRNA destabilization occurs early on when miRNA levels are 
rising (139). This indicates that miRNA binding initially reduces translation of the transcript, 
which is followed by destabilization and degradation of the mRNA (140, 141). 
While a steadily increasing number of miRNAs are discovered thanks to high throughput 
sequencing techniques, the identification of the direct targets is more challenging. Methods such 
as quantitative proteomics or transcriptomics can be used to obtain a global picture of the changes 
which a cell undergoes upon perturbation of a certain miRNA. Overexpression of an miRNA 
which is normally not expressed in a specific cell type was found to alter the transcriptome of this 
cell in the direction of cells which express this miRNA (137). This showed that the cellular 
changes induced by a miRNA can be identified by high throughput methods. However, it is not 
directly obvious which of the altered transcripts are directly targeted. In this case the use of 
bioinformatics prediction tools can help to narrow down the list of potential candidates always 
considering that non-canonical or non-conserved targets won’t be recognized easily. Currently 
used prediction methods consider the seed sequence, free energy of the miRNA-mRNA 
interaction, local mRNA content and secondary structure, and often evolutionary conservation 
(134, 142, 143). 
In contrast to miRNAs, siRNAs are generated from long dsRNAs only by the action of Dicer. 
Under natural conditions, these dsRNAs are introduced into the cell from the outside, e.g. by a 
virus. The siRNA is then introduced into the RISC complex and binding to a perfectly 
complementary target sequence induces RNA cleavage of the target by Argonaut 2 (Ago2). This 
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mode of antiviral defense is very prominent in many species, while it was only observed in a 
subset of human cells (144). 
 
1.3.2 Use of RNA interference for system biology studies 
Since the discovery of RNA interference for which Craig Mellow and Andrew Fire received the 
Nobel Prize in 2006, this technology has revolutionized genetic manipulation of many organisms. 
In comparisons to simpler organisms, loss-of-function studies in cultured mammalian cells were 
extremely difficult. This has changed with the discovery that small double stranded RNA 
molecules introduced into cells will use the cell’s silencing machinery to deplete target 
transcripts. Since many cell lines in the lab are easily transfected, this technology provides the 
tool to systematically target a large number of genes. siRNAs can be synthesized to match any 
target sequence which guides the siRNA loaded RISC complex to the corresponding RNA to 
induce degradation.  
Early on it was realized that siRNAs also induce unwanted off-target effects. Some siRNAs were 
found to trigger an immune response in a cell type specific manner. It was found that Toll-like 
receptors 7 (TRL7) and 8 (TLR8) were mainly responsible for this phenomenon. Certain 
sequence patterns including uridine- and guanosine-rich sequences were preferentially recognized 
(145, 146). Avoiding these sequence patterns in siRNAs enabled the design of molecules with 
fewer immunogenic properties (147) even though a certain level of sequence independent TLR-
response seems to be inherent to non-modified dsRNA molecules (148). However, these 
considerations are mainly of importance when working with immune cells or for therapeutic 
applications.  
Of more concern to the field was the discovery of sequence specific off-target effects. Microarray 
analysis of different siRNAs targeting the same gene showed very distinct effects on the 
transcriptome. Sequence analysis of off-target transcripts revealed that several 3’ UTRs showed 
complementarity to the 5’ end of the guide siRNAs. This indicated that a mechanism of action 
reminiscent of miRNAs causes the off-target effects (149). These studies were expanded later and 
it was found that mutations in the seed sequence of an siRNA could reverse the effect on the 
original off-target transcripts and, instead, target a new set of mRNAs (150, 151). While such off-
target effects can be addresses in small scale studies where individual genes are tested in detail, 
they are a more serious concern for large scale studies such as genome-wide siRNA screens. 
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Screens are often found to show a high false positive discovery rate and the overlap between 
comparable siRNAs screens can be extremely low (152). A meta-analysis of three genome-wide 
HIV screens showed that the overlap between the identified host factors is minimal (153). Among 
the combined list of 842 genes that reduce HIV replication in all three screens, only 34 genes 
were found in at least two siRNA screens and only three were found in all screens. Apart from 
differences in the cell lines or the details of the screens, it is likely that miRNA-like off-target 
effects account for a large part of this observation. A comparison of the enriched pathways that 
were found to contribute to HIV infection of the respective screens showed much higher 
agreement. This clearly shows that there is on-target information in these screens which enables 
identification of relevant host functions involved in HIV infection. However, on the level of 
individual genes, the false positive and false negative discovery rates are high.  
To tackle the problem of miRNA-like off-target effects, strategies aiming at optimized RNAi 
reagents have been developed. siRNA reagents have been modified on several positions to 
improve the on-target to off-target specificity or to avoid the incorporation of the passenger 
strand into the RISC complex (154, 155). Other strategies include the pooling of several different 
siRNAs against the same target. While the different siRNA in the pool have an individual off-
target spectrum, all are able to bind to the intended gene. This should reduce off-targets by 
competition between the different sequences without affecting the knock down of the intended 
target (156). Such competition seems to be important, since simple dilution of the siRNA is not 
sufficient to selectively reduce off-target effects (149, 150).  
While advanced RNAi reagents can improve future experiments, several methods have been 
developed that help improve the analysis of large scale siRNA screens. RNAi screens that were 
performed with several siRNAs per gene were classically analyzed by relatively simple rules. A 
gene was considered a hit if a certain fraction of all siRNAs for this particular target exceeded a 
certain threshold in a given readout (e.g. 2 out of 3, 3 out of 4, etc. rules) (157). The drawback of 
such methods is that it requires a cutoff and genes with effects consistently below this threshold 
will not be considered. Alternative approaches use statistical methods to rank siRNAs and genes 
and provide p-values that reflect the statistical probability. An example is the commonly used 
Redundant siRNA Activity (RSA) method (158). Other methods aim at identifying seed-driven 
off-target effects in siRNAs screens (159). This information can then be used to remove affected 
siRNAs from the analysis or to correct for the off-target effect (160). Excluding untrustworthy 
siRNAs reduces the number of false positives, while correction of the data potentially helps 
1 Introduction 
 
22 
 
recover some of the false negatives. There have also been attempts to even go one step further 
and use the information of the off-target effects to infer which genes are involved in the biology 
of the studied process (161, 162). This relies on the prediction of the targets for the active seed 
sequences and a mathematical model that determines which of those are most likely to contribute 
to the phenotype.  
Aside from its use in improving the rate of true positive hit genes, seed analysis of siRNA screens 
directly allows the identification of natural miRNAs or synthetic miRNA-like molecules involved 
in a certain process (152, 163). This is based on the observation that siRNAs that share the seed 
sequence with a natural miRNA elicit similar biological functions in a cell as their endogenous 
counterparts.   
 
1.4 THE HUMAN PATHOGEN BRUCELLA 
1.4.1 Brucella species and brucellosis 
Brucella species are gram-negative, facultative intracellular pathogens that belong to the class of 
α-Proteobacteria. They were first isolated in Malta in 1887 by Sir David Bruce from the spleens 
of soldiers that died from brucellosis (164). The natural hosts of Brucella include a wide range of 
wild and domestic animals. Brucella causes abortions and infertility in their natural hosts such as 
cattle, goats, or sheep, resulting in severe economic losses in endemic areas. Human brucellosis is 
one of the most important zoonotic diseases worldwide with over half a million new cases 
annually (165). Transmission to human is most commonly caused by direct contact with infected 
animals or by ingestion of contaminated food such as unpasteurized milk, while human to human 
transmission is very rare. The most important species associated with human disease are Brucella 
melitensi and Brucella abortus that infect cattle, goats, or sheep, Brucella suis that infect pigs, 
and to a minor extent Brucella canis infecting dogs. Other Brucella species have been reported to 
infect humans, but these events are uncommon, most likely due to the limited contact between 
humans and the natural host species carrying these strains (166).  
Due to the direct connection of animal and human brucellosis, the most effective intervention to 
prevent the disease is the control of brucellosis in domestic animals. Even though an effective 
live vaccine is available for animals, animal brucellosis is still abundant in many regions of the 
  1 Introduction 
23 
 
world being endemic in many parts of the Middle East, Africa, Latin America, central Asian, and 
several countries around the Mediterranean basin (167). 
Human brucellosis begins as a flu-like disease with symptoms such as fever and body pain. Due 
to the relatively unspecific symptoms, brucellosis is often not correctly diagnosed and treated. 
This allows bacteria do disseminate throughout the body where they can infect diverse tissues. At 
this point, the disease can become chronic and is difficult to treat. A common complication of 
brucellosis is arthritis, which is often seriously debilitating. More life threatening complications 
include liver abscess formation, endocarditis, or neuropathy. Antibiotic treatment is normally 
effective if started early during infection. However, a combination therapy of at least two 
antibiotics over a prolonged period is required to prevent complications or relapses. Due the high 
risk of serious disease and the ability of Brucella to be spread by aerosols Brucella species are 
classified as biosafety level 3 organisms (168). 
 
1.4.2 Intracellular lifestyle of Brucella  
 
Adhesion and entry into host cells 
On the cellular level, Brucella is able to invade phagocytic and non-phagocytic cells (Figure 6). 
Depending on the cell type, different host-pathogen interactions are involved in adhesion of 
bacteria to the cell surface or entry into the host cell. Lipid rafts are required for the uptake of 
non-opsonized bacteria in macrophages (169, 170). Two receptors have been proposed to be 
involved in this process; the class A scavenger receptor (SR-A) which interacts with Brucella 
lipopolysaccharide (LPS) (171) and the cellular prion receptor PrPc which was proposed to bind 
to Hsp60 (172). However, the latter interaction is debated since the results could not be 
confirmed by an independent study (173).  
Receptors containing sialic acid residues are important for adhesion of Brucella to phagocytic 
and non-phagocytic cells by interactions with the surface protein 41 (SP41) (174, 175). 
Furthermore, other Brucella genes have been found to be involved in binding to non-phagocytic 
cells. These include a gene cluster that harbors a bacterial immunoglobulin-like protein (176) and 
different autotransporters (177, 178). The autotransporters showed localization to the new pole of 
Brucella formed after cell division (178), which is in agreement with the finding that most 
bacteria that infect cells are G1-arrested newborn bacteria (179). 
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In phagocytic and non-phagocytic cells bacterial internalization involves actin rearrangements, 
which requires phosphatidylinositide 3-kinase PI3K, the small GTPases Rac, Rho, and direct 
activation of Cdc42 (180). In murine trophoblast giant cells, surface located Hsc70 and ezrin, a 
factor which tethers actin filaments to the plasma membrane, are required for Brucella uptake 
(181, 182). Overall, there is no indication that Brucella actively induces its own uptake via 
secretion of effectors. In line with this, the T4SS is only induced after the internalization of 
bacteria (82). 
 
Intracellular trafficking 
Inside the eukaryotic host cell, Brucella remains enclosed within a membrane, known as the 
Brucella containing vacuole (BCV). Directly after entry the BCV is enriched in cholesterol and 
the lipid raft-associated signaling molecule flotilin-1 (183). Bacteria interact with markers of 
early endosomes such as Rab5 or EEA1 (83, 184, 185). The Brucella secreted cyclic β-1,2-glucan 
is involved in inhibition of phagosome-lysosome fusion and proposed to act by extracting 
cholesterol from the BCV (183, 186). The BCV then traffics along the endocytic pathway, 
acquiring Rab-7, the Rab7 effector RILP, and Lamp-1 (81). Despite a certain degree of 
interaction with lysosomes, bacteria manage to avoid degradation (81). Since no enrichment of 
luminal lysosomal enzymes such as cathepsin D can be found in BCV, Brucella seems to be able 
to avoid full lysosomal fusion (83, 187, 188). Nevertheless, the BCV undergoes acidification 
during trafficking along the endocytic pathway. This is dependent on the action of the vesicular 
ATPase and is required to induce the expression of the bacterial T4SS (82). It is believed that 
secretion of effectors is essential for Brucella to establish its replicative niche, since deletion of 
the T4SS (83) or inhibition of the vesicular ATPase lead to defects in the establishment of the 
intracellular niche (189). 
During later stages of trafficking, several factors involved in ER to Golgi bidirectional trafficking 
are required for Brucella to successfully reach its replicative niche. Bacteria are found to interact 
with Sar1 and COPII complex components and inhibition of Sar1 activity blocked intracellular 
replication (190). Sar1 initiates budding of vesicles from the ER that are destined for the Golgi 
apparatus. It is thus conceivable that Brucella intercepts vesicles at ER exit site.  
Furthermore, components involved in retrograde trafficking have been found to be required for 
intracellular replication. The small GTPase Rab2, which is required for the maturation of the ER-
Golgi intermediate compartment (ERGIC) and trafficking from the Golgi to the ER, was found to 
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localize to the BCV (191). This study could further identify several factors (GAPDH, COPI, and 
Protein kinase C) that interact with Rab2 and regulate retrograde trafficking to be required for 
infection. In agreement with the notion that Brucella hijacks ER-Golgi trafficking, the secreted 
protein RicA was found to interact with the GDP-bound form of Rab2. It remains unclear how 
this interaction affects intracellular trafficking of the BCV. However, it is intriguing that a mutant 
of ricA showed enhanced intracellular proliferation giving good indications that this protein is 
indeed involved in the regulation of trafficking (192). It was proposed that interaction of RicA 
with Rab2 could promote the silent or stealthy infection strategy of Brucella by preventing 
excessive proliferation.  
 
Replication and intercellular spread 
During the phase of trafficking and until Brucella establishes an ER-like replicative niche,  
bacteria do not divide (179). Once proliferation is initiated, the BCV is found in close association 
with ER markers such as calnexin and glucose-6-phosphatase (83). Even though Brucella 
replicates to very high numbers inside cells, basic cellular processes are not affected and cells can 
still undergo cell division (185). Similar to other stealthy pathogens, Brucella is able to inhibit 
apoptosis of infected cells. The exact mechanisms are unclear, but it was shown that the anti-
apoptotic factor BCL2A1 is up-regulated (193) and mitochondrial genes involved in apoptosis 
are repressed in infected cells (194).  
Cell-to-cell spread has only recently been addressed where autophagy factors were found to be 
involved. Interestingly, only autophagy initiation factors such as ULK1, Beclin1, ATG14L, and 
PI3K but not elongation factors are required for this process. Furthermore, it was observed that 
some BCVs acquire Rab7 during late stages of infection which coincides with the potential of 
Brucella to spread to neighboring cells. It was found that cell-to-cell spreading can be blocked by 
the cell-impermeable antibiotic gentamycin indicating an extracellular stage during the spread. 
However, the exact mechanism of egress remains elusive (195). 
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Figure 6. Brucella intracellular life. Scheme depicting the entry, trafficking, and intracellular replication of 
Brucella. Green zooms indicated bacterial factors involved in the corresponding step. Bacteria enter host cells via 
lipid rafts (orange) enriched in cholesterol (yellow dots). Cyclic β-1,2-glucans (CβB) are thought to deplete the 
Brucella containing vacuole (BCV) from cholesterol. The BCV traffics along the endocytic pathway interacting with 
early and late endosomes. Acidification of the BCV leads to the expression of the type IV secretion system (T4SS) 
which secretes effectors such as BPE123 or RicA which interacts with Rab2. Avirulent mutants (e.g. carrying 
deletions in the virB T4SS) are degraded in phagolysosomes. The BCV interacts with components of ER exit sites 
(Sar1, COPII) as well as retrograde trafficking factors (Arf1, Rab2, PKC, GAPDH, βCOP) which constitute COPI 
coated vesicles that mediate vesicular transport from the vesicular tubular clusters (VTC) to the ER. Bacteria also 
interact with IRE1 involved in autophagy and finally replicate in an ER-derived compartment. Picture taken from 
(167). 
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2 AIM OF THE THESIS 
 
The overall aim of my thesis, started in November 2010, was to identify host factors that are 
involved in Brucella infection of human cells. This project was embedded in the InfectX and later 
TargetInfectX consortium that aims at deciphering the human infectome of diverse bacterial and 
viral pathogens. To this end, we performed large-scale, microscopy-based RNA interference 
screening for infection in HeLa cells, where I was part of the team performing the Brucella 
screens. The work performed during my thesis can be separated in two parts which are tightly 
interconnected.  
The first part intended at understanding miRNA-like off-target effects in siRNA screening and 
the role of natural and synthetic miRNAs in Brucella infection. To validate miRNA-like off-
target effects, I tested custom designed oligonucleotides and a human miRNA mimic library for 
their effect on Brucella infection. Furthermore, I used proteome and transcriptome analyses to 
investigate the cellular changes induced by selected miRNAs.  
The second part aims at the identification and characterization of genes involved in Brucella 
infection. Identification of host factors relied on the knowledge gained on off-target effects and a 
validation strategy for candidate genes which was developed from smaller screen covering all 
human kinases. The Brucella genome-wide screen was designed to cover multiple aspects of the 
intracellular lifecycle, covering entry, trafficking, and intracellular replication. To gain a deeper 
understanding of the precise role of the identified host factors, I developed and employed a 
microscopy-based entry assay to separate early from late effects.  
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Summary 
 
Here we describe two phenotypic assays applicable for high-throughput, high-content RNA 
interference (RNAi) screening of host factors involved in Brucella infection of HeLa cells. The 
assays are based on detection of fluorescently labeled bacteria and host cells using automated 
wide-field microscopy. The entry assay allows detection of host factors involved in Brucella 
entry and the endpoint assay covers all steps required for Brucella intracellular replication.   
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Abstract  
 
Brucella species are facultative intracellular pathogens that infect domestic animals as their 
natural hosts. Transmission to humans is most commonly caused by direct contact with infected 
animals or by ingestion of contaminated food and can lead to severe chronic infections.  
Brucella is able to invade professional and non-professional phagocytic cells and replicates 
within endoplasmic reticulum- (ER) derived intracellular vacuoles. The molecular mechanisms 
by which Brucella enters cells, avoids lysosomal degradation, and finally replicates in an ER-like 
compartment remain largely unknown. Here we describe two microscopy-based assays for RNAi 
screens of Brucella entry and replication in HeLa cells. The assays are based on the detection of 
fluorescently labeled bacteria in fluorescently labeled host cells using automated wide-field 
microscopy. The fluorescent images are analyzed using a standardized image analysis pipeline in 
CellProfiler which allows single cell-based infection scoring.   
In the endpoint assay, intracellular replication is measured two days after infection. This allows 
bacteria to traffick to their replicative niche where intracellular proliferation is initiated around 
12 h after bacterial entry. Brucella which have successfully established an intracellular niche will 
thus have strongly proliferated inside the host cell by the end of this assay and occupy a large part 
of the cell. Since intracellular bacteria will greatly outnumber individual extracellular or 
intracellular non-replicative bacteria, a strain constitutively expressing GFP is used in this assay. 
The strong GFP signal in infected cells is then used to automatically identify infected cells.  
In contrast to the endpoint assay, it is essential to differentiate between intracellular and 
extracellular bacteria for the entry assay. Here, we use a Brucella strain encoding for a 
tetracycline-inducible GFP. Induction of GFP with simultaneous inactivation of extracellular 
bacteria by gentamicin enables the differentiation between intracellular and extracellular bacteria 
based on the GFP signal, with only intracellular bacteria being able to express GFP. This allows 
the robust detection of single intracellular bacteria before intracellular proliferation is initiated. 
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Introduction 
 
Brucella species are gram-negative, facultative intracellular pathogens belonging to the class of 
α-Proteobacteria. They cause abortions and infertility in their natural hosts such as cattle, goats, 
or sheep resulting in severe economic losses in endemic areas. Brucellosis is one of the most 
important zoonotic diseases worldwide with over half a million new cases annually1. 
Transmission to human is most commonly caused by direct contact with infected animals or by 
ingestion of contaminated food such as unpasteurized milk. Symptoms of the febrile disease are 
unspecific, which cause difficulties in the diagnosis of brucellosis. If untreated, patients can 
develop a chronic infection with more severe symptoms such as arthritis, endocarditis, and 
neuropathy2.  
On the cellular level Brucella is able to invade phagocytic and non-phagocytic cells and 
replicates within an intracellular compartment known as the Brucella-containing vacuole (BCV). 
Internalization of bacteria requires actin cytoskeleton rearrangement by Rac, Rho, and direct 
activation of Cdc423. Inside the eukaryotic host cell, the BCV traffics along the endocytic 
pathway and despite the interaction with lysosomes, bacteria manage to avoid degradation4.  
Acidification of the BCV by the vesicular ATPase is required to induce the expression of the 
bacterial type IV secretion system (T4SS)5. It is believed that bacterial effectors secreted by the 
T4SS are essential for Brucella to establish its replicative niche, since deletion of the T4SS6 or 
inhibition of the vesicular ATPase lead to defects in the establishment of the intracellular niche7. 
Bacteria do not replicate during the phase of trafficking or until Brucella establishes an ER-like 
replicative niche8. Once intracellular proliferation occurs, the BCV is found in close association 
with ER markers such as calnexin and glucose-6-phosphatase6.  
The molecular mechanisms by which Brucella enters cells, avoids lysosomal degradation, and 
finally replicates in an ER-like compartment remain largely unknown. Host factors involved in 
different steps of infection have mainly been identified by targeted approaches or a small scale 
siRNA screen performed in Drosophila cells9. These have shed light on the contribution of 
individual host factors during Brucella infection but we are still far from a comprehensive 
understanding of the entire process. 
Here we present a protocol that allows the identification of human host factors using large-scale 
RNAi screening in combination with automated wide-field fluorescence microscopy and 
automated image analysis. The reverse siRNA transfection protocol was optimized in the 
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Research and Technology Development (RTD) project InfectX in the frame of SystemsX.ch, the 
Swiss Initiative for Systems Biology. Reverse siRNA transfection of HeLa cells is performed 
with minor modifications as described by Kühbacher et al.10. We have developed an endpoint 
assay that covers a large part of the Brucella intracellular lifecycle except egress and infection of 
neighboring cells. To further characterize the hits identified in the endpoint assay, we use a 
modified protocol to identify factors involved in early steps of the infection.  
A Brucella abortus strain that constitutively expresses GFP is used for the endpoint assay where 
bacteria are allowed to infect cells for two days. During this time, bacteria can enter cells, traffic 
to the ER-derived replicative niche, and replicate in the peri-nuclear space. High levels of 
bacterial GFP signal inside infected cells can then be used to reliably detect infected cells on a 
single cell level.  
To study Brucella entry in a high throughput assay, it is important to be able to distinguish 
between intracellular and extracellular bacteria. Here we present a method that circumvents 
differential antibody staining of intracellular and extracellular bacteria. It is based on a Brucella 
strain expressing a tetracycline-inducible GFP in combination with constitutively expressed 
dsRed. The presence of a constitutive dsRed marker allows identification of all bacteria that are 
present in the sample. GFP expression is induced by the addition of the non-toxic tetracycline 
analog anhydrotetracycline (aTc) simultaneously with inactivation of extracellular bacteria by 
gentamicin (gent). While the cell-impermeable antibiotic gent kills extracellular bacteria, aTc can 
enter the host cell and induce GFP expression selectively in intracellular bacteria. This allows the 
robust detection of single intracellular bacteria using wide-field microscopy. Similar induction 
schemes to selectively express GFP in intracellular bacteria has been used previously to study 
intracellular Shigella11.  
 
Protocol 
 
1. Preparation of screening plates and culturing of bacteria and cells 
 
1.1 Preparation of Brucella abortus starter cultures 
Work with live Brucella abortus strains must be performed inside a biosafety level 3 (BSL3) 
laboratory considering all required regulations and safety precautions. 
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1. Streak Brucella abortus 2308 (B. abortus) from -80°C milk stock on a Tryptic Soy Agar 
(TSA) plate containing 50 μg/ml kanamycin (TSA/Km). Incubate plate for 3-4 days at 
37°C.  
a. Endpoint assay: Brucella abortus 2308 pJC43 (B. abortus pGFP)12 
b. Entry assay: Brucella abortus pAC042.08 (B. abortus pTetR-GFP) 
2. Restreak bacteria on four TSA/Km plates covering the full plates and incubate for 2-3 
days at 37°C. 
3. Using a disposable plastic loop, transfer and resuspend bacteria from the TSA/Km plates 
in 10 ml 10% autoclaved skim milk. Make sure that the bacteria are well resuspended to 
ensure consistent bacterial concentrations in all starter cultures.  
4. Aliquot 250 μl of the bacterial suspension into 2 ml screw cap tubes and freeze at -80°C.  
5. Thaw an aliquot of the starter culture and transfer different amounts of the bacterial starter 
culture to 50 ml Tryptic Soy Broth (TSB) containing 50 μg/ml kanamycin (TSB/Km) in 
250 ml screw cap bottles.  
6. Incubate the bottles overnight in an orbital shaker at 100 rpm and 37°C.  
7. Measure the optical density at 600 nm to determine the volume of starter culture required 
to reach an OD600 = 0.8-1.1. 
 
1.2 Preparation of HeLa cells 
1. Grow HeLa cells in Dulbecco Modified Eagle Medium (DMEM) supplemented with 10% 
fetal calf serum (FCS). 
 
1.3 Preparation of screening plates with siRNAs 
1. Dilute siRNAs in RNase-free water to a final concentration of 0.32 μM and transfer 5 μl 
to black clear-well flat-bottom 384 well-plates. Use columns 1, 2, 23, and 24 for standard 
controls. Negative controls include non-targeting siRNA (scrambled) and mock wells 
without siRNAs. Transfection controls include an siRNA that induces cell death (Kif11), 
as well as positive controls of known host factors involved in Brucella infection (e.g. 
ArpC3, a component of the Arp2/3 complex involved in actin polymerization). 
Commercially available siRNA libraries or custom siRNAs are transferred to the 
remaining wells.  
2. Seal plates with peelable aluminum foils.  
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3. Plates can be stored at -20°C for at least 6 months and up to years depending on the 
manufacturer’s recommendations.  
 
2. Reverse siRNA transfection 
1. Thaw a black 384-well plate by centrifugation at 300 x g for 20 min at room temperature. 
This brings down all the liquid which might adhere to the lid or the side of the wells.  
2. Prepare the transfection medium by diluting Lipofectamine RNAiMAX 1:200 in DMEM 
without FCS at room temperature. Prepare the transfection medium no longer than 20 min 
prior to use. Carefully mix the solution before use.  
3. Add 25 μl transfection medium to each well and mix the solutions by moving the plate 
back and forth.  
4. Incubate the plate for 1 h at room temperature to allow siRNA/Lipofectamine RNAiMAX 
complex formation.  
5. In the meantime, prepare HeLa cells by washing the sub-confluent cells of a 75 cm2 flask 
once with 2.5 ml trypsin.  
6. Add 1.5 ml trypsin and transfer the flask to 37°C for 2-3 min until the cells round up.  
7. Resuspend the cells in 10 ml prewarmed DMEM /16% FCS. 
8. Count cells and prepare a cell suspension of 10’000 cells per ml in DMEM/16% FCS.  
9. Add 50 μl of the cell suspension to each well resulting in 500 cells/well. 
10. Move the plate back and forth to achieve even distribution of the cells. Leave the plate at 
room temperature for 5-10 min to allow for the cells to settle down.  
11. Seal the plate with parafilm and incubate it for 72 h on a pre-warmed aluminum plate in a 
37°C humid incubator with 5% CO2. Pre-warmed aluminum plate allows equal 
temperature distribution throughout the whole plate.  
 
3. Infection and fixation 
1. One day prior to infection inoculate the appropriate amount of B. abortus starter culture in 
50 ml TSB/Km medium in a 250 ml screw cap bottle. Grow bacteria overnight at 37°C on 
an orbital shaker to OD600 = 0.8-1.1 at 100 rpm. 
2. Measure OD600 of the bacterial culture and prepare the infection medium by diluting the 
bacterial culture in DMEM /10% FCS to achieve the desired multiplicity of infection 
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(MOI) (for 2000 HeLa cells a MOI of 10’000 is estimated. MOI titration curve should be 
performed for each cell type to obtain optimal MOI for infection in respective cell types).  
3. Exchange the transfection medium of the 384-well plate with 50 μl of the infection 
medium using an automated plate washer (e.g. ELx50-16, BioTek).  
4. Centrifuge the 384-well plate at 400 x g and 4°C for 20 min to synchronize the infection 
process.  
5. Seal the plate with parafilm and incubate it on a pre-warmed aluminum plate in a 37°C 
humid incubator with 5% CO2 for 4 h.  
6. Wash the cells with DMEM/10% FCS containing 100 μg/ml gent to inactivate 
extracellular bacteria (use 200 μl/well overflow wash with ELx50-16).  
7. For the entry assay, wash cells a second time using DMEM/10% FCS containing 
100 μg/ml gent and 100 ng/ml aTc (use 200 μl/well overflow wash with ELx50-16).  
8. Seal the plate with parafilm and return it to a pre-warmed aluminum plate in the 37°C 
humid incubator with 5% CO2 for another 40 h or 4 h, for the endpoint assay and the entry 
assay, respectively.  
9. For fixation, wash the wells with PBS (use 200 μl/well overflow wash with ELx50-16). 
10. Exchange PBS with 50 μl 3.7% PFA (in 0.2 M HEPES, pH 7.4) using an automated plate 
washer.  Each batch of PFA must be tested prior to use to ensure efficient inactivation of 
B. abortus. 
11. Incubate for 20 min at room temperature. 
12. Exchange the fixation medium with 50 μl PBS. The samples are now ready to be taken 
out from the BSL3 if needed. 
 
4. Staining 
1. Wash cells twice with 50 μl PBS.  
2. Permeabilize cells in 50 μl 0.1% Triton-X-100 in PBS for 10 min.  
3. Add 20 μl of staining solution and incubate for 30 min at room temperature.  
a. Endpoint assay: PBS containing 1 μg/ml DAPI, 1.5 U/ml DY-547-phalloidin 
(optional) 
b. Entry assay: PBS containing 1 μg/ml DAPI, 2 U/ml DY-647-phalloidin (optional)  
4. Wash cells three times in PBS and protect the staining from light with an aluminum foil 
cover. 
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5. Imaging 
Set up automated wide-field microscope for image acquisition. The settings for a Molecular 
Device ImageXpress microscope using MetaXpress software are described below.  
1. Select 10 X objective, camera binning = 1, gain = 1  
2. Select plate format corresponding to the 384-well plate 
3. Acquire 9 sites per well  
4. Use “Enable laser based focus” and “focus on plate and well bottom” 
5. Set   “First well” as initial well for finding sample and “All sites” for site autofocus 
6. Use the DAPI channel to manually set Z-Offset for focus.  
7. Manually select the Z-offset from DAPI for all other channels. 
8. Manually correct the exposure time of all channels to ensure a wide dynamic range with 
low overexposure.  
9. Select the following channels:  
a. Endpoint assay: DAPI, GFP, RFP (optional) 
b. Endpoint assay: DAPI, GFP, RFP, CY5 (optional) 
 
6. Automated image analysis 
We employ CellProfiler 2 13 to segment cellular and bacterial objects and perform automated 
measurements within the identified objects. To follow our protocol, install CellProfiler 2.1.1 or a 
newer version of CellProfiler. Then, load our provided pipeline into CellProfiler and follow the 
instructions below to adjust the required parameters. 
 
6.1 Endpoint assay 
In this image analysis we will apply shading correction to reduce the effects of an 
inhomogeneous light path from the microscope. Computing the shading model at the beginning 
of the pipeline is a lengthy process, but analysis results will be of higher accuracy. 
1. Go to the Menu “File”, select “Import” -> “Pipeline from File…”, and select our provided 
pipeline “BrucellaEndpoint-Ver005.cppipe”. When asked if you want to convert the 
legacy pipeline, answer “Don’t convert”. 
2. Go to “Output” -> “View output settings” and select an input folder with the images and 
an output folder for the resulting Excel sheet. 
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3. The analysis modules work as follows: 
a. Module (1) “LoadImages” load images with DAPI and GFP channels. Adjust the 
name of the “Text that these images have in common” to match the image names. 
b. Modules (2) – (3) “CorrectIlluminationCalculate” create a shading model by 
reading all images and creating a median-averaged image. 
c. Module (4) “CorretIlluminationApply” applies the shading model to the images. 
d. Modules (5) – (6) “ImageMath” correct 12bit images to use the full dynamic range 
[0, 1]. Adjust the parameter “Multiply the first image by” matching the bit depth 
of your microscope camera. For 8 and 16bit images set the parameter to “1.0”, for 
12bit images set the parameter to “16.0”. 
e. Module (7) “MeasureImageIntensity” measures the lower quartile intensity of the 
DAPI and GFP images. The lower quartile intensity is a robust measure for the 
image background in this assay. 
f. Modules (8) – (9) “ImageMath” subtract the lower quartile intensity from the 
image. This is done to remove the background from the images. 
g. Module (10) “ImageMath” subtracts a fraction of the GFP image from the DAPI 
image. This is done to suppress the Brucella signal in the DAPI staining. Adjust 
the parameter “Multiply the second image by” to a value that will suppress the 
Brucella signal in the DAPI staining without suppressing the Nuclei. To identify a 
good value, step over the module, display the output image, right-click the image 
and set “Image contrast” to “Log normalized”. Set the parameter sufficiently high 
that Brucella signal is suppressed, but low enough to avoid black areas that 
indicate over-subtraction. 
h. Module (11) “IdentifyPrimaryObjects” identifies the nuclei in the DAPI stained 
images from which the Brucella signal was suppressed. Set the parameter “Lower 
bound on threshold” high enough that only nuclei are segmented, and background 
is ignored. To identify a good value, step over the module, display the input 
image, right-click the image and display the histogram. The peak of the histogram 
typically indicates background. Set the parameter high enough to ignore 
background, which is important for empty sites. 
i. Module (12) “ExpandOrShrinkObjects” creates expanded nuclei with an 
expansion of 8 pixels. 
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j. Module (13) “IdentifyTertiaryObjects” creates peri-nuclear rings around the nuclei 
from the expanded nuclei, by removing the nuclei from the expanded nuclei. 
k. Module (14) “ExpandOrShrinkObjects” creates a Voronoi cell body around the 
nuclei. A Voronoi cell body is an expansion of the nucleus by 25 pixels. 
l. Module (15) “MeasureObjectIntensity” measures the intensity of the GFP image 
at the nuclei. 
m. Module (16) “FilterObjects” filters for nuclei of infected cells based on the 
minimum mean GFP intensity in the nuclei. Adjust the parameter “Minimum 
value” so that cells with clearly visible Brucella at the nucleus are kept, and all 
others are filtered away. In this step, ignore Brucella outside the nucleus. Start 
with a low value that identifies too many cells, and set it stepwise higher until only 
cells with clearly visible Brucella at the nucleus are kept. 
n. Module (17) “FilterObjects” filters for peri-nuclei of infected cells based on the 
minimum mean GFP intensity in the peri-nuclei. Adjust the parameter “Minimum 
value” so that cells with clearly visible Brucella at the peri-nucleus are kept, and 
all other cells are filtered away. Approach similar as in the previous module. 
o. Module (18) “FilterObjects” filters for Voronoi cell body of infected cells based 
on the minimum upper quartile GFP intensity in the Voronoi cell body. Adjust the 
parameter “Minimum value” so that cells with clearly visible Brucella at the 
Voronoi cell body are kept, and all other cells are filtered away. Approach similar 
as in the previous module. 
p. Modules (19) – (24) combine the previously found “infected nuclei”, “infected 
peri-nuclei” and “infected Voronoi cells” into a single object “InfectedCells” 
q. Module (25) “ExportToSpreadsheet” writes an Excel CSV sheet with the 
summarized readouts for each site. 
r. Modules (26) – (30) are optional, and create color overlay png images with 
infected and uninfected cells outlined on the microscope images. These images 
can be helpful for later inspection, and help in optimization of the analysis. 
s.  Optional: Perform fluorescent intensity, texture, and distribution measurements in 
the remaining objects depending on availability. These can provide further 
information on bacterial distribution, F-actin morphology, etc. 
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4. In the resulting Excel CSV table, the readout “Count_Nuclei” is used to quantify the 
number of cells, and the readout “Count_InfectedNuclei” is used to quantify infected 
cells. 
 
6.2 Entry assay 
In this image analysis we do not apply shading correction because the adversary effect of shading 
is less pronounced in the Entry assay. Users interested in highest accuracy may add shading 
correction at their own discretion. Note that with the low density of objects in the GFP channel, 
much care has to be taken to arrive at a smooth shading model. 
1. Go to the Menu “File”, select “Import” -> “Pipeline from File…”, and select our provided 
pipeline “BrucellaEntry-Ver003.cppipe”. When asked if you want to convert the legacy 
pipeline, answer “Don’t convert”. 
2. Go to “Output” -> “View output settings” and select an input folder with the images and 
an output folder for the resulting Excel sheet. 
3. The Analysis modules work as follows: 
a. Module (1) “LoadImages” loads images with DAPI and GFP channels. Adjust the 
name of the “Text that these images have in common” to match the image names. 
b. Module (2) – (3) “ImageMath” correct 12bit images to use the full dynamic range 
[0, 1]. Adjust the parameter “Multiply the first image by” matching the bit depth 
of your microscope camera. For 8 and 16bit images set the parameter to “1.0”, for 
12bit images set the parameter to “16.0”. 
a. Module (4) “IdentifyPrimaryObjects” identifies the nuclei in the DAPI stained 
images from which the Brucella signal was suppressed. Set the parameter “Lower 
bound on threshold” high enough that only nuclei are segmented, and background 
is ignored. To identify a good value, step over the module, display the input 
image, right-click the image and display the histogram. The peak of the histogram 
typically indicates background. Set the parameter high enough to ignore 
background, which is important for empty sites. 
c. Module (5) “ExpandOrShrinkObjects” creates a Voronoi cell body around the 
nuclei. A Voronoi cell body is an expansion of the nucleus by 25 pixels. 
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d. Module (6) “IdentifyPrimaryObjects” identifies the intracellular Brucella colonies 
in the GFP image. Set the parameter “Lower bound on threshold” high enough 
that only true Brucella are segmented and background is ignored. To identify a 
good value, step over the module, display the input image, right-click the image 
and display the histogram. The peak of the histogram typically indicates 
background. Set the parameter high enough to ignore background in empty sites. 
e. Module (7) “MeasureObjectIntensity” measures the intensity of segmented 
Brucella colonies in the GFP image. 
f. Module (8) “MeasureObjectSizeShape” measures the area of segmented Brucella 
objects. 
g. Module (9) “FilterObjects” filters for segmented Brucella colonies that have a 
minimum area of 2 pixels. Smaller Brucella objects are discarded to reduce the 
effects of pixel noise. The Module subsequently filters for segmented Brucella 
colonies that have a minimum upper quartile intensity. Adjust the parameter 
“Minimum value” so that background and artefacts are filtered away, and only 
true Brucella colonies are kept. 
h. Module (10) “MeasureObjectIntensity” measures the intensity of the filtered 
Brucella colonies in the GFP image. 
i. Module (11) “RelateObjects” relates the filtered Brucella colonies to the Voronoi 
cell body. 
j. Module (12) “FilterObjects” filters for infected cells, which are defined to be all 
cells that have a Brucella colony as child of the Voronoi cell body. 
k. Module (13) “FilterObjects” filters for Brucella colonies that are children of a 
Voronoi cell body. 
l. Module (14) “MeasureImageAreaOccupied” measures the integrated area of 
Brucella colonies that are children of a Voronoi cell body. 
m. Module (15) “ExportToSpreadsheet” writes an Excel CSV sheet with the 
summarized readouts for each site. 
n. Optional: Perform fluorescent intensity, texture, and distribution measurements in 
the remaining objects depending on availability. These can give further 
information on bacterial distribution, F-actin morphology, etc. 
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4. In the resulting Excel CSV table, the readout “Count_Nuclei” is used to quantify the 
number of cells, the readout “Count_InfectedCells” is used to quantify infected cells, and 
the readout “AreaOccupied_AreaOccupied_TrueIntPathogenInCells” is used to quantify 
the area covered by Brucella in infected cells. 
 
7. Infection scoring 
 
7.1 Endpoint assay 
1. In CellProfiler, adjust the GFP thresholds for the nucleus, peri-nucleus, and Voronoi cell 
body. See section 6.1 for details. If the GFP intensity in any of the three objects exceeds 
the threshold, the cell is considered infected. 
2. In Excel, calculate a per well infection rate by dividing the number of infected cells by the 
total number of cells. If multiple sites per well have been imaged, it is required to first 
summarize all sites for each well, to build a per-well number of infected cells and a per-
well total number of cells. 
3. Perform Z scoring normalization to account for plate-to-plate variations if the plates 
contain sufficient non-hit siRNAs. A sufficient number of non-hit siRNAs per plate can 
be assumed if full libraries are screened.    
 
𝑍𝑠𝑐𝑜𝑟𝑒 = 𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 (𝑤𝑒𝑙𝑙) −𝑚𝑒𝑎𝑛 𝑖𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 (𝑝𝑙𝑎𝑡𝑒)
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 (𝑝𝑙𝑎𝑡𝑒)  
 
7.2 Entry assay 
1. In CellProfiler, adjust the GFP threshold for intensity and the minimum area of 2 pixels of 
intracellular bacteria. This allows the exclusion of bacteria that are too dim and 
potentially extracellular or single pixel artifacts. The remaining bacterial objects are 
considered “true intracellular bacteria”. See section 6.2 for details. A cell is considered 
infected if at least one true intracellular bacterial object is identified within the Voronoi 
cell body. 
2. In Excel, calculate a per well infection rate by dividing the number of infected cells by the 
total number of cells. If multiple sites per well have been imaged, it is required to first 
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summarize all sites for each well, to build a per-well number of infected cells and a per-
well total number of cells. 
3. To quantify the bacterial load of infected cells, the average area occupied by true 
intracellular bacteria per cell is estimated. To this end, the integrated area of all true 
intracellular bacteria overlapping with infected cells is summed up per site. To account 
for artefacts, the median of all sites is used as the well readout. This readout is divided by 
the total number of infected cells per well, to gather a readout of average bacterial load 
per infected cell. 
4. If this assay is used as a follow up assay containing a large number of genes involved in 
Brucella infection Z score normalization should not be applied. Instead, normalization 
using mock wells as a reference can be used to account for plate to plate variation.  
 
Representative Results 
 
Figure 1A shows an example of image analysis used to automatically identify infected cells in the 
endpoint assay. Nuclei of HeLa cells nuclei stained with DAPI were identified and a peri-nucleus 
of 8 pixels width surrounding the nucleus and a Voronoi cell body by extension of the nucleus by 
25 pixels was calculated. Since bacteria mainly proliferate in the peri-nuclear space, the GFP 
intensity in this area of the cell is the most robust measure to discriminate between infected and 
non-infected cells. In some cases, bacteria are found to proliferate outside of the peri-nucleus or 
overlay to a large extent with the nucleus. Therefore, these two additional objects were also 
considered for the identification of infected cells. Segmentation as well as GFP intensity 
measurements were performed with the image analysis software CellProfiler 2.  
Brucella requires actin rearrangement for successful invasion of host cells. Thus, depletion of 
actin remodeling components is suitable to serve as positive controls for siRNA screening. Here 
we used ArpC3, a component of the Arp2/3 complex involved in actin polymerization as our 
positive control. As seen in Figure 1B, depletion of ArpC3 reduced the number of cells that show 
proliferating bacteria two days after infection. Applying the automated image analysis pipeline to 
these images allowed the quantification of the observed effect (Figure 1C). The data which are 
shown here originate from the control layout of a genome-wide siRNA screen where they served 
as controls. Z scoring was applied to account for plate-to-plate variations.  
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Figure 2A illustrates the image analysis used to identify infected cells and measure the 
intracellular bacteria load in the entry assay. In contrast to the endpoint assay, the entry assay 
uses bacterial segmentation and a Voronoi cell body as cellular object. Only the GFP signal of 
intracellular Brucella was used to segment the pathogen in this image analysis pipeline. True 
intracellular bacteria were defined by a minimal size of 2 pixels and a GFP intensity which 
exceeds the GFP intensity of extracellular bacteria, which show a dim background GFP signal. A 
cell was considered infected, if at least one intracellular bacterial object overlaps with its Voronoi 
cell body. Furthermore, the bacterial load is estimated by calculating the average area of infected 
cells that is covered by intracellular bacteria. 
As for the endpoint assay, depletion of ArpC3 showed the expected reduction in Brucella 
infection in the entry assay compared to cells treated with a control siRNA (Figure 2B). 
Quantification of the infection rate confirmed that the number of infected cells (Figure 2C) as 
well as the number of intracellular bacteria in infected cells (Figure 2D) was reduced by depletion 
of ArpC3.   
 
Discussion 
 
Bacterial pathogens have evolved numerous strategies to manipulate eukaryotic host cells to their 
benefit. Pathogens causing acute infections often show rapid proliferation which is accompanied 
by significant alarming of the immune system and loss of viability of infected cells. In contrast, 
Brucella and other pathogens that cause chronic infections manage to establish long-lasting 
interactions within host cells. Therefore, bacteria need to fine tune host cell functions to their 
benefit without disrupting the cells homeostasis. A common strategy to identify the host cell 
factors involved in an infection process on a genome scale is the use of systematic gene depletion 
by siRNAs coupled to a functional readout of infection. Here we present protocols suitable for 
high-content high-throughput screening based on detection of fluorescent bacteria.  
An important aspect of successful large-scale screening involves a robust automated image 
analysis and infection scoring. The methods described here rely on the detection of a cell nucleus 
by DAPI staining which is generally very robust, and the definition of an area of interest where 
the pathogen signal is detected. The endpoint assay makes use of the detection of proliferating 
bacteria in the peri-nucleus, nucleus, and Voronoi cell body. This allows robust detection of 
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infected cells. Furthermore, it allows defining different thresholds for the individual 
compartments. While the thresholds can be set relatively low in the nucleus and peri-nucleus, 
higher thresholds should be employed for the Voronoi cell body. This helps to avoid the detection 
of GFP signal from neighboring cells which is important since the endpoint assay lasts for five 
days during which HeLa cells have proliferated and grown to confluency.  
The entry assay in contrast only lasts for three days and HeLa cells are thus not as densely grown. 
Here, only a Voronoi cell body of 25 pixels (16.125 μm) is chosen for three main reasons. First, 
early during infection bacteria might not yet have reached the nuclear or peri-nuclear area and 
may not be detected by measurements within these objects. Second, in contrast to the endpoint 
assay, bacteria have not started intracellular replication. Thus, using the Voronoi cell body object, 
we avoid missing individual bacteria which are located further away from the nucleus. Third, the 
endpoint assay makes use of quantification of the bacterial load which makes it desirable to cover 
as many bacteria as possible with the Voronoi cell body.  
A cell body stain such as the phalloidin staining suggested in this protocol is not essential for the 
detection of infected cells in either assay. Irrespective of the need for a cell body stain for 
infection scoring, we would suggest to make use of this staining if possible. Even though it 
comes with some additional costs of material and imaging time, it provides a number of valuable 
advantages. In both assays, a cell body stain will give additional information of morphological 
changes induced by the siRNA treatment. Altered cell size, cell shape, cell-cell-contacts, or actin 
distributions can be very important indicators of the underlying mechanism of altered pathogen 
infection14. Furthermore, it allows adjusting the size of the Voronoi cell body to fit the actual cell 
size especially when another cell type is used for this protocol. For the entry assay, a cell body 
staining with phalloidin would benefit the accuracy of infection scoring, especially for estimating 
the bacterial load of infected cells on a single cell level. This will be relevant if either a cell line 
with a very irregular shape is chosen or if the siRNA treatment induces morphological changes of 
the cell.  
In the entry assay, the dsRed fluorescent marker which is constitutively expressed in all bacteria 
is not directly used for infection scoring. However, it serves as important quality control. Visual 
inspection of images gives a good indication whether bacteria that are outside cells show no or 
only a very weak signal compared to bacteria in close proximity of cells, indicative of an 
intracellular location. This is an important control to make sure that induction of GFP by aTc as 
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well as inactivation of extracellular bacteria by gentamicin was efficient. Here, it has to be 
considered that in the absence of aTc bacteria express very low levels of GFP.  
In addition, extracellular bacteria (red signal and no/weak GFP signal) that overlap with a HeLa 
cell body can provide further information. In this case, bacteria could either be bound to the cell 
surface or they were internalized but failed to induce the GFP signal, indicative of very rapid 
killing of bacteria inside a host cell. These hypotheses can then be further tested with alternative 
assays such as counting of colony forming units (CFU) on TSA plates.   
A further advantage of using a tetracycline inducible system over differential antibody staining to 
visualize intracellular bacteria is its applicability for live cell imaging. Depletion of host factors 
potentially affects various stages of the infection process which can be resolved by quantifying 
the dynamics of intracellular stages. To this end, the tetracycline inducible system can be used 
with live cell imaging to measure the onset of replication or to provide the information of the 
percentage of intracellular bacteria that initiate replication. 
 
Disclosures 
 
The authors declare no conflicts of interest.  
 
Acknowledgements 
 
This work was supported by grant 51RT 0_126008 for the Research and Technology 
Development (RTD) project InfectX in the frame of SystemsX.ch, the Swiss Initiative for 
Systems Biology. We acknowledge grant 31003A-132979 from the Swiss National Science 
Foundation (SNSF). Work of S.H.L and A.C. was supported by the International PhD Program 
"Fellowships for Excellence" of the Biozentrum. Simone Muntwiler is acknowledged for 
technical assistance. We would like to thank Dirk Bumann from the Biozentrum for providing 
pNF106. We acknowledge Damian Murezzan for optimization of image analysis parameters. 
  
  3.1 Research article I 
61 
 
Materials 
 
Name Company Catalog 
number 
Comment 
Tryptic Soy Agar 
(TSA) 
BD 236950  
Tryptic Soy Broth 
(TSB) 
Fluka 22092  
Kanamycin sulfate Sigma-Aldrich 60615  
Skim milk    
250 ml screw cap 
bottle 
Corning 8396  
DMEM Sigma-Aldrich D5796  
Fetal Calf Serum 
(FCS) 
Gibco 10270 Heat-inactivated 
Greiner CELLSTAR 
384-well plate 
Sigma-Aldrich M2062  
Peelable aluminum 
foil 
Costar 6570  
Lipofectamine 
RNAiMAX 
Invitrogen 13778-150  
Gentamicin Sigma-Aldrich G1397  
Anhydrotetracycline 
hydrochloride 
Sigma-Aldrich 37919 100 ug/ml solution in 100% ethanol is 
kept at -20°C protected from light in 
aluminum-foil 
PBS Gibco 20012  
Paraformaldehyde Sigma-Aldrich P6148 Dissolve in 0.2 M HEPES buffer, pH 
7.4. Store at -20°C and thaw freshly the 
day before use. Each batch must be 
validated to ensure efficient inactivation 
of B. abortus 
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HEPES Sigma-Aldrich H3375  
Triton X-100 Sigma-Aldrich T9284  
DAPI Roche 10236276001  
DY-547-Phalloidin Dyomics 547-33 Optional 
DY-647-Phalloidin Dyomics 647-33 Optional 
Scrambled siRNA Dharmacon D-001810-10  
Kif11 siRNA Dharmacon L-003317-00  
ARPC3 siRNA Dharmacon L-005284-00  
Brucella abortus 
2308 
   
pJC43 (aphT::GFP)   Celli et al.12 
pAC042.08 
(aphT::dsRed, 
tetO::tetR-GFP) 
  Construction: pJC44 4 was digested with 
EcoRI followed by generation of blunt 
ends with Klenov enzyme and 
subsequent digestion with SalI. TetR-
GFP was amplified from pNF106 using 
primer prAC090 and prAC092. 
Following digestion with SalI, the TetR-
GFP product was ligated to the digested 
pJC44 vector. 
Primer prAC090 Sigma-Aldrich  TTTTTGAATTCTGGCAATTCCGAC
GTCTAAGAAACC 
Primer prAC092 Sigma-Aldrich  TTTTTGTCGACTTTGTCCTACTCA
GGAGAGCGTTC 
HeLa CCL-2 ATCC CCL-2  
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Figure legends 
 
Figure 1. Analysis of HeLa cells infected by B. abortus pGFP in the endpoint assay 
A) Endpoint assay: Fluorescence image showing example of endpoint assay (green = B. abortus 
expressing GFP, blue = nuclei stained with DAPI, scale bar = 50 μm). GFP expressing B. abortus 
was allowed to enter HeLa cells for 4 h followed by killing of extracellular bacteria with 
gentamicin. Further incubation for 40 h allows bacteria to replicate inside HeLa cells. Automated 
image analysis: CellProfiler is used to segment DAPI stained nuclei followed by calculation of 
the peri-nucleus (ring of 8 pixels surrounding the nucleus) and Voronoi cell body (extension of 
the nucleus by 25 pixels). A cell is considered infected if the integrated GFP intensity exceeds a 
least one of the thresholds set for the peri-nucleus, nucleus, or Voronoi cell body.  
B) Representative images of a full microscopic site of HeLa cells infected with GFP expressing 
B. abortus 44 h after infection. Cells were either transfected with a scrambled (non-targeting) 
control or siRNA targeting ArpC3. Scale bar = 50 μm 
C) Quantification of infection of HeLa cells depleted for ArpC3. Data are represented as box 
plots of Z scored infection rate (bar = mean; whiskers and outliers of boxplot calculated with 
Tukey method; ***p<0.001; Mann-Whitney test; n = 7)  
 
Figure 2. Quantification of HeLa cells infection by B. abortus pTetR-GFP in the entry assay 
 
A) Entry assay: Fluorescence image showing example of entry assay (green = intracellular B. 
abortus, blue = nuclei stained with DAPI, scale bar = 50 μm). B. abortus pTetR-GFP was 
allowed to enter HeLa cells for 4 h followed by inactivation of extracellular bacteria and 
simultaneous induction of GFP in intracellular bacteria with aTc for 4 h.  
B) Automated image analysis: CellProfiler was used to detect DAPI stained nuclei followed by 
calculation of a Voronoi cell body by radial extension of the nucleus by 25 pixels. Bacteria were 
segmented based on the GFP signal. A cell is considered infected if its Voronoi cell body 
overlaps with at least one segmented bacterial object. The bacterial load in infected cells is 
estimated by the area of segmented intracellular bacteria in infected cells (Feature used: 
AreaOccupied_AreaOccupied_TrueIntPathogen. No number is calculated in non-infected cells). 
C) Example images showing decreased infection of B. abortus pTetR-GFP in cells transfected 
with siRNA targeting ArpC3 compared to control treated cells (scrambled siRNA). The number 
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of infected cells as well as the average number of intracellular bacteria in infected cells is reduced 
upon ARPC3 knock down. 
D) Quantification of infection rate of HeLa cells with ArpC3 depletion. The data are represented 
as bar graphs (bar = mean; normalization to mock; error bars = standard error of the mean; 
*p<0.05; Mann-Whitney test; n = 4) 
E) Estimation of bacterial load of infected HeLa cells with ArpC3 depletion. The data are 
represented as bar graphs (bar = mean; normalization to mock; error bars = standard error of the 
mean; *p<0.05; Mann-Whitney test; n = 4) 
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Genome-wide siRNA screens for Brucella infection used for seed analysis were performed 
together with Dr. Shyan H. Low. I performed the Brucella infection experiment for the validation 
experiment and was involved in the design and preparation of the layout for all pathogen screens 
of the latter. 
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MicroRNAs miR-103 and miR-107 promote infection of Brucella 
and other intracellular pathogens in non-phagocytic cells 
 
Alain Casanova 1, Shyan Huey Low1, Mario Emmenlauer1,4 , Pauli Rämö 1, Alexander Schmidt3, 
Nitish Mittal2, Andreas Gruber2, Mihaela Zavolan2, Christoph Dehio1 
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3.3.1 Statement of own contribution 
 
miRNA mimics and genome-wide siRNA screens for Brucella infection were conducted together 
with Dr. Shyan H. Low. Entry assays, MEF infection, and the transferrin uptake assay were 
performed by myself. Transciptomics data were obtained in collaboration with Dr. Nitish Mittal 
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Abstract  
 
MicroRNAs are small non-coding RNAs that regulate gene expression in eukaryotic cells. It has 
become evident in recent years that miRNAs regulate central processes involved in viral and 
bacterial pathogenesis. In order to identify miRNAs that are involved in Brucella infection, we 
performed a functional miRNA mimic screen for Brucella entry, trafficking, and replication in 
HeLa cells. This revealed miRNAs miR-103 and miR-107 (miR-103/107) as positive regulators 
of Brucella invasion of non-phagocytic cells. The infection of other intracellular pathogens, such 
as Salmonella Typhimurium and adenovirus, were also enhanced by miR-103/107 emphasizing 
their importance in pathogen infection. Proteome and transcriptome studies of cells transfected 
with miR-103/107 mimics revealed an increase of cell surface components as well as an altered 
expression of factors involved in endocytic processes. In agreement with a change in endocytic 
properties, cells transfected with miR-103/107 mimics showed a decrease in clathrin-mediated 
uptake of transferrin. Depletion of several components of clathrin-mediated endocytosis (CME) 
was found previously to enhance Brucella infection. This supports the notion that CME 
negatively affects Brucella infection. Furthermore, it was found that TGF-β receptor 2, a host 
factor required for several intracellular pathogens, is upregulated by miR-103/107. 
Overexpression of TGF-β receptors or stimulation of the pathway by TGF-β was enhancing 
Brucella infection, further confirming the importance of this pathway. Altogether, this suggests 
that miR-103/107 controls several components of the host cell in favor of Brucella invasion and 
infection with other intracellular pathogens. 
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Introduction 
 
MicroRNAs (miRNA) are important post-transcriptional regulators of eukaryotic gene 
expression. They negatively affect gene expression by translational inhibition and destabilization 
of target mRNAs. Most mammalian miRNAs are generated from short transcripts that fold back 
on themselves to form specific hairpin structures. These are consecutively cleaved by the 
endonucleases drosha and dicer and are ultimately incorporated in the RNA induced silencing 
complex (RISC) (1). miRNAs mainly act by partial binding of the miRNA to the 3’ untranslated 
region (UTR) of target mRNAs via Watson-Crick base paring. The binding specificity of a 
miRNA is largely determined by complementarity of the so-called seed region to the target 
mRNA (2). The seed region comprises a stretch of 6-8 nucleotides located at the 5’ end of the 
miRNA. However, apart from canonical binding sites, some miRNAs were found to bind to the 
5’ UTR or coding regions of mRNAs (3, 4) and in some cases miRNA-mRNA interactions are 
determined by base-paring outside the seed region (5). 
miRNAs play a central role as regulators of almost any cellular process ranging from 
reprogramming of cells during differentiation and development to the maintenance of cell 
homeostasis and cell cycle control. It is thus not surprising that also functions related to pathogen 
infection are under the control of miRNAs. Immune cells have been described to respond to 
pathogen infections by differentially regulating several miRNAs in order to fine-tune the immune 
response (6). Further, RNA interference (RNAi) is directly involved in viral degradation in 
certain cell types (7). In return, pathogens make use of host miRNA pathways to their own 
benefit. Viral pathogens have evolved multiple strategies to interfere with the host RNAi 
machinery or they even encode their own miRNAs (8). Bacteria were found to manipulate 
cellular miRNA expression by secretion of effector proteins to manipulate host cell functions 
such as the cell cycle or cell differentiation (9, 10).  
Pathogenic bacteria and viruses have evolved to survive inside mammalian cells with a varying 
degree of dependence on host factors. While all viruses are obligate intracellular organisms, 
many intracellular bacteria are able to survive outside of a host cell. However, an intracellular 
lifestyle offers protection from host immune components such as the complement system or 
antibodies and provides resources favorable for growth and replication. Host cells in return have 
adapted to the threat of pathogen invasion by numerous cellular functions that allow the detection 
of pathogen-specific molecules or damage associated with the attack (11). Depending on the 
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infection strategy of the pathogen the impact on cell viability can differ considerably. Pathogens 
that cause acute infections often lead to the death of infected host cells, which is associated with 
rapid proliferation and spread of the pathogen. In contrast, pathogens that cause chronic 
infections often protect their host cell from cell death to establish a long lasting niche for their 
survival and replication (12).  
Independent of the infection strategy, all intracellular pathogens need to gain access to the 
interior of the cell. Bacteria and viruses have evolved to make use of the full spectrum of 
endocytic pathways that a cell offers. These include macropinocytosis as well as clathrin- and 
caveolin-dependent and -independent mechanisms (13). Some pathogens rely on signaling 
induced on the cell surface by direct or indirect interaction of pathogen molecules and cell 
surface receptor. This applies to all viruses as well as bacterial pathogens that enter cells by a 
zipper-like mechanism (e.g.: Listeria monocytogenes). Other bacterial pathogens make use of 
specialized secretion systems to deliver effector proteins into the host cell that trigger their 
uptake. Examples are Salmonella and Shigella that induce large, actin-rich membrane ruffles on 
the cell surface which resemble macropinosomes (14).  
Brucella species are facultative intracellular pathogens that infect domestic animals as their 
natural hosts. Transmission to humans is most commonly caused by direct contact with infected 
animals or by ingestion of contaminated food and can lead to severe chronic infections (15). 
Brucella is able to invade phagocytic and non-phagocytic cells and replicates within an 
intracellular compartment known as the Brucella-containing vacuole (BCV). Following the 
internalization of bacteria into a eukaryotic host cell, the BCV is transported along the endocytic 
pathway and, despite the interaction with lysosomes, bacteria manage to avoid degradation (16).  
During the phase of trafficking and until Brucella establishes an endoplasmic reticulum (ER)-like 
replicative niche (17), bacteria do not divide. During intracellular proliferation, BCVs are found 
in close association with ER markers such as calnexin and glucose-6-phosphatase (18).  
Despite the importance of miRNAs in pathogen infection, there is very little knowledge around as 
to what impact miRNAs might have on Brucella infection. We thus screened a library of human 
miRNA mimics for their effect on Brucella infection of HeLa cells. By this, several miRNAs 
including miR-103 and miR-107 (miR-103/107) were identified that enhance Brucella infection 
of non-phagocytic cells. Furthermore, these miRNAs also enhanced infection of HeLa cells by 
different bacterial and viral pathogens. To investigate which cellular processes are regulated by 
miR-103/107, we measured changes of the proteome and transcriptome induced by high levels of 
  3.3 Research article III  
91 
 
miR-103/107. Several cell surface factors, partially already described to be important during the 
infection process of certain intracellular pathogens, were identified. Among those was TGF-β 
receptor 2 (TGFBR2) which showed increased protein levels upon transfection of miR-103/107. 
This kinase had been independently identified as crucial for Brucella infection in a siRNA-
mediated mRNA-depletion study (research article IV), where cells were investigated under the 
same experimental conditions as used for the miRNA mimic screen. We could show here, that 
overexpression of the receptor or activation of the pathway by addition of the ligand indeed 
promotes Brucella infection. We speculated that altered endocytosis or recycling of cell surface 
receptors could underlie the observed changes of several cell surface proteins. In agreement with 
this hypothesis CME of transferrin was reduced in miR103/107-treated cells. It will be interesting 
to further dissect the underlying principle of how the increased miR-103/107 levels enhance the 
susceptibility of non-phagocytic cells to Brucella infection and to link these findings to cell 
surface receptors and the endocytic trafficking routes.  
 
Results 
 
Screening for miRNAs identifies miR-103 and miR-107 to promote Brucella infection 
In order to study the effect of human miRNAs on Brucella infection we performed a high-content 
high-throughput miRNA mimic screen in HeLa cells covering over 1200 human miRNAs. HeLa 
cells were transfected for three days with miRNA mimics followed by infection with GFP-
expressing Brucella abortus. After bacterial internalization for 4 h the remaining extracellular 
bacteria were inactivated by gentamycin and the infectious process was continued for a total of 
44 h. This endpoint assay allows the identification of miRNAs involved in Brucella entry, 
trafficking, and replication. It was observed that many miRNAs showed an effect on Brucella 
infection (Fig. 1A). The strongest up and down hits are summarized in Table 1 (a complete list 
can be found in Suppl. Table 1).  
miR-103/107 was found to cause a striking increase in Brucella infection (Fig. 1A, 1B). These 
miRNAs belong to a conserved miRNA family and share an identical sequence except for a 
single nucleotide difference at position 22. Even though miRNAs preferentially interact with their 
mRNA targets by base pairing in the seed region, different non-canonical miRNA-mRNA 
interactions involving base-pairing outside the seed have been found (5). These options cannot be 
readily distinguished for miR-103 and miR-107, since they share most of their sequence. We 
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previously performed siRNA screens using the same experimental setup as for the present 
miRNA mimic screen and identified prominent seed-driven off-target effects (19). We found that 
siRNAs and miRNA mimics that share the same seed sequence also affect Brucella infection in a 
comparable manner. We thus searched for siRNAs with a seed sequence identical to the one of 
miR-103/107 (GCAGCAU) and found two oligos (Fig. 1C, highlighted in bold).  Both siRNAs 
showed a strong positive effect on Brucella infection similar to the one observed for miR-
103/107. These oligos belonged to a genome-wide siRNA library from Qiagen with four siRNAs 
per target gene. The other three siRNAs of the Qiagen library designed against the same targets 
(MMP13 and CTAG1B) did not show an effect on infection, indicating that depletion of these 
genes does not affect Brucella infection per se (data not shown).  This suggests that the two 
siRNAs act like synthetic miR-103/107 miRNAs. Since these oligos only share the seed sequence 
but not the rest of the sequence with miR-103/107 we concluded that the seed sequence 
determines binding specificity for those targets that promote Brucella infection.  
Interestingly, the third strongest up hit, miR-1184, shares with miR-103/107 a GCAGC motif in 
its seed sequence which is shifted within the seed by two positions (Fig. 1C). Two miRNAs with 
an identical sequence motif within the seed which is shifted by one or several positions could in 
principle bind to the same mRNA if the nucleotides on the mRNA which flank the sequence 
motif are complementary to both miRNA seeds. This potentially allows miR-1184 and miR-
103/107 to regulate a partially overlapping set of target genes. Even though the effect of miR-
1184 was not as pronounced as for miR-103/107, it is conceivable that some of the cellular 
targets underlying the observed increase in infection might be shared. Looking at all available 
siRNAs and miRNA mimics of our screens that contain a GCAGC motif in their seed we found a 
number of similar sequences that increase Brucella infection (Fig. 1C). An alignment of all seed 
sequences with a Z-scored infection index ≥ 4 identified a UGCAGC motif (Fig. 1D). Even 
though the complete sequence space of possible seeds containing a GCAGC motif is not fully 
covered in our siRNA screens, it is evident that certain seed families such the well represented 
miR-15 family (miR-15a, miR-15b, miR-16, miR-195, miR-424, miR-497) do not regulate 
Brucella infection. 
 
miR-103 and miR-107 promote Brucella entry into non-phagocytic cells  
To better characterize the effect of miR-103/107 during Brucella infection, we performed an 
image-based follow-up assay to study the effect of these miRNAs on bacterial entry (Fig. 2A). 
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This assay makes use of a tetracycline-inducible GFP to selectively mark intracellular bacteria 
after infection. Following incubation of bacteria with host cells, extracellular bacteria are 
inactivated by the cell-impermeable antibiotic gentamycin. At the same time the non-toxic 
tetracycline analog, anhydrotetracycline (aTc), is added. Since aTc is cell-permeable, it will 
induce GFP expression in intracellular bacteria which are not inactivated by gentamycin. This 
results in GFP expression solely in viable intracellular bacteria. We found that cells treated with 
either a miR-103 mimic or siRNAs sharing the same or a similar seed sequence were more 
strongly infected by Brucella in the entry assay (Fig. 2B-2E).  The number of cells containing 
intracellular Brucella as well as the bacterial load measured by the integrated GFP intensity of 
intracellular bacteria in infected cells was increased. This shows that bacterial entry is enhanced 
by high levels of miR-103/107.  
Since the miR-103/107 family is evolutionary conserved in vertebrates (20), we were interested 
to see whether similar effects on infection would be observed in species other than human. To 
this end, we repeated the experiment in mouse embryonic fibroblasts (MEFs). The transfection 
efficiency as measured by cell death induced by transfection of an siRNA targeting kif11 was not 
as high as for HeLa cells (Fig. 3A). Despite the reduced transfection efficiency, the effect of the 
positive control, an ARPC3 depletion to interfere with actin filament networks, led to a 
detectably lower infection with Brucella. We thus went on to test the effect of miR-103 mimics in 
MEF cells and preliminary results (n=2) indicate an increase in the intracellular bacterial load for 
all infection intervals tested. Enhanced infection relative to the scrambled control siRNA (non-
targeting control) was observed as early as 8 h after infection and remained constant up to 48 h 
indicating that also in MEF cells miR-103 promotes Brucella uptake.  
 
Infection of different intracellular bacterial and viral pathogens is promoted by miR-
103/107  
Since all intracellular pathogens have to enter host cells, we wondered whether the miR-103/107 
family positively affects the infection of other intracellular pathogens. Similar miRNA mimic 
screens using largely standardized protocols were performed on a number of different 
intracellular viral and bacterial pathogens (full screens will be published elsewhere). These 
pathogens use a wide variety of infection strategies throughout their life cycle. Entry into host 
cells is achieved by a trigger mechanism (Salmonella Typhimurium), zipper mechanism (Listeria 
monocytogenes), invasome formation (Bartonella henselae), or receptor-mediated endocytosis 
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(adenovirus, rhinovirus) (13).  Additionally, each screen covers further aspects of the intracellular 
lifecycle of the corresponding organism. With the exception of Bartonella henselae invasome 
formation (21) we consistently observed an increase in infection for S. Typhimurium, L. 
monocytogenes, adenovirus, and rhinovirus (Fig. 4). Even though most effects were not as 
pronounced as for Brucella, it shows that this family of miRNAs alters host cell function in favor 
of infection with the tested pathogens.  
 
Identification of proteome and transcriptome changes induced by miR-103/107 
To gain a comprehensive understanding of the cellular changes induced by miR-103/107 we 
performed proteome as well as transcriptome analyses of HeLa cells transfected with miRNA 
mimics. In a first approach we measured the proteome changes induced by miR-103 or miR-107 
compared to scrambled controls. We were able to identify over 7’000 proteins across samples. 
No differentially expressed proteins could be identified when comparing the samples from miR-
103 and miR-107 treated cells (Suppl. Table 3) and shows that the effect of both miRNAs on the 
detectable proteome is largely identical. In contrast, about 500 proteins were differentially 
expressed in miR-103/107 treated cells compared to the scrambled control when a false discovery 
rate below 1% was used as a threshold (Fig. 5A).  
For the transcriptomics approach, miR-103 and scrambled treated HeLa cells were compared and 
over 14’000 mRNA transcripts could be identified by Illumina sequencing. Since miRNAs act by 
direct binding to target mRNAs leading to inhibition of translation and a destabilization of the 
mRNA we expected to observe similar changes for direct targets using both approaches. Indeed 
the overall correlation of mRNA and protein changes induced by miR-103 compared to 
scrambled-treated cells was good and an even higher agreement was found for predicted direct 
targets of miR-103 (Suppl. Fig. S1). Both approaches showed that miR-103 targets predicted by 
TargetScan (22) or Elmmo (23) software are predominantly down-regulated (Fig. 5A, 
Suppl. Fig. S2, Suppl. Fig. S3), which is agreement with the action of miRNAs. Consistent with 
previous reports we could identify DICER and CDK6 to be strongly down-regulated (24, 25).  
 
miR-103/107 alters protein abundance of cell surface components and affects cell cycle 
To obtain a global picture of the changes induced by miR-103/107 we performed pathway 
analysis with those factors of the proteomics study which were significantly changed. This 
revealed a significant enrichment of upregulated proteins with terms associated to the plasma 
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membrane, enzyme-linked receptor signaling, and cell adhesion (Fig. 6A). A similar picture was 
observed when string analysis was used to identify interacting proteins among the altered factors. 
The strongest clusters of upregulated proteins were EGF signaling, TGF-β signaling, as well as 
adhesion and extracellular matrix (Fig. 7) supporting the notion that the cell surface undergoes 
changes when miR-103/107 levels are increased. For proteins down-regulated upon miR-103/107 
treatment in turn, several components associated with microtubules and vesicular transport came 
up and particularly a very strong effect on cell cycle components was found. Gene ontology 
terms (GO terms) such as DNA replication, cell cycle, and DNA metabolic processes were 
strongly enriched (Fig. 6B). String analysis revealed interactions among down-regulated proteins 
involved in cell cycle regulation such as the cyclin-dependent kinases CDK4 and CDK6 which 
both promote G1/S phase transition. Furthermore, all six components of the DNA helicase 
(MCM2 - MCM7) and all four subunits of DNA polymerase delta (POLD1 - POLD4) showed 
reduced protein levels. Likely related to an influence on the cell cycle, a treatment with miR-
103/107 led to a mild negative effect on cell number after three days of transfection and the effect 
became more prominent with a transfection-duration of five days (Suppl. Fig. S4). 
 
TGF- β receptor 2 is upregulated by miR-103/107 and promotes Brucella infection 
In order to narrow down candidate genes that could account for the increased susceptibility to 
Brucella infection caused by miR-103/107, we used data from a genome-wide siRNA screen for 
Brucella infection that was previously performed in the lab (research article V). Overlay of the 
top 500 up- and down -hits from the screen with proteomics data identified eight candidate genes 
that increase infection when depleted by siRNAs and that were also down-regulated by miR-
103/107  (with decreasing strength: NFIB, KIAA0664, SNX1, ASNA1, PDE8B, SDF2, MAP4, 
PEX14). Among the proteins upregulated by miR-103/107 we found eight genes that had a 
negative effect on infection, suggesting that increasing these host factors might benefit Brucella 
infection (with decreasing strength: TGFBR2, SLC3A2, STK4, STMN3, ADO, LAMB1, 
UBE2D1, CDC34). Interestingly, TGFBR2 was also found among the top hits in a comparative 
kinome-wide siRNA screen covering several intracellular pathogens (research article IV). There 
we found that depletion of TGFBR2 as well as TGFBR1, which form a functional heterotetramer 
during TGF-β signaling, reduced infection of several pathogens whose infection is promoted by 
miR-103/107. This suggests that increased TGFBR2 levels could promote pathogen infection 
observed here. Indeed, overexpression of wild-type TGFBR2 or TGFBR1 in HeLa cells led to a 
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mild yet significant increase in Brucella infection, while dominant negative alleles caused a 
reduction in infection. Furthermore, we found that activation of the pathway by addition of the 
ligand TGF-β1 also promoted infection (Fig. 8). Altogether, these data indicate that elevated 
levels of TGFBR2 could account partially for the increased susceptibility of cells to infection 
when levels of miR-103/107 are increased. 
 
Clathrin-mediated endocytosis is reduced by miR-103/107 
Since several cell surface components that undergo CME, including EGFR and TGFBR2, were 
upregulated by miR-103/107, we wanted to assess whether the rate of CME is altered (26, 27). To 
this end, HeLa cells were transfected with a miR-103 mimic for three days and incubated with 
fluorescently labeled transferrin (Tf). Comparison to cells transfected with a non-targeting 
control oligo revealed that miR-103/107 reduced Tf-uptake (Fig. 9). As the levels of transferrin 
receptor were not significantly altered by miR-103/107 (miR-103/107 vs. control: log2=0.24) we 
conclude that the CME-dependent Tf-uptake is indeed reduced in presence of elevated miR-
103/107 levels. Interestingly, we previously found that siRNA-induced depletion of several 
components involved in either the formation or the uncoating of clathrin coated pits (AP2S1, 
AP2A1, CLTC, EPN1 (research article V) and GAK (research article IV), respectively) enhance 
Brucella infection. There is thus independent evidence that reduced CME benefits Brucella 
infection. 
 
Discussion  
 
miRNAs are well studied regulators of gene expression and have gained increasing importance in 
contributing to cellular traits relevant for host-pathogen interactions. Here, we tested a library of 
over 1200 human miRNAs for their role in Brucella infection of HeLa cells. This identified 
candidate miRNAs involved in entry, trafficking, or replication of this intracellular pathogen and 
presents a rich resource for further investigations.  
We identified two closely related microRNAs, miR-103 and miR-107, that strongly promote 
Brucella infection and we could show that already the stage of bacterial entry is enhanced by 
increased levels of these miRNAs. The family of miR-103/107 miRNAs is broadly conserved 
across species and accordingly, a similar reduction in Brucella entry upon a raise of miR-103/107 
could be observed in mouse embryonic fibroblasts. This suggests that not only the miRNAs are 
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conserved, but also the targets which underlie the increased susceptibility of non-phagocytic cells 
to Brucella infection when miR-103/107 levels are high.  
Interestingly, infection of several other intracellular viral and bacterial pathogens was also 
positively affected by elevated levels of miR-103/107. These pathogens use very distinct 
infection strategies and each of the assays covered aspects of the infection cycle which go beyond 
invasion of the host cell. Therefore, several scenarios are possible that would explain how one 
family of miRNAs could affect such diverse pathogens.  Either, the miRNAs affect multiple 
cellular functions that promote a different relevant step for each pathogen or a single cellular 
mechanism, which benefits all pathogens, is altered. If the latter is the case, it is likely that the 
entry process is affected. Indicative for this is first our finding that this is the stage Brucella 
infection is promoted and second, because all intracellular pathogens share the need of cell 
invasion. 
To shed more light on the cellular changes induced by high levels if miR-103/107, we analyzed 
transfected cells for the changes induced on the proteome and transcriptome levels. Both methods 
showed good correlation, especially for predicted direct targets of miR-103/107. This indicates 
that the miRNAs mainly act via the classical pathways involving translational inhibition as well 
as destabilization of target mRNAs. Proteins deregulated by miR-103/107 populated distinct 
cellular pathways when analyzed by Gene enrichment and protein-protein interaction algorithms. 
Several cell surface-located factors were found to be upregulated. Interestingly, these include the 
transmembrane kinase TGFBR2, which was previously found to be involved in the infection of 
several intracellular pathogens (research article IV). In that study, siRNA depletion of TGFBR2 
was found to decrease pathogen infection. Here, we confirmed that increasing TGF-β receptor 
levels or activation of the pathway by addition of the ligand TGF-β1 enhances Brucella infection. 
Even though the effects were not as pronounced as seen for transfection of miR-103/107, this 
shows that elevated TGFBR2 levels could partially account for the observed effect. It remains to 
be shown if the TGF-β pathway also accounts for the facilitated entry of other pathogens which 
showed enhanced infection by miR-103/107 transfection.  
Arguing that a change in endocytic properties of a cell could benefit a broader spectrum of 
pathogen entry processes, we investigated the effects of miR-103/107 on CME. We found that 
transferrin uptake was negatively affected in cells transfected with miR-103/107. At this point it 
remains open whether transferrin uptake is reduced or recycling to the cell surface is increased. 
Since TGFBR2 as well as EGFR are endocytosed in a clathrin-dependent manner, any of the 
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above-mentioned scenarios could result in a net increase of the protein due to altered degradation. 
Along these lines, we found that additional cell surface proteins relevant for other pathogens were 
also upregulated. MET is mildly, but significantly, upregulated and is the only receptor for 
Listeria monocytogenes entry in HeLa cells that lack E-cadherin (28). Furthermore, we found 
receptors involved in adenovirus entry to be upregulated by miR-103/107. These include 
Integrinβ3 (ITB3) (29), which was among the proteins with the strongest increase, as well as 
coxsackie and adenovirus receptor (CXDAR) which was mildly upregulated (30). Altogether, we 
provide preliminary evidence for the hypothesis that altered miR-103/107 might have a broad 
impact on endocytic processes which, in consequence, might result in changed cell surface 
display of different pathogen receptors. It will be interesting to verify this further in context of the 
respective organisms.  
While high levels of miR-103/107 increased protein levels of all above-mentioned surface 
receptors, they are unlikely to be directly targeted by the miRNAs, since this generally results in 
a negative regulation. Among the 8 candidate genes that promoted Brucella infection in a 
genome-wide siRNA screen and also showed reduced protein levels in the presence of miR-
103/107, three are predicted to be direct targets. These are nuclear factor I B (NFIB), 
phosphodiesterase 8B (PDE8B), and microtubule-associated protein 4 (MAP4). NFIB is a site-
specific transcription factor involved in positive and negative regulation of various cellular 
processes from stem cell biology to brain development (31, 32). PDE8B is involved in regulation 
of cAMP signaling by catalyzing the hydrolysis of cAMP (33). MAP4 promotes microtubule 
assembly, counteracts microtubule catastrophe, and has thus major impact on cell cycle 
regulation (34). Since siRNA mediated depletion of any of these genes in isolation did only 
mildly increase Brucella infection, it remains to be investigated if their combinatorial knockdown 
might phenocopy the effect of miR-103/107. 
Cell cycle related proteins were found to be most strongly enriched among the down-regulated 
proteins in miR-103/107 treated cells. Two cell cycle dependent kinases, CDK4 and CDK6, as 
well as one of the interacting cyclins (CCND3) were found down-regulated. These factors are 
responsible for initiation of G1/S phase transition by phosphorylation of the retinoblastoma 
protein RB1, which in its unphosphorylated form inhibits the action of E2F transcription factors. 
Activity of E2F is required for the synthesis of genes involved in cell cycle progression (35). 
Among those, many were also found to be down-regulated by miR-103/107, indicative of a 
secondary effect of CDK4/6 depletion and a G1 arrest. Comparable effects on the cell cycle were 
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also reported for miRNAs with seed sequences closely related to the seed of miR-103/107, like 
the miR-15 family (miR-15a, miR-15b, miR-16, miR-195, miR-424, miR-497) (36). 
Nevertheless, there is currently no support of the notion that a G1 arrest could be the underlying 
cause for increased susceptibility of cells to pathogen infection as identified here. The miR-15 
family miRNAs did not affect Brucella infection and a report by Maudet and colleagues recently 
reported inhibitory effects of miR-15 on Salmonella infection, although only at later stages 
during infection, which were not tested in the Salmonella screen presented here (9).  
microRNAs miR-103 and miR-107 have previously been implicated in multiple biological 
processes including cancer (24), cell cycle regulation (37), or insulin sensitivity (38). Here, we 
found that Brucella invasion of non-phagocytic cells is strongly promoted by this family of 
miRNAs. Infection with other intracellular pathogens was also enhanced and CME of the host 
cell was reduced. Altogether, this indicates that the endocytic properties of the host cell are 
altered in favor of diverse pathogenic infections which are related to different endocytic routes. It 
will thus be interesting to study the effects of miR-103/107 on further endocytic pathways such as 
macropinocytosis or caveolae in non-phagocytic cells and correlate these to entry of diverse 
pathogens. 
 
  
3.3 Research article III 
 
100 
 
Materials and Methods  
 
Culture of bacteria and cells 
Brucella abortus 2308 strains used in this study contain plasmids pJC43 (39) and pAC042.08 
(research article I) and were grown in tryptic soy broth (TSB) medium (Fluka, 22092) containing 
50 ug/ml kanamycin (Sigma-Aldrich, 60615).  
Salmonella Typhimurium strain S.TmSopE_pM975 was grown in 0.3 M LB medium containing 
50 ug/ml streptomycin and 50 ug/ml ampicillin.  
Bartonella henselae ATCC49882T containing plasmid pCD353 (40) was grown on Columbia 
base agar (CBA; Thermo Scientific, CM0331B) plates supplemented with 5% defibrinated sheep 
blood (Thermo Scientific, SR0051) and 50 ug/ml kanamycin. 
Listeria monocytogenes EGDe.PrfA*GFP (41) was grown in liquid Bacto Brain Heart Infusion 
(BHI) (BD, 237500).  
HeLa cells (human cervical carcinoma epithelial cell line; ATCC, CCL-2) and mouse embryonic 
fibroblasts (MEFs) were grown in Dulbecco´s Modified Eagle Medium (DMEM) (Sigma, 
D5796) supplemented with 10 % heat-inactivated Fetal Calf Serum (FCS; Gibco, 10270).  
 
Reverse transfection 
Reverse siRNA and miRNA mimic transfection was performed as described in research article I. 
Unless otherwise stated, the following conditions were used: 1.6 pmol siRNA or miRNA mimic 
were used per well of a 384 well plate. RNAiMAX (Invitrogen, 13778-150) was used 1:250 in 
DMEM without FCS and RNA:RNAiMAX complex formation was allowed for 1 h at room 
temperature. 500 HeLa cells or the indicated number of MEF cells were reverse transfected in 
DMEM/10% FCS for three and two days prior to infection, respectively. 
For screening of human miRNAs the Human miRIDIAN miRNA Mimic Library version 16.0 
(Dharmacon, CS-00100-E2-01) was used. 
 
Brucella infection 
Brucella infection for the miRNA mimic screen and the entry assay in HeLa cells was performed 
as described in research article I and is summarized here.  
HeLa cells were infected with B. abortus 2308 pJC43 (aphT::GFP) at an MOI of 104. The 
infection process was synchronized by centrifugation at 400 g and 4°C for 20 min. After 4 h of 
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incubation at 37°C and 5% CO2, extracellular bacteria were killed by addition of 100 ug/ml 
gentamicin (Sigma, G1397) in DMEM/10% FCS. After a total of 44 h, cells were washed in PBS 
(Gibco, 20012) and fixed in 3.7% paraformaldehyde (PFA) (Sigma, P6148) for 20 min at RT. 
After permeabilization in 0.1% Triton- X-100 (Sigma-Aldrich, T9284), cell were stained with 
DAPI (1 ug/ml; Roche, 10236276001) and DY-547-phalloidin (1.5 U/ml; Dyomics, 547PI-33).  
For the entry assay Brucella abortus 2308 pAC042.08 (aphT::dsRed, tetO::tetR-GFP) was used 
as described above. After the first gentamicin wash, cell were washed again with DMEM/10% 
FCS containing 100 ug/ml gentamicin and 100 ng/ml anhydrotetracycline (Sigma, 37919) for 4 h 
to induce GFP expression in intracellular bacteria. After fixation, cells were stained with DAPI 
(1 ug/ml).  
Mouse embryonic fibroblasts (MEFs) were infected with B. abortus 2308 pAC042.08 as 
described for the entry assay. Induction of GFP expression in intracellular bacteria started at 4 h 
after inactivation of extracellular bacteria by gentamycin treatment and continued throughout the 
experiment. Fixed cells were stained with DAPI (1 ug/ml). 
 
Imaging, automated image analysis  
Imaging, image analysis, and infection scoring was performed as described in research article IV 
with minor modifications as described here.  
Images were acquired using a Molecular Device ImageXpress microscope with a 10X S Fluor 
objective with 0.45 NA. Laser-based autofocusing on each site was used for acquisition of a 3x3 
image array per site without gain and with a 12 bit dynamic range. Z-offsets for each channel and 
exposure times were manually defined ensuring a high dynamic range and low overexposure. 
DNA was imaged in the DAPI channel, pathogens in GFP, and, depending on the assay, F-actin 
in RFP or Cy5. The Listeria screen uses an additional Cy3 staining as described in detail by 
Kühbacher et al. (41).  
Images were scaled such that pixel intensities of a full plate lie between 0 and 1. Images were 
then corrected for shading (flat field correction, vignetting correction) by applying a shading 
model to the image pixels. Pathogen signal in the DAPI channel was removed to increase the 
quality of the nucleus segmentation. The pathogen signal was removed by subtracting a linear 
transformation of the GFP channel from the DAPI channel. On the corrected images, object 
detection was performed using CellProfiler (42). Firstly, nucleus objects labeled “Nuclei“ were 
segmented in the DAPI channel using OTSU’s method (CellProfiler module 
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IdentifyPrimAutomatic). Secondly, a peri-nuclear ring object labeled “PeriNuclei” was 
constructed by extending the nucleus object by eight pixels and removing the nuclear area from 
the extended nuclear area (CellProfiler modules ExpandOrShrink and IdentifyTertiary). Thirdly, 
a cell body object labeled “Cells” was segmented in the Actin channel using the “Propagation” 
method around the nucleus object (CellProfiler module IdentifySecondaryInformed). Finally, a 
non-actin based cell body object labeled “VoronoiCells” was constructed by extending the 
nucleus object by twenty-five pixels (CellProfiler module ExpandOrShrink). For assays using B. 
abortus 2308 pAC042.08 that allows the detection of intracellular bacteria, the cell body was not 
stained with a fluorescent marker and only a Voronoi cell body is used. Intracellular bacteria 
were segmented in CellProfiler using the GFP signal from intracellular bacteria based on the 
OTSU method or wavelets. 
On the segmented objects, measurements were performed using CellProfiler. From all segmented 
objects (Nuclei, PeriNuclei, Cells, VoronoiCells, Bacteria), shape measurements were extracted. 
Intensity and texture measurements were extracted from all available channels (DAPI, Actin, and 
Pathogen). 
 
Infection scoring for Brucella infections with B. abortus 2308 pJC43 
Infection detection was done on a binary level (infected vs. non-infected) that allows the infection 
index to be defined. The infection index is the ration of infected cells to total cell number in a 
well. We selected a number of image analysis single cell features that were most sensitive to the 
infection phenotype. To quantify B. abortus infection for the endpoint assay, GFP intensity was 
measured in the objects Nuclei, PeriNuclei, and Cells using CellProfiler module 
MeasureObjectIntensity. Thresholds for GFP intensity for each of the objects were set manually 
and a cell was considered infected if any of the thresholds was reached.  
 
Segmentation-based infection scoring for assays using B. abortus 2308 pAC042.08 
A cell is defined as “infected” if a pathogen object of at least 2 pixels and GFP intensity above 
the threshold overlaps with a Voronoi cell body. The bacterial load is quantified using the median 
integrated GFP intensity.  
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Infection assay and analysis of other pathogen infections  
Infection screens in HeLa cells with adenovirus (Ad2_ΔE3B-eGFP (43)), Bartonella (Bartonella 
henselae ATCC49882T containing plasmid pCD353 (40)), Listeria (Listeria monocytogenes 
EGDe.PrfA*GFP (41)), rhinovirus (human rhinovirus serotype 1a (HRV1a (44, 45)), Salmonella 
SopE (Salmonella Typhimurium strain S.TmSopE_pM975) were performed and analyzed as 
described in research article IV.  
 
Transferrin uptake assay 
Transferrin (Tf) uptake assay was performed as described by Hirschmann et al. (personal 
communication: Hirschmann, D.T., Kasper, C.A., and Spiess, M. (in press). Quantitative analysis 
of Tf cycling by automated fluorescence microscopy. Methods Mol. Biol.) with some 
modifications in image analysis. Scrambled siRNA or miR-103 miRNA mimic were mixed with 
RNAiMAX (1:250) in DMEM without FCS and 90 ul were added per well of a 96 well plate. 
After 30 min of incubation at room temperature, 150 ul of a HeLa CCl-2 cell suspension of 
16’000 cells in DMEM/16% FCS was added, resulting in 2400 cell per well and a final FCS 
concentration of 10%. Cells were incubated at 37°C and 5% CO2 for 3 days. The cells were 
washed once with assay medium (DMEM without FCS, buffered with 20 mM HEPES (Gibco, 
15630-080)) and incubated in assay medium for 2 h at 37°C and 5% CO2. The plates were 
transferred to a 37°C water bath and the medium was replaced by 50 ul of assay medium 
containing 50 ug/ml of fluorescently labeled transferrin (568-Tf, Invitrogen, T-23365) for the 
time indicated. Endocytosis was stopped by rapid transfer of the assay plate to a metal plate 
precooled on ice and the addition of 150 ul/well ice-cold PBS. Cells were twice quickly washed 
with ice-cold PBS followed by a wash with ice-cold stripping buffer (150 mM NaCl, 50 mM 
NaAcetate, pH 3.5) to remove surface bound 568-Tf. Cells were fixed with 170 ul/well 3% PFA 
solution for 5 min on ice followed by 10 min at room temperature. Cells were washed once with 
PBS, once with 50 mM ammonium chloride in PBS, followed by 3 washes with PBS. Cells were 
permeabilized for 1 min in 100 ul/well 0.1% Triton-X-100 in PBS and washed four times in PBS. 
Nuclei were stained by DAPI (1 ug/ml) and the actin cytoskeleton by DY-495-Phalloidin 
(1 U/ml; Dyomics, 495-33) followed by four PBS washes. Unless otherwise stated, 200 ul/well 
are used for all washing steps. Imaging and image analysis were performed as described above, 
acquiring 25 sites/well. Nuclei and cell body were segmented using the signals from the DAPI 
and the DY-488-Phalloidin signals, respectively, applying the image analysis pipeline as 
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described above. Internalized Tf was quantified by measuring the mean Tf-568 fluorescence 
intensity per cell averaged over all cells per condition.   
 
Plasmid transfection  
HeLa cells were seeded a day before transfection in a 6 well plate with 2.5*105 cells/well. For 
double transfection, 0.9 μg of plasmid or 0.45 μg of each plasmid (in 200 μl of DMEM without 
FCS) were mixed with 8 μl of Fugene HD (Promega, E2312) (in 200 μl of DMEM without FCS) 
and incubated for 15 min at RT. The medium on HeLa cells was exchanged with 1.5 ml of fresh 
medium and the DNA-Fugene complex was added to the cells. The next morning, cells were 
exchanged with fresh medium and in the evening seeded into a 96 well format (2800 cells/well) 
for infections on the following day.  
 
TGF-β assay  
HeLa cells (2800 cells/well) were seeded a day before infection in a 96 well format with DMEM 
(Sigma)/10% FCS (Gibco) containing TGFβ-1 (R&D Systems, 240-13). Cells were then 
incubated at 37°C and 5% CO2 for another 24 h, after which infection was performed in absence 
of TGFβ-1 in the culture medium.  
 
Quantitative proteomics 
Scrambled siRNA or miRNA mimic were mixed with RNAiMAX (1:250) in DMEM without 
FCS and 600 ul were added per well of a 24 well plate. After 30 min of incubation at RT, 105 
HeLa CCl-2 cells were seeded per well. Cells were incubated at 37°C and 5% CO2 for 3 days. 
Cells were washed with 500 ul/well trypsin and detached from the well by incubation in 500 ul of 
trypsin at 37°C and 5% CO2 for 2-3 min. Cells were washed twice in PBS, the supernatant was 
removed and the cell pellet was frozen in liquid nitrogen and kept at -80°C until processing. Cells 
from 2 wells per sample were pooled for proteomics analysis. 
Sample preparation: For each sample, cells were resuspended in 100 µl of lysis buffer 
(2% sodium deoxycholate (DOC), 100 mM ammonium bicarbonate), sonicated for 2x10 s using a 
vial tweeter and spinned down. A small aliquot of the supernatant was taken to determine the 
protein concentration using a BCA assay (Thermo Fisher Scientific). Aliquots containing 50 ug 
of proteins were taken from each sample, were reduced with 5 mM TCEP for 15 min at 95°C and 
alkylated with 10 mM iodoacetamide for 30 min in the dark at 25°C. After quenching the 
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reaction with 12 mM N-acetyl-cysteine the samples were diluted with 100 mM ammonium 
bicarbonate buffer to a final DOC concentration of 1%. Proteins were digested by incubation with 
sequencing-grade modified trypsin (1/50, w/w; Promega, Madison, Wisconsin) overnight at 
37°C. Then, the samples were acidified with 2 M HCl to a final concentration of 50 mM, 
incubated for 15 min at 37°C and the precipitated detergent was removed by centrifugation at 
10,000 g for 15 min. Subsequently, peptides were desalted on C18 reversed-phase spin columns 
according to the manufacturer’s instructions (Microspin, Harvard Apparatus) and dried under 
vacuum. Dried peptide samples were labeled with an isobaric tag (TMT 10-plex, Thermo Fisher 
Scientific) according to the manufacturer’s instructions. The pooled sample was again desalted on 
C18 reversed-phase spin columns according to the manufacturer’s instructions (Macrospin, 
Harvard Apparatus) and dried under vacuum. 
Off-Gel electrophoresis: TMT-labeled samples were resolubilized to a final concentration of 
1 mg/ml in Off-Gel electrophoresis buffer containing 6.25% glycerol and 1.25% IPG buffer (GE 
Healthcare). Peptides were separated on a 12 cm pH 3-10 IPG strip (GE Healthcare) with a 3100 
OFFGEL fractionator (Agilent) as previously described (46) using a protocol of 1 h rehydration 
at max. 500 V, 50 μA, and 200 mW. Peptides were separated at max. 8000 V, 100 μA, and 
300 mW until 20 kVh were reached. Subsequently, each of the 12 peptide fractions was desalted 
using C18 reversed-phase columns according to the manufacturer’s instructions (Microspin, 
Harvard Apparatus), dried under vacuum and subjected to LC-MS/MS analysis. 
Mass spectrometric analysis: The setup of the μRPLC-MS system was as described previously 
(47). Chromatographic separation of peptides was carried out using an EASY nano-LC 1000 
system (Thermo Fisher Scientific), equipped with a heated RP-HPLC column (75 μm x 50 cm) 
packed in-house with 1.9 μm C18 resin (Reprosil-AQ Pur, Dr. Maisch). Aliquots of 1 μg of total 
peptides were analyzed per LC-MS/MS run using a linear gradient ranging from 95% solvent A 
(0.15% formic acid, 2% acetonitrile) and 5% solvent B (98% acetonitrile, 2% water, 
0.15% formic acid) to 30% solvent B over 180 min at a flow rate of 200 nl/min. Mass 
spectrometry analysis was performed on a dual pressure LTQ-Elite Orbitrap mass spectrometer 
equipped with a nanoelectrospray ion source (both Thermo Fisher Scientific). Each MS1 scan 
was followed by high-collision-dissociation (HCD, both acquired in the Orbitrap) of the 10 most 
abundant precursor ions with dynamic exclusion for 60 sec. Total cycle time was approximately 
2 s. For MS1, 10E6 ions were accumulated in the Orbitrap cell over a maximum time of 300 ms 
and scanned at a resolution of 30,000 FWHM (at 400 m/z). MS2 scans were acquired at a target 
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setting of 50,000 ions, accumulation time of 100 ms and a resolution of 15,00 FWHM (at 
400 m/z). Singly charged ions and ions with unassigned charge state were excluded from 
triggering MS2 events. The normalized collision energy was set to 35%, and one microscan was 
acquired for each spectrum. 
Database searching and protein quantification: Acquired raw-files were converted to the mascot 
generic file (mgf) format using the msconvert tool (part of ProteoWizard, version 3.0.4624 
(2013-6-3)). Using the MASCOT algorithm (Matrix Science, Version 2.4.0), the mgf files were 
searched against a decoy database containing normal and reverse sequences of the predicted 
SwissProt entries of Homo sapiens (www.ebi.ac.uk, release date 16/05/2012) and commonly 
observed contaminants (in total 41,250 sequences) generated using the SequenceReverser tool 
from the MaxQuant software (Version 1.0.13.13). The precursor ion tolerance was set to 10 ppm 
and fragment ion tolerance was set to 0.02 Da. The search criteria were set as follows: full tryptic 
specificity was required (cleavage after lysine or arginine residues unless followed by proline), 2 
missed cleavages were allowed, carbamidomethylation (C), TMT6plex (K and peptide N-
terminus) were set as fixed modification and oxidation (M) as a variable modification. Next, the 
database search results were imported to the Scaffold Q+ software (version 4.3.3, Proteome 
Software Inc., Portland, OR) and the protein false identification rate was set to 1% based on the 
number of decoy hits. Specifically, peptide identifications were accepted if they could be 
established at greater than 93.0% probability to achieve an FDR less than 1.0% by the scaffold 
local FDR algorithm. Protein identifications were accepted if they could be established at greater 
than 5.0% probability to achieve an FDR less than 1.0% and contained at least 1 identified 
peptide. Protein probabilities were assigned by the Protein Prophet program (48). Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis alone were 
grouped to satisfy the principles of parsimony. Proteins sharing significant peptide evidence were 
grouped into clusters. Acquired reporter ion intensities in the experiments were employed for 
automated quantification and statically analyzed using a modified version of our in-house 
developed SafeQuant R script (47). In brief, reporter ion intensities were corrected for isotopic 
impurities according to the manufacturer’s instructions. Intensities for each peptide and protein 
identification were summed, globally normalized across all acquisition runs, and employed for 
ratio calculation and statistical analysis. 
Mapping and counting of sequencing reads per gene (represented by the longest transcript of each 
gene) were done with CLIPZ (49). Subsequently, the relative expression level of each gene 
  3.3 Research article III  
107 
 
(RPKM) was calculated by normalizing the raw read count by the transcript length as well as by 
the size of the sequencing library (sum of all considered reads). Finally, log2 fold-changes were 
calculated by subtracting the log2 mean expression of control cells from the log2 mean 
expression in of miR-103 transfected cells. 
 
Directional mRNA sequencing 
HeLa cells were transfected as described above for proteomics analysis. Cells from one well were 
used per condition and three biological replicates for scrambled and miR-103 miRNA mimic 
treated cells were processed in parallel during mRNA preparation and sequencing.  
Libraries for mRNA sequencing were prepared using the “Directional mRNA-seq sample 
preparation” protocol from Illumina with minor modifications. In brief, poly(A)+ RNA was 
isolated directly from cells using Dynabeads® mRNA DIRECT™ Kit (61011, Life 
Technologies) according to the manufacturer protocol. After isolation, 50 ng of mRNA was 
chemically fragmented by incubating the mRNA solution with twice the volume of alkaline 
hydrolysis buffer (50 mM sodium carbonate [NaHCO3/Na2Co3] pH 9.2, 1 mM EDTA) at 95°C 
for 5 min to get the fragments of approximately 200-300 bases. Fragmented mRNA was 
immediately purified with the RNeasy MinElute Cleanup Kit (74204, Qiagen) to stop the reaction 
and to remove small RNA fragments (<100 bases). Purified fragmented mRNA was treated with 
thermo-sensitive alkaline phosphatase FastAP (EF0651, Fermentas) at 37°C for 30 min and then 
at 75°C for 5 min to inactivate FastAP. Fragmented mRNA was further incubated with ATP and 
T4 polynucleotide kinase (EK0032, Fermentas) at 37°C for 1 h and subsequently purified. 
Ligation of RNA 3’-adapter (RA3, part # 15013207, Illumina) was done using T4 RNA Ligase 2, 
truncated K227Q (M0351L, New England Biolabs Inc) according to the Illumina protocol. The 
ligation step is followed by RNA purification as mentioned above to remove free 3’-adapters. 
The RNA 5’-adapter (RA5, part # 15013205, Illumina) was ligated using T4 RNA ligase 
(EL0021, Fermentas) according to the Illumina protocol followed by an RNA purification step to 
remove free 5’-adapters. cDNA was synthesized using RNA RT Primer (RTP, part # 15013981, 
Illumina) using SuperScript III (18080044, Invitrogen) as per Illumina protocol. Libraries were 
amplified for 14 cycles of PCR using a forward PCR primer (RNA PCR Primer (RP1), part # 
15005505 Illumina) and a reverse PCR primer (Illumina PCR Primer, Index). Different indexed 
reverse PCR primers were used for library preparation from different samples to facilitate 
multiplexing. Libraries were sequenced for 51 cycles on an Illumina HiSeq 2000 machine.  
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Figure and table legends  
 
Figure 1. miR-103 and miR-107 promote Brucella infection of HeLa cells 
HeLa cells were transfected for 3 days, followed by infection with B. abortus 2308 pJC43 for 44 
h. Cells were stained for DNA with DAPI and F-actin with DY-547-phalloidin. Automated image 
analysis and infection scoring was applied to quantify cell counts and infection rate for each 
condition.  
A) Dotplot of miRNA mimic screen using Dharmacon miRIDIAN miRNA mimics. Dots 
represent the average of two independent replicates for Z score normalized cell number and 
infection index. miR-103 and miR-107 are highlighted in green and the sequences of the mature 
miRNAs are shown. The seed sequences are underlined and the GCAGC motif shared with miR-
1184 is highlighted in green.  
B) Fluorescence image showing B. abortus infection of HeLa cells transfected with miR-103 and 
miR-107 miRNA mimics compared to scrambled (non-targeting) control (green = B. abortus, 
blue = nuclei stained with DAPI, scale bar = 50 um).  
C) Effect of siRNAs (black circle) and miRNA mimics (red circle) containing a GCAGC motif 
within their seed sequence on Brucella infection. Independent replicates are averaged and the 
vertical line indicates the mean effect of the different RNAi molecules of the respective seed 
sequence.  The seed sequence of siRNAs identical to the seed of miR-103 and miR-107 is in 
bold.  A complete list of readouts and RNAi reagents can be found in Suppl. Table 2. 
D) Sequence logo (http://weblogo.berkeley.edu, (50)) of siRNA or miRNA mimic seeds that 
increased Brucella infection by a Z score of at least 4. 
 
Figure 2. High levels of mir-103 or siRNAs containing similar seed sequences increase entry 
of Brucella in HeLa cells 
A) Entry assay: Fluorescence image showing example of entry assay (green = intracellular B. 
abortus, blue = nuclei stained with DAPI, scale bar = 50 μm). TetR-GFP expressing B. abortus 
was allowed to enter HeLa cells for 4 h followed by killing of extracellular bacteria and 
simultaneous induction of GFP in intracellular bacteria with anhydrotetracycline for 4 h.  
Automated image analysis: CellProfiler pipeline is used to detect DAPI-stained nuclei followed 
by calculation of a Voronoi cell body by the radial extension of the nucleus by 25 pixels. Bacteria 
are segmented based on the GFP signal. A cell is considered infected if at least one segmented 
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bacterial object of sufficient size and intensity overlaps with the Voronoi cell body. The bacterial 
load in infected cells is estimated by the integration of the GFP intensity of all segmented 
bacterial objects. 
B) Example images showing increased infection rates of TetR-GFP expressing B. abortus in cells 
transfected with miR-103 miRNA mimics or molecules with similar seed sequences. 
C) Brucella infection rate of HeLa cells. Data are represented as bar graphs (bar = mean; 
normalization to mock; error bars = SEM; ***p<0.001, **p<0.01; Mann-Whitney test; n = 7 
(SCRAMBLED, miR-103 mimic), n=5 (ALLSTARS, siRNA 1, siRNA 2)) 
D) Estimate of bacterial load of infected cells. The data are represented as bar graphs (bar = 
mean; normalization to mock; error bars = SEM; ***p<0.001, **p<0.01; Mann-Whitney test; n = 
7 (SCRAMBLED, miR-103 mimic), n=5 (ALLSTARS, siRNA 1, siRNA 2)). 
E) Sequences used for transfection with the corresponding underlined seed region. The following 
materials were used: miR-103 mimic (Dharmacon, C-300523-03); siRNA1 (Qiagen, 
SI03075947); siRNA2 (Qiagen, SI03070529). 
 
Figure 3. Preliminary results indicate that high levels of miR-103 increase Brucella entry in 
mouse embryonic fibroblasts (MEF)  
A) Cell counts of MEF cells transfected with the cell killer control kif11 for the time indicated. 
Data are represented as bar graphs (bar = mean; error bars = range; n = 2). 
B) Estimate of bacterial load in MEF cells infected with Brucella for 8 h, 24 h, and 48 h. Cells 
were transfected for 48 h with the RNAi reagents as indicated. B. abortus pAC42.08 expressing a 
tetracycline-inducible GFP was added for 4 h, followed by inactivation of extracellular bacteria 
by gentamicin and induction of GFP by anhydrotetracycline for 4 h, 20 h, or 44 h. Data are 
represented as bar graphs (bar = mean; bacterial load = infection rate * mean area of intracellular 
bacteria in infected cells; error bars = range; n = 2). 
C) Fluorescence images illustrating Brucella infection of MEF cells treated with either a 
scrambled control siRNA, ARPC3 siRNA, or a miR-103 miRNA mimic. Total infection time = 8 
h; scale bar = 50 μM; green = intracellular Brucella; blue = DAPI staining of DNA. 
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Figure 4. miR-103/107 enhance infection of different intracellular viral and bacterial 
pathogens 
Effect of miR-103 and miR-107 miRNA mimics on infection rate of intracellular pathogens in 
HeLa cells. Z scored infection index of two independent replicates are averaged and the vertical 
line indicates the mean effect of miR-103 and miR-107 miRNA mimics. Pathogens used: 
adenovirus (Ad2_ΔE3B-eGFP), Bartonella (Bartonella henselae ATCC49882T containing 
plasmid pCD353), Brucella (Brucella abortus 2308 pJC43 (aphT::GFP), Listeria (Listeria 
monocytogenes EGDe.PrfA*GFP), rhinovirus (human rhinovirus serotype 1a (HRV1a), 
Salmonella (Salmonella Typhimurium strain S.TmSopE_pM975) 
 
Figure 5. Proteome changes induced by elevated levels of miR-103/107 levels  
A) Volcano plot showing differential protein levels in cells transfected with either miR-103 or 
miR-107 miRNA mimics compared to control cells transfected with scrambled control. False 
discovery rate (FDR) representing Benjamin-Hochberg correction is calculated comparing miR-
103 (n=3) together with miR-107 (n=3) to scrambled (n=3). Direct targets of miR-103/107 
predicted by TargetScan are highlighted (TargetScan Release 6.2, Total context+ score, predicted 
targets with only conserved sites). Color code represents confidence of target prediction (red = 
high confidence, white = low confidence).  
B) Effect of siRNA depletion of corresponding targets on Brucella infection. Among the 
identified proteins only those are shown, which appear in the top 500 up or down hit list of a 
genome-wide siRNA screen for Brucella infection (research article V). The green color gradient 
represents targets that we found to increase Brucella infection upon target depletion, the red 
gradient those targets that reduce Brucella infection upon depletion. 
 
Figure 6. Gene ontology (GO) enrichment terms of proteins changed by elevated miR-
103/107  
GO analysis was performed using DAVID (http://david.abcc.ncifcrf.gov/ (51, 52). As input, 
genes which showed significantly altered protein levels (q < 0.01) were used. Selection of non-
similar, significantly enriched GO terms (q < 0.05) is shown as bar graphs of -Log10(q). In 
brackets the number of genes found in the sample is shown. BP = Biological function; CC = 
cellular compartment, KEGG = KEGG pathways.  
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A) GO enrichment for upregulated targets enriched for terms involving cell surface related 
functions. 
B) GO enrichment for down-regulated targets enriched for cell cycle related terms. 
 
Figure 7. String network of protein changes induced by miR-103/107 
Proteins significantly changed (q < 0.01) in cells with high miR-103/107 levels were used as 
input for STRING analysis (http://string-db.org/ (53)). Proteins with at least one high confidence 
(> 0.95) edge are displayed. Red and green color gradients in the boxes indicate the strength of 
down-regulation and upregulation, respectively. Colors outlining the boxes are based on 
functional pathways. 
 
Figure 8. Effect of TGF-β signaling components on Brucella infection 
A) Activation of TGF-β signaling by TGF-β1 increases Brucella infection. HeLa cells were pre-
incubated for 24 h with DMEM containing TGF-β1 before infection with GFP-expressing B. 
abortus for 44 h. Data represent normalized infection rates in reference to cells that were not pre-
incubated with TGF-β1 with the mean ± STDEV of at least three independent experiments. 
B and C) Overexpression of wild type or dominant negative TGFBR increase or reduce Brucella 
abortus infection, respectively. HeLa cells were transfected with B) wild type TGFBR (pCMV5-
TGFBR1 or pCMV5B-TGFBR2) or C) dominant-negative TGFBR (pCMV5B-TGFBR1 K232R, 
pCMV5 TGFBR2 Δcyt, pCMV5B-TGFBR2 K227R). After 1.5 days of overexpression, cells 
were infected with GFP-expressing B. abortus for 2 days. Data represent normalized infection 
rates in reference to non-transfected cells with the mean ± STDEV of at least four independent 
experiments. 
 
Figure 9. miR-103 reduces transferrin uptake by HeLa cells 
A) Time course of transferrin (Tf) uptake by HeLa cells. HeLa cells were transfected with a miR-
103 mimic (black) or scrambled control siRNA (grey) for 3 days followed by incubation with 
fluorescent transferrin (Tf-568) for the time indicated. Nuclei and actin cytoskeleton were stained 
with DAPI and 488-Phalloidin, respectively. An automated image analysis pipeline was used to 
segment nuclei and cell bodies in the acquired fluorescence images. Internalized Tf was 
quantified by measuring the mean Tf-568 intensity per cell averaged over all cells per condition. 
Error bars = standard error of the mean; n= 5). 
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B) Fluorescent images showing internalized transferrin 20 min after addition to HeLa cells. Scale 
bar = 50 μM. 
 
Supplementary Figure S1. Correlation of protein and mRNA levels after miR-103/107 
treatment 
mRNA log2 fold-changes versus log2 protein ratios after filtering out genes with absolute protein 
ratios higher than 5.0. Scatter plot of all available genes (grey) versus the top 100 miR-103 
targets from TargetScan (black). 'n' specifies the number of genes plotted and 'r' the Pearson 
correlation coefficient. 
 
Supplementary Figure S2. Cumulative distributions of protein log2 ratios 
The cumulative distribution of the log2 fold-changes of all genes, the predicted top 150 Elmmo 
hsa-miR-103 targets and the top 150 TargetScan hsa-miR-103 targets are shown. Targets 
predicted by Elmmo as well as by TargetScan are down-regulated significantly upon miR-103 
transfection. 
 
Supplementary Figure S3. Cumulative distributions of mRNA log2-foldchanges  
The cumulative distribution of the log2 fold-changes of all genes, the predicted top 150 Elmmo 
miR-103 targets and the top 150 TargetScan miR-103 targets are shown. Both, Elmmo as well as 
TargetScan targets are down-regulated significantly upon miR-103 transfection. 
 
Supplementary Figure S4. Effect on cell number and Brucella infection of different 
concentrations of miR-103 miRNA mimic, scrambled, and kif11 
RNAi reagents used: kif11 (Dharmacon, L-003317-00), miR103 mimic (Dharmacon, C-300523-
03), SCRAMBLED (Dharmacon, D-001810-10). HeLa cells were transfected for 3 days prior to 
infection.  
A) Entry assay showing the relative bacterial load in HeLa cells infected with B. abortus 
pAC42.08 and number of HeLa cells. Bacterial load is calculated by multiplication of the 
normalized infection rate multiplied by the normalized median of the integrated GFP intensity of 
infected cells. The data are represented as bar graphs (bar = mean; normalization to mock; error 
bars = SEM; n = 4) 
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B) Endpoint assay showing the relative infection rate in HeLa cells infected with GFP expressing 
B. abortus and number of HeLa cells. The data are represented as bar graphs (bar = mean; 
normalization to mock; error bars = SEM; n = 4) 
 
Supplementary Table 1. Top ten up and down hits in miRIDIAN miRNA mimic screen 
regulating Brucella infection 
Z scored effect of miRNA mimic on Brucella infection averaged over two independent replicates. 
Negative and positive values indicate decreased or increased Brucella infection, respectively. 
Names of mature miRNAs with their corresponding seed region covering nucleotides at position 
2-8 from the 5’ end are shown.  
  
3.3 Research article III 
 
118 
 
 
 
Figure 1 
  3.3 Research article III  
119 
 
 
 
Figure 2 
 
3.3 Research article III 
 
120 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
  3.3 Research article III  
121 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 
3.3 Research article III 
 
122 
 
 
Figure 5 
  3.3 Research article III  
123 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 
3.3 Research article III 
 
124 
 
 
 
 
 
 
 
 
 
Figure 7 
  3.3 Research article III  
125 
 
 
Figure 8 
3.3 Research article III 
 
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 
  3.3 Research article III  
127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1 
3.3 Research article III 
 
128 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2 
  3.3 Research article III  
129 
 
 
 
  
 
 
 
 
 
Supplementary Figure 3 
3.3 Research article III 
 
130 
 
 
 
 
 
 
 
 
Supplementary Figure 4 
 
  3.3 Research article III  
131 
 
miRNA  Seed 
sequence 
Infection rate  
(Z scored) 
hsa-miR-103a-3p GCAGCAU 7.59 
hsa-miR-107 GCAGCAU 7.14 
hsa-miR-1184 CUGCAGC 4.60 
hsa-miR-653 UGUUGAA 4.19 
hsa-miR-3177-3p GCACGGC 3.80 
hsa-miR-520b AAGUGCU 3.78 
hsa-miR-3117-3p UAGGACU 3.71 
hsa-miR-210 UGUGCGU 3.70 
hsa-miR-30a-5p GUAAACA 3.57 
hsa-miR-17-3p CUGCAGU 3.48 
hsa-miR-664a-3p AUUCAUU -1.49 
hsa-miR-92b-3p AUUGCAC -1.49 
hsa-miR-511 UGUCUUU -1.51 
hsa-miR-301a-3p AGUGCAA -1.51 
hsa-miR-1293 GGGUGGU -1.52 
hsa-miR-148a-5p AAGUUCU -1.55 
hsa-miR-629-3p UUCUCCC -1.55 
hsa-miR-548v GCUACAG -1.61 
hsa-miR-1908 GGCGGGG -1.66 
hsa-miR-3678-5p CCGUACA -2.15 
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3.4.1 Statement of own contribution  
 
Brucella infection screens were conducted together with Dr. Shyan H. Low and Dr. Raquel 
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Genome-wide siRNA screen in HeLa cells reveals role of endosome 
to Golgi transport during Brucella infection 
 
A. Casanova1*, S. H. Low1*, R. Conde-Alvarez3, M. Emmenlauer1, P. Rämo1, H.B. Tekaya1, S. 
Muntwiler1, S. Salcedo2, J.P. Gorvel2 and C. Dehio1 
 
* These authors contributed equally to this work 
 
Manuscript in preparation 
 
 
3.5.1 Statement of own contribution  
 
siRNA screens and MOI titrations were performed together with Dr. Shyan H. Low, except for 
the Qiagen druggable library, which was conducted by Dr. Shyan H. Low and Dr. Raquel Conde-
Alvarez. The entry assay was developed and conducted by me. Image analysis was performed by 
Mario Emmenlauer and data normalization by Dr. Pauli Rämö. Vps35 rescue and Retro-2 
inhibitor studies were carried out by Dr. Shyan H. Low.  Figures are produced by me and Dr. 
Shyan H. Low, except the representation of the decision tree infection scoring in Figure 1 which 
is provided by Mario Emmenlauer. The manuscript is written by me and Dr. Shyan H. Low. 
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Abstract 
 
Brucella is a zoonotic pathogen that causes animal and human brucellosis worldwide. As natural 
hosts, Brucella infects various animal species including cows, goats, and pigs, causing abortion 
and birth of weak offspring. Humans infected as incidental hosts, suffer from a febrile disease 
known as Malta fever that can develop into chronic infections with more severe symptoms such 
as endocarditis or meningitis. Therefore, brucellosis is a significant threat to the economy and 
general health in endemic areas. Brucella is able to invade phagocytic and non-phagocytic cells 
and replicates in an intracellular compartment known as the Brucella-containing vacuole (BCV). 
Following entry into a host cell, the BCV traffics along the endocytic pathway and despite 
interacting with endo-lysosomal compartments, some bacteria manage to escape degradation. At 
later stages of infection when intracellular proliferation occurs, the BCV is found in close 
association with the endoplasmic reticulum (ER). Despite many advances in the field, the 
molecular mechanisms on how Brucella enters cells, avoids lysosomal degradation, and finally 
establishes an intracellular niche remain largely unknown. To study Brucella entry and 
replication in human cells, we performed a genome-wide, high-throughput microscopy-based 
RNA interference (RNAi) screen in HeLa cells. This allowed us to unravel host signaling 
pathways involved in Brucella infection, which includes actin-remodeling pathway, transforming 
growth factor (TGF-β) or fibroblast growth factor (FGF) signaling, ER-Golgi bidirectional 
transport, and some components of the endocytic pathway. To dissect the stage of infection that is 
regulated by these signaling pathways, a high-throughput entry assay was employed to study 
early stages of the infection. We showed that TGF-β and FGF signaling pathways are involved in 
bacterial entry into non-phagocytic cells. Furthermore, we identified a novel host factor, Vps35, 
to be involved in a post-entry process during Brucella infection. Vps35 is a component of the 
retromer complex that mediates transport between endosomes and the trans-Golgi network 
(TGN). Furthermore, we showed that Retro-2, an inhibitor which blocks retrograde transport of 
toxins for endosomes to the Golgi apparatus, significantly reduced Brucella infection in a dose-
dependent manner. This further confirms the importance of endosome to Golgi transport during 
Brucella infection. 
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Introduction  
 
Brucella is a facultative intracellular zoonotic pathogen that infects humans as incidental host. 
Brucella causes animal and human brucellosis, with about 500,000 new cases of human 
brucellosis annually worldwide (1). This places Brucella as the most important zoonotic bacterial 
pathogen, with Brucella melitensis, Brucella abortus, and Brucella suis being the most common 
species that have been reported to cause human infections (2). Transmission of Brucella occurs 
via direct contact with infected livestock, ingestion of contaminated food products, or aerosol 
inhalation. Direct human-to-human transmission has only rarely been reported thus far. In animal 
brucellosis, the infection of reproductive organs causes abortion or the birth of weak offspring. 
Human brucellosis on the contrary is associated with a febrile disease commonly known as Malta 
fever. Without treatment, Brucella can cause a chronic infection in various organs and lead to 
more severe symptoms such as endocarditis or meningitis (2). There is currently no effective 
vaccination for humans and even a complex antibiotic treatment for a prolonged duration is not 
able to completely protect against relapses (3). Therefore, Brucella remains a significant threat to 
the economy as well as public health in endemic areas.  
Brucella infects phagocytic as well as non-phagocytic cells where bacteria replicate and persist 
inside the host. Bacteria adhere to the host cell surface via interaction with sialic acid residues 
that are present on eukaryotic receptors or bind to fibronectin and vironectin (4, 5). 
Internalization then requires actin remodeling via activity of Rac, Rho, and direct activation of 
Cdc42 (6). Upon internalization, Brucella is contained within a vacuole termed Brucella 
containing vacuole (BCV) that interacts with the early endosomal markers Rab5, early endosomal 
antigen (EEA1), transferrin receptor (TfR), as well as the lipid rafts component flotillin-1 (7-10). 
Next, the BCV interacts with the late endosomal markers Rab7, Rab7’s effector Rab interacting 
lysosomal protein (RILP), Lamp1, and transiently with autophagosomal markers (9, 11). 
Acidification of the BCV upon reaching a late endosomal compartment serves as a trigger for the 
expression of the VirB type IV secretion system (T4SS) (12, 13). The T4SS is believed to secrete 
yet unknown effectors that are essential for Brucella to avoid fusion with lysosomes, since VirB 
mutants are degraded in phagolysosomes (7, 14). Brucella that manage to divert from the 
endocytic pathway are then able to interact with the endoplasmic reticulum (ER) at ER exit sites 
(ERES) via interaction with the small GTPase Sar1 and the COPII complex (7, 15). In addition, 
the small GTPase Rab2 was found to interact with the Brucella effector RicA. Rab2 controls 
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vesicular-trafficking from Golgi to ER in the ER-Golgi intermediate compartment (ERGIC) and 
is required for fusion of BCVs with ER-derived vesicles and intracellular replication of Brucella 
(16, 17). This indicates that anterograde as well as retrograde trafficking components are required 
during infection. The VirB T4SS has also been shown to be important for a sustained interaction 
with the ER (7). Once in its replicative niche, Brucella requires the host factor inositol-requiring 
enzyme (IRE1-alpha) that regulates host cell unfolded protein response (18). To complete the 
infectious cycle, autophagy initiation proteins were recently shown to be vital for Brucella 
egression and cell-to-cell spreading (19). 
Despite various efforts to understand the interaction of Brucella with host cells, relatively few 
host factors are known. It is still unclear whether Brucella exploits host cell receptors to invade 
non-phagocytic cells and the role of T4SS effectors or their interacting partners at various stages 
of the intracellular life cycle of Brucella remains an open question. It is known that Brucella 
diverts from the endocytic pathway to reach an ER-derived compartment. However, the details of 
this process are still unclear and remain as one of the important unresolved questions of Brucella 
intracellular trafficking. Furthermore, host factors that are needed for the maintenance of the 
BCV in its replicative niche are still largely unexplored.  
The retromer complex is an essential component of the endosomal protein sorting machinery. It is 
involved in vesicular transport from endosomes to the trans-Golgi network (TGN) and recycling 
of cargo to the plasma membrane (20-22). In mammalian cells, the retromer complex is 
composed of two functional subcomplexes: Vps26-Vps29-Vps35 that is involved in cargo 
selection and is generally known as the cargo selective trimer (CST), and proteins from the 
sorting nexin (Snx) family (23) that interact with the CST. Vps35 is the core component of the 
CST with a direct role in cargo binding (24, 25) while Vps26 and Vps29 independently associates 
at either end of the complex. There are two different types of retromer complexes depending on 
the components of sorting nexins associated to it. The SNX-BAR-retromer, which is comprised 
of Snx1, Snx2, Snx5, and Snx6 associated with the CST, is able to induce and stabilize the 
formation of membrane tubules (26-28). This is due to their membrane curvature sensing BAR 
(Bin/amphiphysin/Rv) domain and phosphatidylinositol 3-phosphate [PtdIns(3)P] or 
phosphatidylinositol 3,5-bisphosphate [PtdIns(3,5)P2] binding PX (phox homology) domain (29, 
30). The SNX3-retromer however only consists of the complex of SNX3 and CST (28, 31). 
SNX3 does not contain a BAR domain but has a PX domain that binds with high affinity to 
PtdIns(3)P (32). 
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While the retromer serves critical functions in cellular homeostasis, different toxins and 
pathogens have also been identified to hijack or manipulate retrograde endosome-Golgi transport 
to their own benefit. Shiga and cholera toxins require retrograde trafficking to reach the Golgi 
and further the ER (33) while human papillomavirus (HPV) stably interacts with the retromer 
during cell entry, which is later required for reaching a Golgi-like compartment (34). Also, 
Coxiella burnetii which replicates in a lysosome-like vacuole, requires the retromer complex for 
intracellular proliferation (35). In other cases, bacteria intercept with the endosome-Golgi 
pathway. For instance, Salmonella inhibits retrograde trafficking of cation-independent mannose 
6-phosphate receptor (CIMPR) and lysosome function (36) while Legionella effector RidL 
promotes intracellular replication by binding directly to Vps29 and PtdIns(3)P to inhibit the 
function of the retromer (37). 
To understand on a systems level the host factors that are involved in Brucella entry and 
replication, we performed a genome-wide RNA interference (RNAi) screen targeting the human 
genome in HeLa cells. This revealed novel host pathways involved in Brucella infection 
including components of the endosome-Golgi transport pathway. Knockdown of components of 
the retromer complex, especially the CST, led to a decrease in Brucella infection. Furthermore, 
our entry assay suggests that Vps35 is involved in a post-entry step of the infection cycle. 
Inhibitor studies using Retro-2 which blocks retrograde transport of toxins between endosomes 
and Golgi (38) showed a significant decrease in Brucella infection. Therefore, our studies 
indicate that Brucella requires functional retrograde transport between the endocytic pathway and 
the Golgi apparatus during its infection.  
 
Results  
 
A high-throughput microscopy-based RNA interference (RNAi) assay for Brucella infection 
of human cells  
 
To identify host factors involved in Brucella infection, we performed a high-throughput 
microscopy-based RNAi assay in HeLa cells as described previously (research article I). As seen 
in Supplementary Figure 1, the conditions that we used in our screens did not reach saturation 
and intracellular trafficking of Brucella under these conditions is consistent with previous studies 
(39). Wild-type B. abortus as well as a virB9 mutant acquire Lamp1 markers at 6 hours post 
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infection (hpi). At 24 hpi, the virB9 mutant remains in a Lamp1 containing endo-lysosomal 
compartment while wild-type B. abortus is excluded from this compartment (Supplementary 
Figure 2i and 2ii).  
The experimental workflow used in our siRNA screens is summarized in Figure 1A. Reverse 
siRNA transfection was performed for 72 h in HeLa cells after which cells were infected with 
GFP-expressing B. abortus 2308. After 4 h of infection, extracellular bacteria were inactivated by 
gentamicin-containing medium. The infection was allowed to continue for a total of 44 h. In 
unperturbed cells, this allows Brucella to traffic to an ER-derived compartment and intracellular 
replication leads to the formation of a micro-colony (Figure 1B). Cells were fixed at 44 hpi and 
stained with DAPI and phalloidin-547 for nuclei and F-actin, respectively. Fluorescence images 
were acquired with automated microscopes and image analysis was performed with CellProfiler 
(40). This allows for an automated detection of objects such as the nucleus, perinucleus (8 pixels 
or 5.16 μm wide zone surrounding the nucleus), or cell body (Figure 1A and B), and the 
extraction of features for example pathogen intensity (GFP intensity) from these objects. 
Decision tree based infection scoring was performed with the extracted features (Figure 1B) to 
calculate single cell infection scores which were used to determine a well-based infection rate. In 
short, if the mean GFP intensity in at least one of the defined objects of a cell (nucleus, 
perinucleus, or cell body) exceeds a given threshold, the cell is considered infected. The 
thresholds are set in a way that only cells which contain a high number of bacteria, indicative of 
intracellular proliferation, will be detected as infected. Finally, Z scoring normalization was 
performed to account for plate-to-plate variations. 
 
Genome-wide siRNA screen for host factors involved in Brucella entry and replication in 
HeLa cells 
 
To study on a systems level the interaction of Brucella with human host factors, primary genome-
wide siRNA screens were performed in HeLa cells. Three and one replicates of a Dharmacon and 
a Qiagen library, respectively, were screened. The Dharmacon library contains a single pool of 
four siRNAs targeting each gene while the Qiagen library comprises four individual siRNAs for 
each target. 
Each plate contained control siRNAs to monitor the quality of the screens. The transfection 
controls Kif11 (Dharmacon) and AllStarsDeath (Qiagen) that are toxic to cells resulted in a 
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strong reduction in cell number upon knockdown (Supplementary Figure 3B). Positive control 
siRNAs targeting known host factors of Brucella infection such as Rac1, Cdc42, and ATP6V1A 
(6, 12), showed an expected reduction of infection compared to mock (transfection reagent only) 
and scrambled siRNA without specific host targets (Supplementary Figure 3A). Furthermore, we 
compared the results from the independent replicates of the Dharmacon library. As shown in 
Supplementary Figure 4i, we obtained good correlation (Pearson Correlation Coefficient R = 0.5-
0.7) in both normalized infection index as well as normalized cell number between the 
independent replicates of the Dharmacon pooled library. Altogether, this shows that with our 
experimental workflow we were able to obtain reproducible data between independent replicates 
and identify host factors that are involved in Brucella infection. 
To account for the well-known confounding off-target effects in siRNA technology, we 
performed statistical analysis of the primary screening data with the Redundant siRNA Analysis 
(RSA) algorithm (41). This reduces the number of false positives caused by off-target effects of 
single siRNAs and favors genes with a reproducible phenotype from different siRNAs, indicating 
that the effect observed on Brucella infection is due to the depletion of the intended gene. 
Using datasets obtained from screening with Dharmacon and Qiagen libraries as input for RSA 
analysis, we were able to rank genes according to statistical significance (P value). Figure 1C 
summarizes the general workflow that was used for analyzing the screening data and selecting 
genes for further validation. Some of the genes that were in the top ranks of our RSA analysis 
were directly selected for validation. To further prioritize, we performed gene ontology (GO) 
enrichment studies of the top hits using the DAVID functional annotation database (42). As seen 
in Figure 2A, genes that appear in the top 200 RSA ranks for reducing Brucella infection upon 
knockdown show GO enrichment terms of retrograde vesicle mediated transport from Golgi to 
ER, regulator of cellular component size, enzyme linked receptor protein signaling pathway, 
intracellular protein transport, regulation of actin filament polymerization, and phosphorylation. 
Figure 2B shows enrichment terms for genes that are in the top 200 RSA ranks for increasing 
Brucella infection upon knockdown. It includes the terms RNA processing, cell cycle, 
microtubule-based process and cytoskeleton organization. Genes present in the enriched 
pathways were also included for validation even if they did not show the strongest phenotype in 
the primary screens. This screen was performed in the framework of InfectX, a consortium that 
aims at identifying the human infectome of several viral and bacterial pathogens. Therefore, we 
also included genes in our secondary screens that were selected by other pathogen groups that 
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performed the same genome-wide screens. This strategy ensures sufficient negative controls on 
each screening plate that is needed for plate normalization.  
 
Genome-wide RNAi screen reveals novel pathways involved in Brucella infection 
 
Secondary screens for all selected targets were performed with up to three siRNAs each from the 
Ambion Silencer and Ambion Silencer Select unpooled libraries as well as one esiRNA from the 
pooled Sigma MISSION library (replicate correlations are shown in Supplementary Figure 4ii). 
This strategy to confirm selected genes with many additional siRNAs was proven successful in 
previous kinome-wide screens (research article IV), to reduce the false discovery rate caused by 
off-target effects. Finally, RSA analysis was performed with genes reducing or increasing 
infection, using the combination of all data from both primary and secondary screens 
(Supplementary Table 1). Figure 3 represents the high confidence STRING database  protein-
protein interaction network of top ranking genes from the RSA analysis that reduce and increase 
Brucella infection upon knockdown (43). We were able to confirm components that are known to 
be crucial for Brucella infection, e.g. subunits of the v-ATPase complex, Rab7A, Rac1, and 
Cdc42 (6, 11, 12). Furthermore, multiple components of pathways involved in TGF-β or FGF 
signaling, actin remodeling, endosome to Golgi transport, endocytic pathway, ER-Golgi 
bidirectional transport, ubiquitin conjugation, nucleotide metabolism, cell cycle, and clathrin 
coated pits were found in our top ranking gene lists suggesting a role of these signaling pathways 
during Brucella infection.  
 
Entry assay identifies Vps35, a component of the retromer complex, as a host factor 
involved in a post-entry process 
 
To dissect the process which is regulated by the identified genes during Brucella infection, we 
performed an assay to study early steps of infection in a high-throughput format (described in 
research article I). The entry assay is based on the infection of HeLa cells with B. abortus that 
express GFP under a tetracycline inducible system and dsRed from a constitutive promoter. Since 
induction of GFP expression is performed simultaneous to gentamicin addition to the medium, 
only intracellular bacteria are able to express GFP while extracellular bacteria are inactivated by 
gentamicin in the medium. As shown in Figure 4A, all Brucella express dsRed while only 
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intracellular bacteria induce GFP expression. For the entry assay, bacteria were allowed to enter 
cells for 4 h, after which GFP expression was induced for another 4 h. Image analysis was 
performed with a CellProfiler pipeline that detects the nucleus of cells (DAPI-stained) as well as 
single bacteria based on the GFP signal. A voronoi cell body is calculated by extension of the 
nucleus by 25 pixels (16.125 μm) and infection scoring separates infected from uninfected cells. 
An infected cell is defined by the presence of at least one bacterium of sufficient size and GFP 
intensity that overlaps with the voronoi cell body. 
As shown in Figure 4B, most of the genes tested showed a direct correlation between the results 
of the entry assay and the endpoint assay (indicated by the line of linear regression). This was the 
case for components from the TGF-β signaling, endocytic pathway, Golgi to ER transport, or the 
actin-remodeling pathway, indicating a role of these pathways during Brucella entry into HeLa 
cells. This suggests that the reduced infection that is seen with the endpoint assay upon 
knockdown of these components is likely due to a perturbed entry of Brucella. Interestingly, 
Vps35 showed no effect on Brucella entry upon knockdown even though there was a significant 
reduction in the number of cells that showed the formation of a micro-colony two days after 
infection (endpoint assay). This suggests that Vps35, a key component of the retromer complex is 
involved in a post-entry step during Brucella infection.  
 
Endosome to Golgi transport is required for Brucella infection 
 
Besides Vps35, Vps26a knockdown also strongly reduced Brucella infection in the genome-wide 
screen, comparable to the effect of the positive controls ArpC3 and Rab7a (Figure 5A). siRNA 
depletion of Vps29 and Vps26b, the paralogue of Vps26a, only led to a mild reduction in 
Brucella infection. In contrast, depletion of Snx1 and Snx5, two of the four sorting nexins 
associated with the Snx-BAR-retromer enhanced infection while the other two components, 
SNX2 and SNX6 did not show an effect on Brucella infection upon knockdown. SNX3, 
component of the SNX3-retromer showed a mild reduction in infection while USP6NL, a Rab 
GTPase activating protein (GAP) for Rab43 shown to be involved in Shiga toxin endosome to 
TGN trafficking (44) increased Brucella infection upon knockdown.  
To confirm the specificity of Vps35 knockdown and its effect on Brucella infection, a 
complementation experiment with a Vps35 cDNA insensitive to the shRNA was performed. 
While shRNA knockdown of Vps35 inhibited Brucella infection, co-expression of the shRNA-
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insensitive cDNA of Vps35 could rescue the phenotype (Figure 5B), confirming that depletion of 
Vps35 indeed negatively affects Brucella infection. 
To further investigate the role of retrograde transport from endosomes to Golgi in Brucella 
infection, experiments were performed with Retro-2. This is a specific inhibitor of retrograde 
trafficking from endosomes to the TGN of ricin toxin, Shiga-like toxin, cholera toxin B subunit, 
and human papillomaviruses (34, 38). The effect of Retro-2 on this transport pathway is selective, 
with no effect on most retrograde cargoes except syntaxin 6, syntaxin 5, and syntaxin 16 and no 
perturbation of the morphology of compartments or other trafficking steps (38). Furthermore, this 
compound has been shown to protect mice from lethal nasal exposure to ricin, illustrating the 
potential in vivo applications of this drug (38). For our studies, Retro-2 was added to HeLa cells 
either together with GFP-expressing B. abortus (Figure 6A) or 4 h after infection when cells were 
washed with gentamicin-containing medium to inactivate extracellular bacteria (Figure 6B). The 
inhibitor was then kept throughout the experiment. Brucella infection decreased in a dose-
dependent manner upon increased doses of the inhibitor. This supports a role of retrograde 
trafficking from endosomes to TGN in Brucella infection. Inhibition of infection was also seen 
when the drug was added after bacteria have entered cells, suggesting that the endosome-Golgi 
pathway is important for a post-entry process during Brucella infection. 
 
Discussion 
 
Studies that have been performed thus far to understand Brucella interaction with the host were 
mainly hypothesis driven, include a small-scale RNAi screen in Drosophila S2 cell, or proteomics 
studies to identify host components of the BCV (7, 11, 15, 16, 18, 19). To identify on a systems 
level host factors involved in Brucella infection, we performed a genome-wide RNAi screen in 
HeLa cells. We could identify novel host factors covering different signaling pathways to have a 
role in Brucella infection and using a high-throughput entry assay, host factors could be further 
separated according to their impact on Brucella entry. We identified Vps35, a component of the 
retromer complex to be involved in a post-entry process during Brucella infection. Importantly, 
the role of endosome-Golgi transport during a post-entry step in Brucella infection could be 
independently validated using a drug that has been shown to inhibit transport of toxins via this 
pathway. 
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Vps35 is a component of the retromer complex that regulates endosome to Golgi transport (23). 
Furthermore, other components of the retromer complex including Vps26a and to a lesser extent 
Vps29 and Vps26b also reduced Brucella infection upon knockdown in our genome-wide siRNA 
screen. It has been reported that Vps26a and Vps26b have preferences towards different cargoes 
(45). As we generally did not observe a strong effect upon depletion of Vps26b compared to 
Vps26a, it is possible that mainly Vps26a is needed during Brucella infection. The varying 
effects on Brucella infection of the different Snxs suggest that they might have different roles 
during infection. Alternatively, the efficiency of different siRNA knockdowns might vary and 
should be validated. Combinatorial knockdown of Snxs will give a better understanding to 
whether there are redundancies in the function between these different Snx proteins.  
Furthermore, inhibition of retrograde trafficking with the drug Retro-2 caused a defect in 
Brucella infection, even when the drug was added to cells when bacteria were already 
internalized which suggests that the endosome-Golgi retrograde trafficking pathway is required 
after bacteria have invaded the host cell. This is consistent with our entry assay results that 
showed that Vps35 is dispensable for Brucella entry in HeLa cells. Since it is still unclear how 
Brucella traffics from an endocytic compartment to its ER-derived replicative niche, the retromer 
complex could provide a possible route via transient interaction with the Golgi. It is conceivable 
that Brucella uses a similar pathway as ricin or Shiga-like toxin. In support of this notion, 
USP6NL, a Rab GAP that is involved in Shiga toxin transport from endosomes to the trans-Golgi 
network by regulating Rab43 (44), led to an increase in Brucella infection upon knockdown. It is 
thus tempting to speculate that USP6NL regulation of Shiga toxin transport is needed by Brucella 
in a similar manner. Alternatively, the retromer complex could be involved in the establishment 
or maintenance of the replicative niche potentially providing host factors which follow retrograde 
trafficking.  
Besides the retromer complex, we could identify several other pathways which are involved in 
Brucella infection. Among the most prominent clusters are components of signaling pathways of 
actin-remodeling, TGF-β or FGF signaling, endosome to Golgi transport, endocytic pathway, 
ER-Golgi bidirectional transport, or clathrin coated pit components.  Some of the individual 
components of these signaling pathways are known to be important for Brucella infection. 
Rab7A is needed for trafficking to the replicative niche (11), subunits of the v-ATPase complex 
for acidification of the BCV which serves as a signal for the expression of type IV secretion 
system (12, 13), Rac1 and Cdc42 are involved in internalization into non-phagocytic cells (6), 
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COPB subunit of the COPI complex was implicated in Brucella replication (16), and Sec61 has 
been shown to localize to the BCV during replication (9).  
The entry assay showed that depletion of components of other pathways than endosome-Golgi 
transport affect Brucella entry into host cells. Genes associated with actin-remodeling (Rac1, 
Cdc42, CYFIP1, NCKAP1, ACTR3), TGF-β signaling (TGFBR1, TGFBR2, SMAD4), endocytic 
pathway (RAB7A), and Golgi to ER transport (COPG) showed reduced Brucella entry and a 
subsequent decrease in the formation of an intracellular micro-colony upon knockdown.  
Studies with drug inhibitors have shown the importance of Rac1 and Cdc42 in Brucella uptake 
into eukaryotic cells (6) and the role of these factors was confirmed in our RNAi screens. In 
addition, we identified numerous components of the actin-remodeling pathway that have not been 
described previously. As expected, knockdown of RACGAP1 that reduces levels of active Rac1 
led to an increase in Brucella infection while ARHGEF9 that is an activator of Cdc42 decreases 
infection upon knockdown. Upstream or downstream components of Rac1 such as the WAVE 
complex (NCKAP1, CYFIP1, ABI1), the Arp2/3 complex (ARPC2, ARPC3, ACTR3, ACTR2), 
or kinases (PTK2B, CRK) that are involved in the formation of branched actin networks, 
lamellipodia, and membrane ruffling were found in the genome-wide screen and all tested factors 
were required for Brucella entry into host cells. In addition, Cdc42 and its interacting partner 
TRIP10 or TNK2 that are involved in filopodia formation are also down hits in our screen. This 
further confirms the role of actin remodeling networks regulated by Cdc42 or Rac1 during 
Brucella infection with extension of host factors in this signaling process. 
We further identified anterograde as well as retrograde trafficking to be required for Brucella 
infection. Components of the COPI complex (COPG, COPB2, COPA, COPZ1, ARCN1 (COPD)) 
reduced Brucella infection upon knockdown. This is consistent with a previous study that found 
COPB depletion to negatively affect Brucella replication (16). In this same study, the authors 
reported that Brucella replication was affected by prolonged treatment with Brefeldin A. This 
drug causes a redistribution of the Golgi to the ER, suggesting that Golgi to ER trafficking is 
important for Brucella replication. However, studies carried out by other research groups showed 
that COPI dependent transport is not required during Brucella infection (7, 15). In these studies, 
BCVs were shown in close vicinity of COPII components labeled with Sec31 antibody but not 
with COPI components labeled with anti-β-COP antibody as seen with immunofluorescence 
studies. Also, dominant negative ARF1 that regulates Golgi to ER transport did not affect 
bacterial replication in HeLa cells, similar to their previous results with Brefeldin A treated cells. 
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These controversies might be explained by the different experimental settings of these studies. In 
the case of siRNA treatment over a prolonged period, many intracellular trafficking routes 
including pathways outside the ER - Golgi network might be affected. This could explain the 
results of the entry assay that showed an involvement of COPG1 in bacterial entry. In support of 
this hypothesis, a functional COPI complex is required during Salmonella Typhimurium invasion 
in maintaining cholesterol, sphingolipids, Rac1, and Cdc42 at the plasma membrane (46). It is 
conceivable that Brucella entry follows a similar route as described for Salmonella, requiring 
COP components for membrane ruffling (46) and should be investigated with further studies. We 
also identified a component of the COPII complex (Sec13) to reduce Brucella infection upon 
depletion. This is consistent with previous studies showing the importance of the COPII complex 
and ER exit sites for the interaction of Brucella with the ER and subsequent replication (15, 16). 
Taken together, these findings show the importance of intact bidirectional vesicular trafficking 
between the ER and Golgi for successful Brucella infection. However, the exact molecular details 
of the individual components have to be confirmed and likely involve additional cellular 
components that regulate the composition of the plasma membrane. 
Members of the TGF-β and FGF signaling pathways were also found to promote Brucella 
infection. TGF-β signaling components (TGFBR2, TGFBR1, TGFB1, TGFB2, SMAD2) all led 
to a decrease in Brucella infection upon knockdown. The fact that both subunits of the 
heterotetrameric receptor complex, TGFBR1 and TGFBR2, showed an effect on Brucella 
infection upon individual knockdown strengthens the notion that TGF-β signaling is important 
for Brucella infection. It has previously been reported that patients with brucellosis show higher 
levels of TGF-β1 in their sera that is correlated with depressed function of T cell responses (47). 
B cells were also shown to produce TGF-β at early stages of infection with Brucella in mice (48). 
Therefore, this suggests a role of this pathway during Brucella infection in terms of 
immunosuppression of the host. However, since our RNAi screen was performed in HeLa cells, it 
is conceivable that TGF-β signaling has another non-immunological role during host cell 
infection, specifically during early steps as suggested by the results of the entry assay. 
Components of the FGF signaling pathway (FGFR1, FGF2 and FGF10) were also shown to 
reduce Brucella infection upon knockdown. It has been reported that FGF2 enhances Chlamydia 
trachomatis binding and uptake into non-phagocytic cells in a heparin sulfate proteoglycan (HSP-
G) dependent manner. The pathogen additionally stimulates production of FGF2 that enhances 
subsequent rounds of infection (49). Therefore, it would be interesting to investigate the roles of 
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TGF-β or FGF signaling during Brucella invasion in HeLa in comparison to other cell types of 
interest such as trophoblast cell lines or immune cells.  
Among the host factors that restrict Brucella infection, we identified components of clathrin-
coated pits. Depletion of several factors (AP2S1, CLTC, AP2A1, and EPN1) caused an increase 
in Brucella infection in our screen. This suggests that Brucella prefers to enter the host via a 
clathrin-independent pathway in HeLa cells. This is in contrast to a recent publication by Lee et 
al. that showed reduction in Brucella infection upon siRNA treatment against CLTC or with 
inhibitor experiments using clathrin inhibitor, chloropromazine (50). It remains unclear whether 
this controversy is due to differences in the experimental setup or the use of different bacterial 
strains. siRNA treatment experiments performed by Lee et al. focused on bacterial entry while 
our screen is an end point infection assay. The effect of clathrin component depletion towards 
bacterial entry into HeLa cells and its subsequent intracellular fate remains to be investigated in 
our studies. Validation with siRNA-independent approaches could also aid in addressing this 
controversy. 
In summary, we were able to identify novel signaling pathways as well as novel host factors of 
pathways that have been previously associated with Brucella infection. Altogether, many 
additional genes were identified and will provide a rich resource for future discoveries. Most of 
the identified hits that were tested in the entry assay were found to be involved in Brucella entry, 
including the TGF-β signaling pathway or factors involved in actin remodeling. Importantly, we 
identified retrograde transport between the endocytic pathway and the Golgi to be involved in a 
post-entry process during Brucella infection. This trafficking route has not been described for 
Brucella infection before and provides the hypothesis that Brucella requires this pathway to 
arrive at or maintain its replicative niche.  
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Materials and methods 
 
Wet lab procedures  
Materials  
RNAiMAX (Invitrogen, 13778-150); Dulbecco Modified Eagle Medium (DMEM) (Sigma, 
D5796); HeLa (human cervical carcinoma epithelial cell line, ATCC, CCL-2); Fetal Calf Serum 
(FCS) (Gibco, 10270): heat inactivated at 56°C for 30 min before use; tryptic soy broth (TSB) 
(Fluka, 22092); kanamycin sulfate (Sigma-Aldrich, 60615); gentamicin (Sigma, G1397); Triton-
x-100, sigma-ultra (Sigma-Aldrich, T9284); DAPI (Roche, 10236276001); phalloidin-547 
(Dyomics, 547PI-33); albumin from bovine serum (BSA) (Sigma, A9647); paraformaldehyde 
(Sigma, P6148); phosphate buffered saline (PBS) (Gibco, 20012); Retro-2 (Calbiochem, 
554715), Fugene HD (Promega, E2312), mouse monoclonal anti-Lamp1 [H4A3] antibody 
(Abcam, ab25630), Anhydrotetracycline hydrochloride (Sigma, 37919) 
 
Cloning of pAC042.08 for entry assay 
pJC44 (11) was digested with EcoRI followed by generation of blunt ends with Klenov enzyme 
and subsequent digestion with SalI. TetR-GFP was amplified from pNF106 (unpublished) using 
primer prAC090 (TTTTTGAATTCTGGCAATTCCGACGTCTAAGAAACC) and prAC092 
(TTTTTGTCGACTTTGTCCTACTCAGGAGAGCGTTC). Following digestion with SalI, the 
TetR-GFP product was ligated to the digested pJC44 vector. This generated a plasmid that 
constitutively expressed dsRed and a tetracycline-inducible GFP. The plasmid was then 
transferred into B. abortus 2308 by conjugation. 
 
siRNA reverse transfection 
Reverse siRNA transfection was performed as describe in research article I with minor 
modifications. Genome-wide screens were performed with Dharmacon ON-TARGETplus 
SMART pool and Qiagen Human Whole Genome siRNA Set HP GenomeWide (QU) siRNA 
libraries. For the validation screens Ambion Silencer, Ambion Silencer Select and Sigma 
MISSION esiRNA libraries were used. All experiments were conducted in a 384 well plate 
format. All plates contained general siRNA controls for transfection efficiency and toxicity (e.g. 
Kif11) as well as positive controls (e.g. Cdc42, Rac1) that are known to have an effect on 
Brucella infection (6). In addition, negative controls such as mock (transfection reagent only) and 
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scrambled (non-targeting siRNA) were added to each plate.  
The following specifications apply to all siRNA screens except the QU siRNA library where 
specifications are given in brackets. 25 μl (QU: 15 ul) of RNAiMAX in DMEM without FCS 
(1:250 dilution) was added to each well containing 1.6 pmol siRNA (QU: 1 pmol) or 15 ng 
esiRNA. Screening plates were then incubated at room temperature (RT) for 1 h. Following 
incubation, 500 HeLa cells were added per well in a volume of 50 μl (QU: 30 ul) DMEM/16% 
FCS, resulting in a final concentration of 10% FCS. Plates were incubated at 37°C and 5% CO2 
for 72 h prior to infection.  
 
Infection  
Infections were performed as describe in research article I. In short, B. abortus 2308 pJC43 
(aphT::GFP) (15) was grown in TSB medium containing 50 μg/ml kanamycin for 20 h at 37°C 
and shaking (100 rpm) to an OD of 0.8- 1.1. 50 μl of DMEM/10% FCS containing bacteria was 
added per well to obtain a final MOI of 10000. Plates were then centrifuged at 400 g for 20 min 
at 4°C to synchronize bacterial entry. After 4 h incubation at 37°C and 5% CO2, extracellular 
bacteria were killed by exchanging the infection medium by 50 μl DMEM/10% FCS 
supplemented with 100 μg/ml gentamicin. After a total infection time of 44 h, cells were fixed 
with 3.7% PFA for 20 min at RT. 
For the entry assay, B. abortus 2308 pAC042.08 was used as described above. GFP expression 
was induced for 4 h by the addition of anhydrotetracycline (100 ng/ml) during the gentamicin 
killing of extracellular bacteria as described above and kept throughout the experiment.  
 
Inhibitor experiment  
HeLa cells were seeded in 96 well plates (2800 cells/well) one day before infection. Retro-2 was 
added to cells together with GFP expressing B. abortus 2308 or during gentamicin wash at 4 hpi 
and cells were maintained at 37°C with 5% CO2. Retro-2 was kept throughout the experiment. 
 
Rescue experiment  
Plasmids from the suppression / rescue system include empty vector, shVPS35, shVPS35/WT 
rescue and shVPS35 /Δ6 rescue are kind gifts from Daniel Billadeau (51). HeLa cells were 
seeded in the morning of the day of transfection in a 6 well plate with 125,000 cells / well. In the 
evening, , 0.9 μg of plasmid (in 200 μl of DMEM without FCS) were mixed with 8 μl of Fugene 
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HD (in 200 μl of DMEM without FCS) and incubated 15 min at RT. HeLa cells were exchanged 
with 1.5 ml of fresh medium and DNA-fugene complex was added to the cells. The next day 
morning, cells were exchanged with fresh medium and 1 day later in the evening splitted into a 
96 well format (2800 cells / well) for infection the next day. 
 
Staining  
Cells were washed twice with PBS and permeabilized with 0.1% Triton-x-100 for 10 min. After 
washing twice with PBS, 20 μl of staining solution that contains DAPI (1 μg/ml) and DY-547-
phalloidin (1.5 U/ml) in 0.5% BSA/PBS was added to cells. For the entry assay, cells were not 
stained with DY-547-phalloidin. Cells were then incubated with the staining solution for 30 min 
at RT, washed twice with PBS, followed by final addition of 50 μl PBS.  
For Lamp1 colocalization experiment, HeLa cells on coverslips were permeabilized with 0.1% 
Triton-x-100 for 10 min at RT, washed with PBS before incubated with 0.5% BSA/PBS for 30 
min at RT. Afterwards, cells were labeled for Lamp1 using mouse monoclonal anti-Lamp1 
[H4A3] antibody (1:100) and secondary antibody Alexa Fluor 546 Goat Anti-mouse IgG (1:100). 
 
Imaging with high-throughput microscopy 
Microscopy was performed with Molecular Devices ImageXpress microscopes. MetaXpress plate 
acquisition wizard with no gain, 12 bit dynamic range, 9 sites per well in a 3x3 grid was used 
with no spacing and no overlap and laser-based focusing. DAPI channel was used for imaging 
nucleus, GFP for bacteria, and RFP for F-actin or dsRed of bacteria in the entry assay. Robotic 
plate handling was used to load and unload plates (Thermo Scientific). The objective was a 10X 
S Fluor with 0.45NA. The Site Autofocus was set to “All Sites” and the initial well for finding 
the sample was set to “First well acquired”. Z-Offset for Focus was selected manually and 
manual correction of the exposure time was applied to ensure a wide dynamic range with low 
overexposure. 
 
Image analysis 
Object detection 
Images were first scaled that pixel intensities of a full plate are in the 0 to 1 range. Images were 
then corrected for shading (flat field correction, vignetting correction) by applying a shading 
model to the image pixels. Shading-corrected images were stored in floating points to reduce the 
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loss of information. Pathogen signal in the DAPI channel was removed to increase the quality of 
the nucleus segmentation. The pathogen signal was removed by subtracting a linear 
transformation of the GFP channel from the DAPI channel. After the pathogen signal reduction, 
DAPI images were stored in double precision to reduce loss of information. On the corrected 
images, object detection was performed using CellProfiler (40). Firstly, nucleus objects labeled 
“Nuclei“ were segmented in the DAPI channel using OTSU’s method (CellProfiler module 
IdentifyPrimAutomatic). Secondly, peri-nuclear ring object labeled “PeriNuclei” was constructed 
by extending the nucleus object by eight pixels and removing the nuclear area from the extended 
nuclear area (CellProfiler modules ExpandOrShrink and IdentifyTertiary). Thirdly, a cell body 
object labeled “Cells” was segmented in the Actin channel using the “Propagation” method 
around the nucleus object (CellProfiler module IdentifySecondaryInformed). Finally, a non-actin 
based cell body object labeled “VoronoiCells” was constructed by extending the nucleus object 
by twenty-five pixels (CellProfiler module ExpandOrShrink). 
For the entry assay, the cell body was not stained with a fluorescent marker and only a voronoi 
cell body is used. Intracellular bacteria are detected using the GFP signal. 
 
Feature extraction 
On the segmented objects, measurements were performed using CellProfiler. On all segmented 
objects (Nuclei, PeriNuclei, Cells, VoronoiCells, Bacteria) shape measurements were extracted. 
Intensity and texture measurements were extracted with respect to all available channels (DAPI, 
Actin, Pathogen). All measurement result files of CellProfiler were stored in the openBIS 
database alongside the original images.  
 
Infection scoring  
Infection detection and measurement 
Infection detection was done on a binary level (infected vs. non-infected) that allows the infection 
index to be defined. The infection index is the number of infected cells / total number of cells in 
the well.  
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Decision Tree Infection Scoring (DTIS) 
We selected a number of image analysis single cell features that were most sensitive to the 
infection phenotype. The N features are evaluated in a decision tree, which is a complete binary 
tree with N levels and 2^N nodes. Each node is evaluated by applying a threshold to the 
corresponding feature. During traversal of the tree, if the feature exceeds the threshold, 
evaluation continues with the one child, and if the feature does not exceed the threshold, 
evaluation continues with the other child. Nodes of the lowest level connect to one of the two 
distinct end states “infected” and “uninfected”. The connection of the nodes to children and the 
choice of features are performed once by an expert and remain static for all plates. The choice of 
the decision tree thresholds is affected by plate-specific parameters like quality of the staining, 
cell vitality and microscope illumination, and must be adjusted on a plate-by-plate basis. To 
quantify B. abortus infection for the endpoint assay, GFP intensity was measured in the objects 
Nuclei, PeriNuclei, Cells and VoronoiCells using CellProfiler module MeasureObjectIntensity.  
 
Segmentation based infection scoring for entry assay 
Segmentation of pathogen objects in CellProfiler was used to detect pathogen colonies or single 
pathogens in the cell. This segmentation method was based on the OTSU method or wavelets. A 
cell is defined as “infected” if a pathogen object of at least 2 pixels and GFP intensity above the 
threshold overlaps with a voronoi cell body. 
 
Data normalization 
Z-Scoring 
Several approaches have been described in the literature to correct the differences from wet lab 
procedures for plate batches (52). Negative controls (mock and scrambled siRNAs) sometimes 
show non-typical phenotypes (such as relatively high cell number) and good positive controls 
were not available for all primary siRNA screens. Therefore, we chose non-control based data 
normalization methods for primary and secondary screens. We used Z-Scoring to normalize 
variations between plates as: 
𝑥𝑛𝑒𝑤 =  𝑥𝑜𝑙𝑑−𝜇 𝜎  
Here, μ is the mean of all siRNA well readouts in the plate, σ is the standard deviation of all 
siRNA well readouts in the plate, xold is the raw well readout and xnew is the normalized well 
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readout. The non-control based normalization assumes that all genes are randomly distributed 
among all plates and that there are relatively few positive phenotype genes in the whole screen. 
For the entry assay, data were normalized to mock wells since the assumptions for Z-Scoring do 
not apply for assays that mainly contain hit genes.  
 
Statistical analyses 
Redundant SiRNA Analysis (RSA) 
The Redundant SiRNA Analysis (RSA) ranks all siRNAs targeting a given gene over all siRNAs 
in the screens (41). It assigns the p-values for each gene based on a hypergeometric distribution 
that indicates whether the distribution of ranks of this gene is shifted significantly towards low 
ranks. RSA was run using the R-package ↓”RSA↓” release 1.3 with parameters: l=-1.5 and u=1, 
where l refers to the threshold where a single siRNA readout is considered to be true positive at 
the low end and u refers to the threshold where a single siRNA readout is considered to be true 
positive at the high end. 
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Figure legends  
 
Figure 1. Experimental workflow of high-throughput microscopy-based RNAi screen A) 
Diagram illustrates the general workflow of our RNAi screen including wetlab procedures 
followed by image acquisition and image analysis, infection scoring, and data normalization. B) 
Image on the right represents HeLa cells infected with GFP-expressing B. abortus with scale bar 
50 μm. Segmentation of the cell body (white) as well as the nucleus surrounded by a perinucleus 
(light green) is shown in the middle. On the right, a graphical illustration shows the Decision tree 
based infection scoring. Decision tree infection scoring is performed using features that are 
extracted from identified objects, e.g. GFP intensity (pathogen intensity) in nucleus (f1), 
perinucleus (f2) and cell body (f3). A cell is considered infected if either one of these features 
exceeds a threshold that is manually determined. C) Workflow of gene selection for validation by 
additional siRNAs and analysis of the full data set.  
 
Figure 2. Gene ontology (GO) enrichment terms of primary genome-wide RNAi screen 
using DAVID functional annotation database  
GO terms that represent biological processes are shown. Bar graph shows –LogP values of 
enrichment terms for top 200 RSA lists of A) genes that reduce Brucella infection upon siRNA 
knockdown or B) genes that increase Brucella infection upon siRNA knockdown. RSA was 
performed using individual siRNAs from Qiagen unpooled library combined with the average of 
three replicates of the Dharmacon pooled library. GO terms that cover at least 5 components of 
our list and with a P value lower than 0.05 are shown. A higher –LogP value indicates a higher 
significance for the GO term shown. 
 
Figure 3. Genome-wide RNAi screen reveals pathways involved in Brucella infection 
Diagram represents host factors that are involved in Brucella infection. RSA was performed by 
combination of primary and secondary screening data. Individual siRNAs from the Qiagen 
library and the averages of independent replicates of the Dharmacon, Ambion, and Sigma 
libraries were used as input. To identify targets that increase Brucella infection upon knockdown, 
siRNA experiments with a Z scored cell number < -1 were removed before RSA analysis. To 
illustrate the interaction network within our hit lists, RSA top 350 genes that reduce Brucella 
infection and RSA top 350 genes that increase Brucella infection were added to the STRING 
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database. The edges between genes indicate high-confidence (>0.95) STRING database 
interactions and only genes that contain at least one interacting partner are shown. Genes that 
reduce Brucella infection upon knockdown are surrounded by a blue outline, while a red outline 
indicates genes that increase infection. Nodes are colored based on their functional pathways.  
 
Figure 4. Entry assay identifies the retromer complex component Vps35 as a host factor 
involved in post-entry process of Brucella infection 
A) Images in the upper row represent HeLa cells infected with B. abortus expressing GFP under 
a tetracycline inducible system and dsRed under a constitutive promoter. Cells were infected for 
4 h followed by induction of GFP in intracellular bacteria for 4 h. Nuclei are stained with DAPI 
(blue). Scale bar represents 50 μm. Lower row shows CellProfiler based object segmentation of 
the nuclei (in white) as well as GFP positive bacteria (in pink). A voronoi cell body is calculated 
by extension of the nucleus by 25 pixels (in white). Decision tree infection scoring is used to 
separate infected (1) from uninfected (2) cells. Cells are considered infected if at least one 
segmented bacterial object with sufficient size and GFP signal overlays with the voronoi cell 
body. B) Scatter plot shows infection rates of the entry assay versus the endpoint assay, 
normalized to the mock dataset. Each point corresponds to the average of 3 replicates using a 
single siRNA or esiRNA for the targets indicated. With the exception of Vps35 (red), a direct 
correlation between the infection rates of both assays was observed as indicated by the linear of 
regression (dotted line). 
 
Figure 5. Retromer components are involved in Brucella infection 
A) Effect of siRNA knockdown of retromer components on Brucella infection. Each dot 
represents Z scored infection index averaged over all independent replicates with a certain siRNA 
reagent. All siRNAs tested during primary and validation screens are shown. Horizontal line 
indicates median over all data points per gene. B) Rescue experiment of Vps35 depletion. HeLa 
cells were transfected with the shRNA/rescue constructs and expressed for 2.5 days before 
infection with GFP-expressing B. abortus for 44 h. Data represents normalized infection in 
reference to empty vector, the mean ± STDEV of three independent experiments. 
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Figure 6. Retrograde endosome-Golgi transport is required for Brucella infection  
HeLa cells were incubated with Retro-2 A) during addition of bacteria to the cells (0 hpi) or B) at 
4 hpi when cells were washed with gentamicin-containing medium. The inhibitor was kept in the 
medium throughout the rest of the experiment. Cells were fixed around 44 hpi. Data represents 
normalized infection in reference to non-treated HeLa cells, the mean ± STDEV of three 
independent experiments for Figure 6A (except for 20 µM dataset which has only two 
independent experiments) and at least four independent experiments for Figure 6B.  
 
Supplementary Figure 1. Infection rate increases in a MOI-dependent manner in HeLa cells  
Bar graph represents infection index dependent on the MOI and the time of infection prior to 
gentamicin treatment to kill extracellular bacteria. Data are normalized to dataset MOI 10000 and 
entry time of 4 h, the experimental condition used in our RNAi screens. Each dataset shows the 
mean ± STDEV of three independent experiments. 
 
Supplementary Figure 2. B. abortus ΔvirB9 mutant interacts with the endo-lysosomal 
compartment at 24 hpi, while most B. abortus avoids this compartment, with low or high 
MOI of bacteria  
Images represent infection of HeLa cells with i) GFP expressing B. abortus ΔvirB9 mutant or ii) 
GFP expressing Brucella abortus at 6 hpi or 24 hpi, with MOI 1000 or MOI 10000. Samples 
were stained with Lamp1 antibody and images were taken with the 60x objective and FEI MORE 
with TIRF microscope. Image in stacks were deconvolved with HUVGENs remote manager and 
one representative slice around the middle of a stack is shown. Scale bar represents 10 μm. 
 
Supplementary Figure 3. Control plots for Brucella infection and siRNA transfection of 
genome-wide screens 
 A) Z score normalized infection index of control siRNAs for Brucella infection used in the 
Dharmacon pooled (DP) and Qiagen unpooled (QU) genome-wide siRNA libraries. Whiskers 
and outliers of boxplot are calculated with the Tukey method. B) Cell number of siRNA 
transfection controls designed to kill transfected cells. Transfection with Kif11 or AllStarsDeath 
results in a median of 19 and 5 cells per well, respectively. Whiskers and outliers of boxplot are 
calculated with the Tukey method. C) Images represent HeLa cells infected with GFP-expressing 
B. abortus and stained with DAPI (blue). Scale bar represents 50 μm. 
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Supplementary Figure 4. RNAi screen correlation plots  
Graph shows i) Pearson correlation coefficient (R) of normalized infection index or normalized 
cell number between independent replicates of our primary screen with Dharmacon pooled 
library or ii) correlation of normalized infection index between independent replicates of 
individual siRNAs within the Ambion unpooled library. 
 
Supplementary Table 1. RSA list for genes that i) reduce or ii) increase Brucella infection  
Table shows list of genes that are ranked according to their P value. Data represents output from 
RSA analysis using dataset from the primary screen (Dharmacon and Qiagen libraries), 
secondary screen (Ambion and Sigma libraries) and kinome screens (Ambion library). 
Independent replicates were averaged before RSA analysis was performed.  
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4 CONCLUDING REMARKS 
4.1 GENOME-WIDE SIRNA SCREENING  
4.1.1 Sequence specific off-target effects – challenges and opportunities 
 
High-throughput, genome-wide perturbation studies using siRNAs are valuable tools to identify 
novel genes and pathways of biological functions in organisms where knockouts are technically 
challenging. One of the mayor difficulties of siRNA screening are so called off-target effects. 
These include all unwanted effects which do not relate to the depletion of the intended target of 
the siRNA (on-target). Screens often show a high false positive discovery rate and the overlap 
between comparable siRNA screens can be extremely low (1). A meta-analysis of three genome-
wide HIV screens showed that the overlap between identified host factors was only mildly better 
than expected by chance (2). Soon after the introduction of siRNA technology, transcriptome 
analysis of siRNA treated cells identified miRNA-like off-target effects (3). In this case, siRNAs 
guide the RISC complex to mRNAs with partial complementarity and reduce expression of those 
genes, which is reminiscent of the action of miRNAs.  
When analyzing genome-wide siRNA screens for host factors that are involved in the infection of 
intracellular pathogens, only low correlations between different siRNA libraries were found 
(research article II). Overall, testing of two different siRNAs which are designed to target the 
same gene often resulted in very distinct effects on cell number and pathogen infections. 
However, when we compared siRNAs designed against different targets that contain the same 
heptameric sequence at position 2-8 at the 5’ end of the siRNA, we found a very high correlation. 
Position 2-8 of a natural miRNA is called the seed region, which largely determines the target 
specificity of the miRNA (4). This indicates that the siRNAs in our screens often act like 
miRNAs. In research article II we could validate this finding by designing custom siRNAs which 
only contain active seed sequences but cannot bind to any mRNA by perfect complementarity. 
This allowed us to identify seed sequences with a variety of biological functions that were 
covered by the analysis of siRNA induced phenotypes. We found seeds which inhibited or 
promoted infection of one or several pathogens, reduced or increased cell number, or affected 
several phenotypes simultaneously. Some of the identified seed sequences are found in natural 
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human miRNAs and testing of miRNA mimics could confirm the effect that was predicted from 
off-target analysis of the genome-wide siRNA screens. Altogether, seed analysis allowed us to 
identify natural miRNAs and synthetic miRNA-like molecules which regulate the growth of cells 
and infection of bacterial and viral pathogens. Importantly, this analysis can be applied to 
published siRNA screens to identify miRNAs which are involved in the corresponding processes 
if the sequences of the siRNAs are published. 
While the knowledge gained from off-target effects can be valuable, it may not answer the 
question of which genes underlie the process studied by the siRNA screen. Here, a number of 
strategies can be considered to counteract off-target effects and optimize the true positive 
discovery rate. For screens where several siRNAs per gene have been tested, statistical methods 
that rank siRNAs and genes according to statistical probability can be used. These do not depend 
on sequence information of the siRNAs and can also be applied to siRNA pools. An example is 
the commonly used Redundant siRNA Activity (RSA) method (5). Similarly, we could show in 
research article IV that statistical analysis of different siRNA screens which are performed using 
identical sets of siRNAs can improve the discovery of hits for each individual screens. With this 
approach, genes which are involved in the biology of different screens gain statistical power 
while factors uniquely involved in a single screen remain unaffected.  
Other methods depend on the identification of seed-driven off-target effects (6). Seed analysis 
only yields valuable information for those seeds which are present in many different siRNAs. In 
this case, the effect of the seed sequence can be well estimated. Optimally, siRNA libraries would 
thus be designed in a way that only a limited number of seeds are use, but all of them in 
sufficiently high numbers that the seed effect can be quantified during each screen. The seed 
information can then be used to remove seed-driven siRNAs from the analysis or to correct for 
the off-target effect (7). While excluding siRNAs mainly reduces the number of false positives, 
correction of the data potentially helps to then recover some of the false negatives. However, this 
approach requires an estimate of how strongly the original data should be corrected. It assumes 
that on- and off-target phenotypes are to some degree additive, which might not always be the 
true. Depending on the underlying biology, on- and off-target effects can be synergistic or 
epistatic which complicates their disentanglement. To avoid over-correction, only a subset of the 
full data should be corrected and compared to the remaining uncorrected part. Improved 
correlation between the two sets indicates that the correction recovered some of the on-target 
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information. Yet it is important to remember that corrections of individual siRNAs might not 
always be beneficial due to the reasons mentioned above.   
Alternative methods even go one step further and use the information of the off-target effects to 
directly infer the genes that are involved in the process of study (8, 9). These rely on the 
prediction of all potential genes which might be targeted by an siRNA. The measured phenotype 
of a certain siRNA is assumed to be the sum of the effects for all those targets which are involved 
in the phenotype. Thus, the challenge is to identify among the long list of genes which can be 
targeted by the siRNA those, which affect the phenotype. If such an analysis is performed for a 
large number of siRNAs, a mathematical model can be used to fit phenotypic readouts to each 
gene until the model fits the actual measurements of the siRNAs from the screen. The result of 
such an analysis is a list of genes and their corresponding effect on the phenotype. 
In summary, multiple published methods are available that can improve genome-wide siRNA 
screening data. These methods are based on very different approaches and rely to varying extents 
on the quantity and type of siRNA products used. It is thus likely that every method reveals a 
subset of all genes that are involved in a specific biological process.   
For smaller screens, off-target effects cannot be readily calculated and alternative approaches are 
required. In such cases, experimental setups can be used to directly control for miRNA-like off-
target effects. siRNA-specific controls which carry certain mutations in the siRNA but keep the 
seed region intact can be used. If the phenotype is not affected by mutations outside the seed 
sequence, a miRNA-like off-target effect has to be assumed and no conclusion on the depletion 
of the intended target can be drawn  (10, 11). 
An alternative approach to experimentally reduce sequence specific off-target effects is pooling 
of siRNAs. While every siRNA in the pool has an individual off-target spectrum, all can bind to 
the intended target. This should then reduce off-target effects by competition between the 
different sequences without affecting the knockdown efficiency on the intended target (12). 
Competition seems to be important, since simple dilution of the siRNA is not sufficient to 
selectively reduce off-target effects (3, 13). Also the number of siRNAs which are combined is 
important and increasing the number of oligos per pool correlates with reduced off-targets (12). 
In agreement with this, we could still observe off-target signal in pools consisting of four siRNAs 
although with reduced strength compared to unpooled siRNAs.  
A logical consequence of the above statement is that testing many different siRNAs (with 
different seed sequences) for the same gene individually should also average out off-target effects 
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and show the effect of depletion of the gene of interest. This approach is generally applied to 
validate primary hits from genome-wide screens and can be performed in high-throughput. In 
research article IV we have tested up to 12 different RNAi reagents for all human kinases. We 
also found that the confidence to identify true positive hits directly correlates with the number of 
siRNAs tested. 
Once interesting candidate genes have been found, it is advisable to perform alternative 
validations. Complementation of the knockdown with an siRNA-resistant construct or 
inactivation of the target with small molecules are suitable approaches. Lately, the development 
of efficient genome-editing tools presents an attractive alternative to RNAi even though these are 
not yet readily applicable for genome-wide screening (14-16). Nevertheless, full loss-of-function 
studies of non-essential genes have become possible in a wide variety of mammalian cell types.   
 
4.1.2 Identification of host factors and pathways involved in Brucella infection 
 
Having identified the off-target effects in our siRNA screens, we set out to identify genes and 
pathways that are implicated in Brucella infection of human cells. Since we performed genome-
wide screens with both, pooled and unpooled siRNAs, we decided to analyze the data using the 
statistical method RSA which is independent of seed analysis and can also be applied to siRNA 
pools (5). It was previously reported that even though the overlap between hit lists of comparable 
screens is very low due to off-targets, identified pathways show a much better overlap (2). This is 
likely due to different off-target effects which cause distinct false positives and negatives 
depending on the siRNA library which is used. However, if relevant pathways are sufficiently 
well described in literature, they can be consistently identified even though some components 
might be missed in one or the other screen. Therefore, we performed gene enrichment analysis 
with the top ranking genes of the hit list generated by RSA. This identified several significantly 
enriched pathways, some of which were known to be important for Brucella infection.  
To validate individual genes we decided to re-screen interesting candidates with six additional 
siRNAs and one pool of siRNAs. This is a relatively high number of additional siRNAs 
considering that the primary screen already consisted of five different RNAi reagents. The aim 
was to reduce the false positive discovery rate and is based on our finding that hit detection 
directly correlates with the number of siRNAs tested per gene (research article IV). Some of the 
genes that were in the top ranks of the RSA analysis were directly selected for validation. A 
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second set of genes was chosen from enriched pathways. In this case, we also included pathway 
members that did not show a strong effect on Brucella infection in the primary screen reasoning 
that they might have been missed in the primary screen due to technical or off-target related 
reasons. Since these screens were performed in the framework of the InfectX consortium, we also 
re-screened all the genes that were selected by the other research groups which study different 
intracellular pathogens. This is beneficial in several ways; it provides sufficient negative controls 
which are important for plate normalization, it optimizes the use of siRNA reagents, and 
potentially allows for the identification of host factors shared between different intracellular 
pathogens.  
Applying this validation strategy, we could identify genes involved in Brucella infection in 
several cellular pathways. Some of these were previously reported, such as subunits of the v-
ATPase complex, Rab7A, Rac1, and Cdc42 (17-19). Furthermore, multiple components of 
pathways which have not been connected to Brucella infection previously could be identified. 
involved in TGF-β or FGF signaling, actin remodeling, endosome to Golgi transport, endocytic 
pathway, ER-Golgi bidirectional transport, ubiquitin conjugation, nucleotide metabolism, cell 
cycle, and clathrin coated pits were found in our top ranking gene lists suggesting a role of these 
pathways in Brucella infection. 
The genome-wide screen covered multiple aspects of the Brucella infection from entry into the 
host cell up to proliferation inside the replicative niche. To further understand the molecular role 
of the identified host factors during the infection process we performed an entry assay on some of 
the hits covering the major pathways. Most of the host factors that were selected showed a direct 
correlation of infection between the results of both assays indicating that depletion of these 
factors affects bacterial entry. This might seem surprising, because some of these genes have well 
known functions in intracellular trafficking, such as ER-Golgi bidirectional trafficking or 
endosome maturation. However, it is important to consider that depletion of vesicular trafficking 
components over the course of three days can cause secondary effects on several other trafficking 
routes including endocytic pathways. This was illustrated by the finding that the COPII complex, 
involved in ER-Golgi transport, is required for Salmonella invasion since it maintains cholesterol, 
sphingolipids, Rac1, and CDC42 at the plasma membrane (20). Similar phenomena could also 
apply to prolonged depletion of other components of vesicular trafficking that were tested here. 
As an example, depletion of Rab7, which has previously been implicated in Brucella trafficking 
(19), was found here to affect Brucella entry into HeLa cells.  
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To fully understand the role(s) of the identified host factors, additional experiments will be 
required. Especially for factors related to trafficking it will be important to study their effects on 
Brucella infection using methods that induce rapid perturbation to circumvent secondary effects. 
If available, the use of drugs or temperature sensitive mutants could be suitable approaches to 
unravel the exact role if individual components. In addition it will be interesting to follow 
Brucella infection in cells depleted for some of these host factors over time using live microcopy. 
This will help to understand whether depletion of a gene that was found to reduce invasion also 
perturbs later steps during infection. Tracking of individual bacteria will show whether the onset 
of cell division, intracellular survival rates, or the speed of intracellular replication are affected by 
depletion of certain host factors. 
Among the tested genes, only depletion of Vps35 did not affect Brucella entry of HeLa cells but 
reduced infection in the endpoint assay. Vps35 is an essential component of the retromer which is 
involved in vesicular transport from endosomes to the trans-Golgi network (TGN) and recycling 
of cargo to the plasma membrane (21-23). The importance of this pathway for Brucella infection 
was further validated by the use of the specific inhibitor Retro-2. This drug has been shown to 
selectively block retrograde trafficking of different toxins and human papillomaviruses from 
endosomes to the trans-Golgi-network (24, 25), without affecting the trafficking of other 
retrograde cargoes, the morphology of compartments, or other trafficking routes. We found that 
addition of the drug after Brucella entry into host cells could block intracellular replication. This 
emphasizes the importance of this pathway during a post-entry process of Brucella.  
It remains to be investigated whether the BCV traffics through this compartment before reaching 
its replicative niche, or whether this transport route delivers membranes or host factors which are 
required for intracellular proliferation. Until now, it has not been described that Brucella traffics 
through Golgi compartments, yet, the interaction might be very short-lived. Live imaging using 
fluorescently labeled Golgi and retromer markers might reveal such interactions and give 
indications whether bacteria that ultimately manage to replicate within a cell showed previous 
interactions with the retromer. Alternatively, Brucella might depend on retrograde transport to 
establish or maintain the replicative niche. In this case, chemical inhibition at later stages during 
the infection will give further insight into the exact mechanism of retrograde trafficking during 
Brucella infection.    
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4.2 ROLE OF MIRNAS IN PATHOGEN INFECTION 
4.2.1 miR-103/107 promote Brucella entry in non-phagocytic cells 
 
miRNAs are small RNA molecules that belong to the repertoire of regulatory elements for gene 
regulation in eukaryotic cells. They negatively affect target gene transcription by translational 
inhibition and destabilization of the mRNA (26). miRNAs act by partial base pairing of the 
miRNA to target mRNAs which allows each miRNA to regulate a large number of different 
transcripts. The binding specificity of a miRNA is largely determined by complementarity of the 
seed region to the target mRNA (4). The seed comprises a stretch of 6-8 nucleotides located at 
the 5’ end of the miRNA. While miRNAs are well known for their roles in developmental 
regulation or cell differentiation, there is increasing evidence for their involvement during 
pathogen infection (27).  
In order to investigate the role of human miRNAs in Brucella infection, we screened a library of 
over 1200 human miRNA mimics. We found that a large number of miRNAs affect Brucella 
infection when transfected into HeLa cells. Among those miR-103 and miR-107 (miR103/107) 
caused a striking increase in infection (research article III). This effect was visible early during 
infection, indicating that already entry into the host cell was enhanced. miR103/107 belong to a 
broadly conserved family of miRNAs (28) and transfection of a miR-103 mimic into mouse 
embryonic fibroblasts resulted in a similar increase of Brucella uptake. This suggests that in 
addition to the conservation of the miRNA itself, also the targets which protect cells from 
infection and are repressed by miR-103/107 are conserved. It will be interesting to test whether 
this effect is restricted to non-phagocytic cells or whether miR-103/107 also promotes Brucella 
infection in professional phagocytes such as macrophages.  
Even though miRNAs preferentially act by target recognition of the seed sequence, alternative 
miRNA-mRNA interactions have been described (29, 30). Because miR-103 and miR-107 share 
almost the same sequence it is not possible to distinguish whether the targets relevant for 
increased infection are recognized by the seed or other parts of the miRNA. Off-target analysis of 
the genome-wide siRNA screens indicated that miR-103/107 act via the seed sequence, since 
siRNAs sharing the seed with these miRNAs also strongly increased Brucella infection. To 
formally proof this, the seed sequence of miR-103 or miR-107 could be mutated and these 
variants could be tested for their effect on Brucella infection.  
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The information that the miRNA dependent phenotype is seed mediated can be used to predict 
potential targets since most prediction software rely on seed based miRNA-mRNA target 
interactions (31). However, the list of predicted targets is generally in the range of several 
hundred genes complicating direct target-phenotype associations. To experimentally determine 
the effect of miR-103/107 on cells we analyzed the proteome and transcriptome changes induced 
by transfection of miRNA mimics. We found an overall good correlation between mRNA and 
protein changes, which was even higher for the genes which are predicted to be direct targets. It 
is expected to find a higher correlation for direct targets, because secondary effects can be very 
diverse with distinct influences on protein and transcript abundance. Furthermore, both 
approaches showed that miR-103 targets predicted by different algorithms were down-regulated 
(31, 32). This is in agreement with the general notion that miRNAs destabilize the target mRNA 
und thereby reduce protein biosynthesis (33, 34).  
Proteome analysis revealed that several factors associated with the cell surface, such as TGF-β or 
FGF receptors, showed increased protein levels. This is also reflected in the gene ontology 
analysis of upregulated proteins, where terms such as insoluble fraction, cell adhesion, or plasma 
membrane were found to be significantly enriched. This indicated that the endocytic properties of 
cells could be altered when miR-103/107 levels are high, which is in agreement with the 
observation that clathrin-mediated endocytosis (CME) of transferrin was reduced in HeLa cells 
upon miR-103 transfection. It remains to be investigated whether this is caused by a reduced 
endocytosis rate or increased recycling of the receptor to the cell surface. Both scenarios could 
explain why certain proteins such as the TGF-β receptor 2 (TGFBR2), which undergo CME, 
were enriched (35). In this respect, it will be important to test the uptake of additional ligands 
which are endocytosed in a clathrin-dependent manner. Furthermore, protein quantification of the 
surface composition of cells transfected with miR-103/107 will show whether receptors are 
indeed enriched on the cell surface or stabilized in intracellular compartments.  
Interestingly, depletion of several components involved in CME was found to enhance Brucella 
infection in the genome-wide siRNA screen (research article V). This would be in line with the 
notion that reduced CME benefits Brucella infection but contradicts recent work by Lee et al. 
who found opposing effects (36). It remains to be investigated whether the different HeLa cell 
line or the specific biovar of B. abortus used in this study account for these inconsistencies. 
However, it is conceivable that Brucella favors clathrin-independent endocytic mechanisms to 
enter non-phagocytic cells. These could be induced to compensate for a reduction of CME. 
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Macropinocytosis, which is well-known for its role in bacterial uptake (37), was found to be 
upregulated in HeLa cells when CME was inhibited (38). It will thus be interesting to study the 
contribution of macropinocytosis and other endocytic mechanisms in the presence and absence of 
high levels of miR-103/107 to Brucella uptake in HeLa cells. 
Among the proteins upregulated by miR-103/107, TGFBR2 was found previously (research 
article IV) to be required for Brucella infection, and depletion of several components of the TGF-
β signaling pathway negatively affected Brucella entry into HeLa cells (research article V). We 
thus hypothesized that increased activity of this pathway could benefit Brucella infection. 
Overexpression of TGF-β receptors 1 and 2 or pretreatment of cells with the ligand TGF-β1 
indeed increased Brucella infection. The effects were not as pronounced as seen with transfection 
of miR-103/107 mimics, but it is conceivable that the increased TGFBR2 levels could account for 
parts of the phenomenon. Epistasis experiments with simultaneous transfection of miR-103/107 
mimics and siRNA depletion of TGFBR2 could give indications whether this hypothesis holds 
true. 
The expression of direct targets of a miRNA is generally repressed in the presence of the miRNA, 
while the surface receptors described above represent proteins which were upregulated upon 
increased cellular levels of miR-103/107. Thus, they are unlikely to qualify as direct targets. 
Among the genes which were repressed by miR-103/107 the strongest enrichment was found for 
proteins which are involved in cell cycle progression from G1 to S phase. In agreement with a 
function on cell cycle, it was previously reported that miR-103/107 can repress the growth of 
tumor cells (39, 40). Consistently, we found a mild reduction in HeLa cells number three days 
after transfection with miR-103/107 mimics, which was aggravated during the following two 
days. Since the reduction in cell number at the time of infection is only very mild, we can exclude 
that the observed increase in infection is caused by an increased ratio of bacteria to cells. It 
remains unclear whether alterations of the cell cycle are involved in the increased susceptibility 
of HeLa cells to Brucella infection. However, other miRNAs, such as members of the miR-15/16 
family, which also affect G1/S phase transition in a similar manner as miR-103/107, did not 
promote Brucella infection (41-43). 
Beside the cell cycle genes we could also identify factors which were down-regulated by miR-
103/107 on the protein level and identified in the genome-wide siRNA screen to promote 
infection upon depletion. Among those, three are predicted to be direct targets of miR-103/107 
and thus candidates that could underlie the phenotype. The most promising is NFIB, since 
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siRNA-mediated depletion caused a stronger increase in Brucella infection compared to 
knockdowns of MAP4 or PDE8B. NFIB is a transcriptional regulator of the nuclear factor I 
family which regulate a large number of genes involved in processes ranging from stem cell 
biology to brain development (44, 45). Again, siRNA mediated depletion of NFIB did only show 
a mild increase in Brucella infection suggesting that it could only account for parts of the 
phenotype. 
Taken together, it seems that not a single target underlies the strong induction of Brucella 
infection by transfection of miR-103/107 to non-phagocytic cells. This notion is supported by the 
observation that such as strong increase in infection could not be observed for any gene-specific 
knockdown in a consistent manner in the full genome-wide siRNA screen. Either, we were not 
able to identify this gene due to technical limitation such as off-target effects or this factor does 
not exist. The latter would suggest that simultaneous depletion of several host factors by miR-
103/107 acts synergistically. miRNAs are known for their pleiotropic effects and their capacity to 
strongly alter the transcriptome of a cell in the direction of cells which naturally express this 
miRNA (33). While miR-103/107 are broadly expressed throughout different tissues, it is 
difficult to directly correlate its role to cell type specific functions (28). It is conceivable that 
miR-103/107 alter the endocytic capacities or the surface composition of non-phagocytic cells in 
favor of Brucella uptake.  
To unravel the molecular network of miR-103/107 targets that underlie the full phenotype, 
combinatorial siRNA depletion studies could be employed. Promising candidates would be 
factors which were found depleted in miR-103/107 treated cells and are predicted to be direct 
targets. These include several transcription factors, cell cycle regulators, and individual genes 
with functions that could relate to membrane dynamics. In addition to siRNA depletion, also the 
use of chemical interference of certain functions such as the cell cycle, or specific endocytic 
pathways could give further indications of their importance during Brucella infection.  
 
4.2.2 miR-103/107 enhance infection of diverse intracellular pathogens 
 
Within InfectX, several research groups screened the miRNA mimics library for their effect on 
different bacterial and viral pathogens. We found that in addition to Brucella, also several other 
pathogens showed enhanced infection upon miR-103/107 transfection (research article III). 
These include Salmonella Typhimurium, Listeria monocytogenes, adenovirus, and rhinovirus, 
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which use a wide variety of different entry mechanisms and intracellular replication strategies 
(37). The screens that were performed with these organisms all covered cell invasion and further 
aspects of the intracellular life for the corresponding pathogens. It thus remains to be investigated 
whether pathogen entry into cells or a subsequent step of the infection is promoted by miR-
103/107. However, since all these pathogens need to gain access to the interior of the host cell 
and because this is the stage which we found affected during Brucella infection, it is conceivable 
that also the uptake of other organisms is promoted by miR-103/107. In support of this, several 
cell surface proteins which are required by distinct pathogens showed elevated protein levels in 
HeLa cells upon miR-103/107 transfection (research article III). We thus speculate that similar 
to Brucella, elevated entry levels could underlie the observed increase in infection for other 
pathogens. This would support the notion, that high levels of miR-103/107 affect cells in a way 
that generally promotes pathogen infection which could be explained by changed endocytic 
properties. 
Apart from Brucella, genome-wide siRNA screens were also performed with all the above 
mentioned bacterial and viral pathogens. This information has so far remained untapped for the 
efforts to identify the direct target(s) which underlie the effects of miR-103/107 on pathogen 
infection. The Brucella siRNA screen provided only limited candidates which at the same time 
showed increased infection upon siRNA knockdown, decreased protein levels upon miR-103/107 
transfection, and qualify as direct miR-103/107 targets. However, a similar analysis for the other 
pathogen screens could reveal additional factors which might have been missed in the Brucella 
screen for different reasons, one of which could be off-target effects. While we found that certain 
miRNA-like off-target effects have an impact on the infection of several pathogens, others can be 
very specific (research article II). Therefore, they could mask the identification of a host factor in 
one screen while others might be unaffected. A similar analysis of all those screens as presented 
here on the example of Brucella could thus help to identify the molecular components which 
underlie the increased susceptibility of cells to pathogen infection induced by miR-103/107. 
Because miR-103/107 are involved in the infection process of diverse intracellular pathogens 
they could be attractive targets for the development of novel intervention strategies to combat 
infectious diseases. Most antimicrobials directly target the pathogen, which is often associated 
with a rapid appearance of resistances (46). Strategies which interfere with host factors that are 
essential for the infection could potentially circumvent this problem and might also be used 
against different pathogens that depend on the same host function. To further investigate whether 
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miR-103/107 could be used as a target against infectious diseases, it will be important so study 
whether depletion of miR-103/107 renders cells less susceptible to pathogen infection. Especially 
cells which are infected by the pathogen in a natural setting should be studied. In the case of 
human brucellosis, bacteria reside in macrophages or dendritic cells before the spread to various 
tissues in later stages of the infection (47, 48). 
Because miR-103/107 is broadly conserved across vertebrates and we found that they promote 
Brucella infection in mouse cells it would be interesting to test whether inhibition of miR-
103/107 could protect mice from Brucella infection. To this end, miRNA inhibitors could be 
delivered to specific regions of the body, for example the liver, which contains high titer of 
Brucella in the mouse model (49-51).  
 
4.2.3 Perspectives on miRNA-like off-target analysis 
 
For the identification of direct targets which underlie the phenotype regulated by a miRNA 
different approaches can be followed. Bioinformatics predictions are readily available but contain 
many false positives, might miss relevant non-canonical targets, and from the long list of 
candidates it can be difficult to identify the one(s) involved in the process. Experimental 
procedures, such as mRNA sequencing of cells perturbed by the miRNA of interest, will yield a 
more comprehensive understanding of the cellular changes, but these also include indirect effects. 
Since such experiments are labor and resource intense, they can currently only be applied for 
selected miRNAs.  
For large RNAi datasets, like the ones that we have generated with the Brucella screens, it might 
be possible to narrow down the number of potential direct targets underlying the effect of certain 
miRNAs from the long list of bioinformatics predictions. We observed that miR-103/107 (seed: 
GCAGCAU) and miR-1184 (seed: CUGCAGC) strongly promote Brucella infection and all 
contain a GCAGC motif within their seed sequence (research article III). Two miRNAs with an 
identical sequence motif within the seed which is shifted by one or several positions could in 
principle bind to the same site on an mRNA if the nucleotides on the mRNA which flank the 
sequence motif are complementary to both miRNA seeds (in this case complementary to 
CUGCAGCAU). This potentially allows miR-1184 and miR-103/107 to regulate a partially 
overlapping set of target genes. Since only a subset of all possible miR-103/107 targets would 
also meet binding criteria for miR-1184, this information could be used to narrow down 
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candidates. Such an approach could be applied to all those miRNAs where shifted seed motifs in 
miRNA mimics and siRNAs are available in sufficiently high numbers to perform off-target 
analysis and gain confidence that the observed effects are dependent on the seeds of the 
molecules. 
Overall, we found that the effects of miRNA mimics strongly correlate with the mean effects of 
all siRNAs that share the same seed sequence, provided that the number of siRNA is sufficiently 
large to average out the on-target effects (research article II). This indicates that miRNAs mainly 
act via their seed sequence in our screens. However, for some miRNA mimics we found that this 
is not the case (data not shown). Technical problems of individual miRNA mimics or the unlikely 
case that many siRNAs that share the same seed sequence also target genes that are involved in 
the phenotype could account for such observations. Alternatively, the miRNA might not regulate 
the underlying targets of the phenotype via the seed region, but by alternative miRNA-mRNA 
interactions (29, 30). Therefore, it might be possible to identify miRNAs which affect a specific 
phenotype (e.g. cell viability or pathogen infection) by non-canonical miRNA-mRNA 
interactions. Depending on the availability of siRNAs which match different parts of this 
particular miRNA, it might even be possible to narrow down which part of the miRNA is 
required to bind the target(s). This could be achieved by searching for siRNAs which share 
certain conserved motifs with the miRNA and cause the same phenotypic effect upon 
transfection.  In analogy to the seed-analysis performed in research article II this could identify 
non-canonical miRNA-like off-target effects for very specific cases and shed more light on the 
molecular mechanisms of target recognition of miRNAs which are not seed mediated.  
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